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Abstract 
The methanogenic archaea are responsible for maintaining an efficient scheme of 
fermentation in many environments and habitats, including the gastrointestinal tracts of 
animals and humans. The principal members of gut methanogenic communities are members 
of the Methanobrevibacter genus, with lesser numbers of Methanosphaera and 
Methanomassiliicoccus spp. Much of our understanding of gut methanogens has been 
produced using axenic cultures and genomic data for ~30 Methanobrevibacter spp. but the 
functional relevance of these other archaeal lineages to digestive function remains poorly 
understood. With this background, the goals of my PhD research are: i) to increase the biotic 
representation of the Methanosphaera genus through the recovery of axenic isolates from 
different environments; ii) characterise the metabolic properties of these isolates in terms of 
their methanogenic pathways and; iii) expand our functional understanding of this genus via 
reconstruction of “population genomes” from existing metagenomic datasets and comparative 
genome analyses. During the latter stages of my PhD, I chose to make a transition in my 
research activities to include some biomedical focus and take advantage of my relocation to 
the University of Queensland Diamantina Institute. Here, I have examined variations in 
methanogenic archaeal populations in some clinical studies, as well as evaluated the 
immunostimulatory properties of some gut archaea. 
 
Chapter Two describes the enrichment, isolation, and pathways of methane formation by a 
strain of Methanosphaera sp. (WGK6) recovered from the Western Grey kangaroo 
(Macropus fulginosus). In contrast with the human isolate, strain WGK6 was found to utilize 
ethanol to support growth, but principally as a source of reducing power. Both the WGK6 
and Msp. stadtmanae DSMZ 3091
T
 genomes are very similar in terms of their size (~1.7 
Mbp), synteny, and G:C content. However, the WGK6 genome was found to encode 
contiguous genes encoding putative alcohol- and aldehyde- dehydrogenases, which are absent 
from the Msp. stadtmanae genome. These two genes provide a plausible explanation for the 
ability of WGK6 to utilize ethanol for methanol reduction to methane. Furthermore, my in 
vitro studies suggest that ethanol supports a greater cell yield per mol of methane formed 
compared to hydrogen-dependent growth. Taken together, this expansion in metabolic 
versatility can explain the persistence of these archaea in the kangaroo foregut, and their 
abundance in these “low methane emitting” herbivores.  
 
Chapter Three describes the isolation of a hydrogen-dependent methylotrophic archaeon 
assigned to the Methanosphaera genus from bovine animals in northern Australia (strain 
BMS). The BMS genome was sequenced to closure and surprisingly, found to be 
substantially larger (2.9 Mbp) than the WGK6 and Msp. stadtmanae genomes (~1.8 Mbp). I 
then interrogated metagenomic datasets produced from human stool and ruminant digesta 
samples, to recover 7 “population genomes” assigned to the Methanosphaera genus, with 5 
of these genomes also predicted to be large (> 2.1 Mbp). The Methanosphaera pan-genome 
consists of 5321 genes and 305 of these were assigned to the core-genome, which principally 
consists of the genes coordinating methanogenesis, anaerobic metabolism, and related 
functions. The whole genome phylogeny analysis of all genomes suggests a monophyletic 
origin for the genus Methanosphaera, with those isolates possessing smaller genomes being 
the most recently evolved lineages. 
 
Chapter Four investigates whether and how the composition of the methanogenic archaea in 
patients with chronic kidney disease is altered in response to synbiotic administration, as an 
intervention designed to mitigate uremic toxin production. The synbiotic intervention was 
found to have no measurable impact on the methanogen profiles of the patients, with 
Methanobrevibacter smithii the predominant archaeon and an infrequent occurrence of 
Methanomassiliicoccus, but no detectable populations of Methanosphaera spp. I also have 
assessed the immunogenic properties of Mbb. smithii DSMZ 861
T
, Msp. stadtmanae DSMZ 
3091
T
, Mbb. ruminantium DSMZ 1093
T
, and my new Methanosphaera isolates, using human 
peripheral blood mononuclear cells (PBMC) and a mouse macrophage cell line. I first 
showed that Msp. stadtmanae DSMZ 3091
T
 cell preparations produce a stronger TNF-α 
response from PBMC than Mbb. smithii DSMZ 861
T
, as well as the other Methanosphaera 
isolates WGK6 and BMS, but Mbb. ruminantium DSMZ 1093
T
 cells produced the strongest 
TNF-α response. In subsequent studies using methanogen cell preparations and different 
sources of PBMC (also from healthy subjects) I measured the release of a broader range of 
cytokines, using a multi-bead array and flow cytometry techniques. In these studies, Mbb. 
smithii DSMZ 861
T
 was more immunogenic compared to Msp. stadtmanae DSMZ 3091
T
, but 
both types of cells induce a similar cytokine profile from the PBMC preparations. Last, I used 
a murine macrophage cell line bearing a reporter gene activated by the NF-κB transcription 
system, which further confirmed that cell preparations of all these archaea induce reporter 
gene activation via this important pathway of stress response. Collectively, these results 
suggest all these methanogens possess immunostimulatory properties that remain cell 
associated, and the findings are discussed with respect to gastrointestinal inflammation and 
also the development of anti-methanogen vaccines.  
 
Chapter 5 provides an integrative overview of the findings arising from my research, which 
provide a deeper understanding into the genus Methanosphaera, in terms of its evolutionary 
development, nutritional ecology, and host adaptation. I believe my findings are novel and 
provide new insights into the role of methanogenic archaea in gut function; and this 
knowledge will be useful to address key challenges facing agriculture (e.g. methane 
abatement strategies) and human health (e.g. as triggers of inflammation and immune 
response in gut and respiratory disease). 
  
Declaration by author 
This thesis is composed of my original work, and contains no material previously published 
or written by another person except where due reference has been made in the text. I have 
clearly stated the contribution by others to jointly-authored works that I have included in my 
thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical 
assistance, survey design, data analysis, significant technical procedures, professional 
editorial advice, and any other original research work used or reported in my thesis. The 
content of my thesis is the result of work I have carried out since the commencement of my 
research higher degree candidature and does not include a substantial part of work that has 
been submitted to qualify for the award of any other degree or diploma in any university or 
other tertiary institution. I have clearly stated which parts of my thesis, if any, have been 
submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University 
Library and, subject to the policy and procedures of The University of Queensland, the thesis 
be made available for research and study in accordance with the Copyright Act 1968 unless a 
period of embargo has been approved by the Dean of the Graduate School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the copyright 
holder(s) of that material. Where appropriate I have obtained copyright permission from the 
copyright holder to reproduce material in this thesis. 
 
Publications during candidature 
Published peer-reviewed papers 
Hoedt EC, Ó Cuív P, Evans PN, Smith WJM, McSweeney C, Denman SE, and Morrison M 
(2016). Differences down-under: alcohol-fuelled methanogenesis by archaea present in 
Australian macropodids. ISME Journal DOI: 10.1038/ismej.2016.41. Writing from this 
manuscript has been incorporated into Chapter 2. 
 
Published peer-reviewed literature reviews  
Hoedt EC, Evans PN, Denman SE, McSweeney C, Ó Cuív P, and Morrison M (2015). 
Methane matters in animals and man: from beginning to end. Microbial Australia 36:4 DOI: 
10.1071/MA15003. Writing from this manuscript has been incorporated into Chapter 1. 
 
Hoedt EC, Ó Cuív P, and Morrison M (2016). Methane Matters: from blue-tinged moos, to 
boozy roos, and the health of humans too. Animal Frontiers 6:3 DOI 10.2527/af.2016-0029. 
Writing from this manuscript has been incorporated into Chapter 1, 4 and 5. 
 
Conference abstracts  
Hoedt EC, Smith W, Evans P, Ó Cuív P and Morrison M: An ethanol-dependent pathway of 
methanol reduction to methane in a newly isolated Methanosphaera sp. from the Western 
Grey kangaroo. 4
th
 ASM Conference on Beneficial Microbes, 2012 Oct. 22 – 26; San 
Antonio, TX, USA.  
 
Hoedt EC, Ó Cuív P, and Morrison M: Newly isolated Methanosphaera sp. and 
Methanoplasmatales sp. from Australian bovine. CGIF Congress on Gastrointestinal 
Function, 2013 April 15-17; Chicago, USA. QAAFI Animal Science Olympics, 2013 July 
26; Brisbane, Australia. 
 
Hoedt EC, Ó Cuív P, and Morrison M: Newly isolated Methanosphaera sp. and 
Methanoplasmatales sp. from Australian bovine. MLA postgraduate student conference, 
2013 October 4-7; Coffs Harbor, Australia.  
Hoedt EC, Ó Cuív P, Evans P, Denman SE, Smith W, and Morrison M: The foregut 
microbiota of kangaroos include methylotrophic methanogens that can also use ethanol to 
support methanogenesis and growth. ISME 15 conference, 2014 August 24-29; Seoul, South 
Korea. 
 
Hoedt EC, Ó Cuív P, Wheeler L, Lacaze P, and Morrison M: A novel isolate of 
Methanosphaera sp. isolated from cattle possesses a large genome compared to methanogens 
isolated from other gut environments. MLA postgraduate student conference, 2014 
November 2-6; Manly, NSW, Australia.  
 
Hoedt EC, Ó Cuív P, Park DH, Tyson GW and Morrison M, Expansion of the genus 
Methanosphaera reveals a greater metabolic versatility relevant to host adaptation. MLA 
postgraduate student conference, 2015 November 1-5; Manly, NSW, Australia. 
  
Publications included in this thesis 
Hoedt EC, Evans PN, Denman SE, McSweeney C, Ó Cuív P, and Morrison M (2015). 
Methane matters in animals and man: from beginning to end. Microbial Australia 36:4 doi: 
10.1071/MA15003. Writing from this manuscript has been incorporated into Chapter 1. 
 
Contributor Statement of contribution 
Author Hoedt EC (Candidate) Wrote the paper (50%) 
Author Evans PN  Edited paper (5%) 
Author Denman SE Edited paper (5%) 
Author McSweeney C Edited paper (5%) 
Author Ó Cuív P Edited paper (5%)  
Author Morrison M Wrote and edited paper (30%) 
 
Hoedt EC, Ó Cuív P, Evans PN, Smith WJM, McSweeney C, Denman SE, and Morrison M 
(2016). Differences down-under: alcohol-fuelled methanogenesis by archaea present in 
Australian macropodids. ISME Journal doi: 10.1038/ismej.2016.41. Writing from this 
manuscript has been incorporated into Chapter 2. 
 
Contributor Statement of contribution 
Author Hoedt EC (Candidate) Designed experiments (60%) 
Wrote the paper (70%) 
Author Ó Cuív P Designed experiments (5%) 
Author Evans PN Designed experiments (5%) 
Author Smith WJM Illumina 454 genome preparation 
Author McSweeney C Supported research 
Author Denman SE Assembled Illumina 454 output 
Author Morrison M 
Designed experiments (30%) 
Wrote and edited paper (30%) 
 
Hoedt EC, Ó Cuív P, and Morrison M (2016). Methane Matters: from blue-tinged moos, to 
boozy roos, and the health of humans too. Animal Frontiers 6:3 DOI 10.2527/af.2016-0029. 
Writing from this manuscript has been incorporated into Chapter 1, 4 and 5. 
 
Contributor Statement of contribution 
Author Hoedt EC (Candidate) Wrote the paper (60%) 
Author Ó Cuív P Edited paper (10%) 
Author Morrison M Wrote and edited paper (30%) 
 
Contributions by others to the thesis  
Dr Paul Evans collected Western Grey kangaroo digesta samples in 2008 used for isolation 
work, Wendy Smith assisted with the 454 sequencing of Methanosphaera sp. WGK6 and Dr 
Stuart Denman assembled the resulting genomic data in Chapter 2. Dr Páraic Ó Cuív 
assembled the PacBio sequence data for Methanosphaera sp. BMS genome in Chapter 3. Dr 
Anh Do assisted with the calibration of the BD LSR II fluorescence-assisted cell sorter and 
Sian Pottenger cultured the RAW264.7 macrophage cell line in preparation for assay work 
detailed in Chapter 4. All work presented here was critically revised by my primary 
supervisor Prof. Mark Morrison.  
 
Statement of parts of the thesis submitted to qualify for the award of another degree 
The content presented in Chapter Two, page 17 paragraph 3 to page 21 paragraph 1 has also 
been presented as part of a BSc Honours at the University of Queensland with the degree 
awarded on the 19
th
 December 2011. 
Acknowledgements 
To my supervisors, I am so grateful for all the guidance and support given to me over the 
years. Words cannot express how grateful I am to my primary supervisor Professor Mark 
Morrison for accepting me into his group when I was just an undergraduate and providing me 
invaluable mentorship over the years, I couldn’t have achieved what I have without it. To Dr 
Phil Hugenholtz and Dr Gene Tyson I’m very grateful for their support and openness to 
discuss any new ideas as well as their invaluable scientific experience.  
 
To the people working at CSIRO, thank you all for your support and friendship over the 
years. Special mentions to go to Dr Stuart Denman for advice on many different technical 
aspects; Chris McSweeney for allowing me to stick around the lab even after my move to UQ 
Diamantina Institute at the Translational Research Institute. Jane Cheung, Wendy Smith and 
Leanne Dierens also deserve honourable mentions for their friendship, help and chocolate 
over the years. 
 
To everyone within Diamantina Institute I am very grateful for your support, but a special 
mention goes to Dr Páraic Ó Cuív for the many discussions of scientific ideas over the years. 
This thank you also extends to Dr Erin Shanahan, Dr Anh Do, Dr Ashok Raj and Sian 
Pottenger for jumping into the world of immunology with me. I would also like to thank 
everyone at Australian Centre for Ecogenomics for teaching me the computational aspects of 
biology, in particular Donovan Parks, Rochelle Soo, Caitlin Singleton and Nancy Lachner. 
Paul Evans deserves an extra special mention for teaching me anaerobic techniques and 
remaining sane after all the years of questions. 
 
To my family and friends all of your love, support and food over the years are responsible for 
keeping me on track during this emotional rollercoaster; I couldn’t have done it without all of 
you. From the very bottom of my heart thank you. 
 
Finally, I gratefully acknowledge the scholarships provided by the University of Queensland 
Australian Postgraduate Award system as well as the Meat and Livestock Industry for also 
providing a top-up and technical assistances grant without which my PhD would not have 
been possible. 
Keywords 
methanogen, methane, macropodid, ruminant, human, Methanosphaera, population genome, 
pan-genome, immunostimulatory 
 
Australian and New Zealand Standard Research Classifications (ANZSRC) 
ANZSRC code:  060503 Microbial Genetics, 20% 
ANZSRC code:  060309 Phylogeny and Comparative Analysis, 30% 
ANZSRC code:  060599 Microbiology not elsewhere classified, 50% 
 
Fields of Research (FoR) Classification 
FoR code: 0603 Evolutionary Biology, 20% 
FoR code: 0604 Genetics, 20% 
FoR code: 0605 Microbiology, 60% 
  
Table of contents  
Abstract ...................................................................................................................................... ii 
Declaration by author ................................................................................................................. v 
Publications during candidature ................................................................................................ vi 
Publications included in this thesis .......................................................................................... vii 
Contributions by others to the thesis ......................................................................................... ix 
Statement of parts of the thesis submitted to qualify for the award of another degree ............. ix 
Acknowledgements .................................................................................................................... x 
List of figures in the thesis ..................................................................................................... xvii 
List of tables in the thesis........................................................................................................ xix 
List of abbreviations used in the thesis .................................................................................... xx 
Chapter 1 Introduction and Literature Review .......................................................................... 1 
1.2 Methane emissions, methanogenic archaea and the ruminant host ............................. 3 
1.3 Australia’s macropodids as the “low” methane agricultural model ............................ 5 
1.4 Interactions between methanogenic archaea and the human host ............................... 6 
1.5 Summary and research goals ....................................................................................... 9 
Chapter 2 Differences down-under: alcohol-fuelled methanogenesis by archaea present in 
Australian macropodids ........................................................................................................... 11 
2.1 Introduction ............................................................................................................... 11 
2.2 Materials and Methods .............................................................................................. 12 
2.2.1 Animal sampling protocol and digesta preservation. ......................................... 12 
2.2.2 DNA extraction and PCR-DGGE analysis of Western grey kangaroo digesta 
samples. 12 
2.2.3 Enrichment and isolation of Methanosphaera sp. WGK6 ................................. 13 
2.2.4 Substrate utilization tests for strain WGK6 and Methanosphaera stadtmanae 
DSMZ 3091
T
 .................................................................................................................... 13 
2.2.5 Comparative growth studies with Methanosphaera stadtmanae strain DSMZ 
3091
T
 14 
2.2.6 Taxonomic assignment of strain WGK6, genome sequencing and analysis ..... 15 
2.2.7 RT-PCR analysis of WGK6 alcohol (walc) and aldehyde (wald) dehydrogenase 
gene expression................................................................................................................. 16 
2.2.8 Taxonomic assignment of WGK6 alcohol and aldehyde dehydrogenase genes 17 
2.3 Results ....................................................................................................................... 17 
2.3.1 Analysis of foregut digesta samples and isolation of Methanosphaera sp. 
WGK6 17 
2.3.2 Alcohol-fuelled methanogenesis by Methanosphaera sp. WGK6 .................... 20 
2.3.3 Alcohol-fuelled methanogenesis is coupled with ethanol utilization and acetate 
formation by Methanosphaera sp. WGK6 ....................................................................... 22 
2.3.4 The WGK6 genome encodes dehydrogenase genes that are absent from the 
DSMZ 3091
T
 genome ....................................................................................................... 25 
2.3.5 The walc and wald genes are constitutively expressed and cotranscribed by 
Methanosphaera sp. WGK6. ............................................................................................ 26 
2.3.6 Orthologs of the dehydrogenase genes from strain WGK6 are also present in 
other members of the Methanobacteriales. ....................................................................... 27 
2.4 Discussion ................................................................................................................. 31 
2.5 Published journal article detailing work carried out in Chapter 2............................. 36 
Chapter 3 Culture- and metagenomics-based expansion of the genus Msp. reveals their 
evolutionary depth and metabolic versatility ........................................................................... 37 
3.1 Introduction ............................................................................................................... 37 
3.2 Materials and Methods .............................................................................................. 38 
3.2.1 Animal sampling, enrichment and isolation of Methanosphaera sp. BMS ....... 38 
3.2.2 Methanosphaera sp. BMS substrate utilization and growth kinetics ................ 39 
3.2.3 Methanosphaera sp. BMS genome sequencing and closure ............................. 40 
3.2.4 Nucleotide pattern analysis and Mauve alignment of Methanosphaera genomes
 40 
3.2.5 Comparative analyses of Methanosphaera spp. genomes ................................. 41 
3.2.6 Retrieval of Methanosphaera population genomes using MetaBAT ................ 41 
3.2.7 Whole genome phylogeny ................................................................................. 42 
3.2.8 Comparative analysis of select functional gene sets across all Methanosphaera 
spp. isolate and population genomes ................................................................................ 42 
3.2.9 Average nucleotide identity matrix and pan/core development plot ................. 42 
3.3 Results ....................................................................................................................... 43 
3.3.1 Methanosphaera sp. BMS is a hydrogen-dependent methylotroph................... 43 
3.3.2 The Methanosphaera sp. BMS genome is larger than the DSMZ 3091
T
 and 
WGK6 genomes ............................................................................................................... 45 
3.3.3 Genome “barcode” validates fidelity of Methanosphaera sp. BMS assembly .. 47 
3.3.4 Methanosphaera sp. BMS has a larger mobilome compared to other 
Methanosphaera isolates .................................................................................................. 48 
3.3.5 The Methanosphaera population genomes extracted from other metagenome 
sequence datasets are comprised of two “genomotypes” ................................................. 53 
3.3.6 All Methanosphaera isolate and population genomes possess a high degree of 
synteny 55 
3.4 Discussion ................................................................................................................. 67 
Chapter 4 Variations in Methanobrevibacter and Methanosphaera spp. populations in clinical 
studies and assessment of their immunomodulatory properties .............................................. 72 
4.1 Introduction ............................................................................................................... 72 
4.2 Materials and Methods .............................................................................................. 74 
4.2.1 Samples from the SYNERGY study .................................................................. 74 
4.2.2 Clinical samples from healthy subjects.............................................................. 74 
4.2.3 PBMC isolation procedures ............................................................................... 75 
4.2.4 Faecal DNA extraction, PCR and qPCR methods ............................................. 75 
4.2.5 Methanogen culture and cell preparations ......................................................... 76 
4.2.6 ELISA-based assay of TNF-α release from PBMC following methanogen 
challenge ........................................................................................................................... 77 
4.2.7 PBMC cytokine release in response to Mbb. smithii DSMZ 861
T
 and Msp. 
stadtmanae DSMZ 3091
T
 cell preparations using the Biolegend LEGENDplex bead 
array 78 
4.2.8 RAW264.7 cell preparation and NF-κB ELAM luciferase assay ...................... 79 
4.2.9 Statistical analyses ............................................................................................. 80 
4.3 Results ....................................................................................................................... 80 
4.3.1 Synbiotic treatment of CKD patients has no effect on abundance or composition 
of the methanogen community ......................................................................................... 81 
4.3.2 The TNF-α release from PBMC varies in response to challenge with the 
different methanogens ...................................................................................................... 83 
4.3.3 The cytokine profiles released from the PBMC of healthy subjects was similar, 
in response to Msp. stadtmanae DSMZ 3091
T
 and Mbb. smithii DSMZ 861
T
 cells, and 
LPS 85 
4.3.4 The five methanogen cell preparations induce similar NF-κB activated 
responses from RAW264.7 macrophage cells .................................................................. 88 
4.3.5 The NF-κB response of RAW264.7 cells to Msp. stadtmanae DSMZ 3091T and 
Mbb. smithii DSMZ 861
T
 is limited to whole cell preparations ....................................... 89 
4.4 Discussion ................................................................................................................. 90 
Chapter 5 General discussion................................................................................................... 99 
Chapter 6 Appendix ............................................................................................................... 108 
6.1 Western Grey kangaroo digesta sample descriptions .............................................. 108 
6.2 Glycerol 30% stock solution ................................................................................... 109 
6.3 Dissociation of cells from plant material ................................................................ 110 
6.4 RBB+C DNA extraction method ............................................................................ 111 
6.5 Primers used for during thesis ................................................................................. 112 
6.6 DGGE denaturing solutions .................................................................................... 113 
6.7 BRN-RF30 media recipe ......................................................................................... 114 
6.8 Antibiotic stock solution benzyl penicillin and streptomycin sulfate ..................... 115 
6.9 Sequence cleaning protocol ..................................................................................... 116 
6.10 BRN-RF10 medium recipe...................................................................................... 117 
6.11 The basic annotations for both WGK6 and DSMZ 3091
T
 ...................................... 119 
6.12 Values and equations used to calculate Gibbs free energy ..................................... 121 
6.13 High molecular weight DNA extraction for Msp. sp. BMS .................................... 122 
6.14 NCBI SRA chosen for MetaBAT ........................................................................... 124 
6.15 PBMC extraction from whole blood diagram ......................................................... 126 
6.16 Standard curves for LEGENDplex cytokine ........................................................... 127 
6.17 LEGENDplex statistics ........................................................................................... 129 
Chapter 7 References ............................................................................................................. 133 
 
  
List of figures in the thesis 
Figure 1.1. An extract from Liu and Whitman (2008) ............................................................... 2 
Figure 1.2. The three different metabolic schemes for methanogenesis .................................... 3 
Figure 2.1. Nested PCR-DGGE analysis ................................................................................. 18 
Figure 2.2. Photomicrographs of Msp. sp. WGK6 .................................................................. 19 
Figure 2.3. Phylogenetic analysis of the 16S rRNA gene sequence for strain WGK6 ............ 20 
Figure 2.4. Growth of Msp. sp. WGK6 and Msp. stadtmanae DSMZ 3091
T
 .......................... 22 
Figure 2.5. Longitudinal monitoring of the utilization of ethanol or H2, and methanol, as well 
as the formation of acetate and methane .................................................................................. 24 
Figure 2.6. Alignment of the Msp. stadtmanae DSMZ 3091
T 
and Msp.sp. WGK6 genomes . 26 
Figure 2.7. RT-PCR analysis of the walc and wald transcripts ............................................... 27 
Figure 2.8. The phylogenetic tree of alcohol dehydrogenase genes ........................................ 29 
Figure 2.9. The phylogenetic tree of aldehyde dehydrogenase genes ..................................... 30 
Figure 2.10. Comparison of the genes flanking the alcohol and aldehyde dehydrogenase 
genes ........................................................................................................................................ 31 
Figure 2.11. A model for methanol reduction via hydrogen or ethanol .................................. 33 
Figure 3.1. Photomicrographs of Msp. sp. BMS...................................................................... 43 
Figure 3.2. Longitudinal monitoring of the growth of Msp. stadtmanae DSMZ 3091
T
, strain 
BMS and strain WGK6 ............................................................................................................ 44 
Figure 3.3. The degree of genome synteny evident between the Msp. stadtmanae DSMZ 
3091
T
, WGK6 and BMS genomes ........................................................................................... 47 
Figure 3.4. The tetramer nucleotide frequency distributions (“barcode”) patterns ................. 48 
Figure 3.5. Venn diagram depiction of the core, shared and unique genes ............................. 50 
Figure 3.6. Linear representations of the genomes of DSMZ 3091
T
, WGK6 and BMS ......... 52 
Figure 3.7. Mauve alignments of the “small” (< 2.0 Mbp) genomes ...................................... 56 
Figure 3.8. Mauve alignments of the “large” (> 2.1 Mbp) Msp. spp. population genomes .... 57 
Figure 3.9. The whole genome phylogenetic tree .................................................................... 58 
Figure 3.10. The phylogenetic tree of methyl-coenzyme M reductase component A2 ........... 59 
Figure 3.11. EDGAR software alignment of gene regions containing the energy conserving 
hydrogenase gene ..................................................................................................................... 60 
Figure 3.12. The phylogenetic tree of energy conserving hydrogenase gene .......................... 61 
Figure 3.13. The clustalW alignment for the aldehyde and alcohol dehydrogenase genes ..... 63 
Figure 3.14. The average nucleotide identity matrix ............................................................... 68 
Figure 3.15. Development plots depicting the growth of the core and pan-genome ............... 70 
Figure 4.1. ELISA-based measurement of the concentrations of TNF-α released into culture 
fluids from PBMC, in response to 4 hours challenge .............................................................. 84 
Figure 4.2. ELISA-based measurement of the concentrations of TNF-α released into culture 
fluids from PBMC, in response to 12 hours challenge ............................................................ 85 
Figure 4.3. Cytokines concentration profiles produced from the PBMC harvested from three 
donors (HMI004-006) as determined using the LEGENDplex assay ..................................... 87 
Figure 4.4. The qPCR Melt curve for positive control Mbb. smithii ....................................... 88 
Figure 4.5. The immunomodulatory response of RAW264.7 mouse macrophage cells in 
response to whole cell preparations of the 5 methanogen strains ............................................ 89 
Figure 4.6. The immunomodulatory response of RAW264.7 mouse macrophage cells in 
response to either whole cells, cell washes, or the residual medium fluids ............................. 90 
Figure 5.1. Phylogenetic analysis of Msp. spp. isolate and clone 16S rRNA gene ............... 103 
Figure 6.1. The standard curves for each of the 13 cytokines assayed with the LEGENDplex
................................................................................................................................................ 128 
  
List of tables in the thesis 
Table 3.1. General genome features for Msp. isolate genomes DSMZ 3091
T
, WGK6 and 
BMS ......................................................................................................................................... 46 
Table 3.2. Comparison of the COG categories for Msp. isolates ............................................ 51 
Table 3.3. Summary statistics of the Msp. isolate and MetaBAT-recovered population 
genomes ................................................................................................................................... 54 
Table 3.4. Gene counts for CAZyme families ......................................................................... 65 
Table 3.5. Profile of genes assigned to encode pathways for ammonia assimilation. ............. 67 
Table 4.1. The prevalence and composition of the methanogen populations present in stool 
samples collected from patients enrolled in the SYNERGY study ......................................... 82 
Table 4.2. Glycosyltransferase protein gene counts ................................................................ 96 
Table 4.3. Total protein concentrations for 0.5 mg/mL of dry weight .................................... 98 
Table 6.1. Description of Western Grey kangaroos sampled ................................................ 108 
Table 6.2. Primers used during this thesis. ............................................................................ 112 
Table 6.3. Basic genome annotations of isolate Msp. strains WGK6 and DSMZ 3091
T
 ...... 119 
Table 6.4. Gibbs free energy equation ................................................................................... 121 
Table 6.5. The NCBI SRA projects ....................................................................................... 124 
Table 6.6. Statistics for cytokines .......................................................................................... 129 
 
  
List of abbreviations used in the thesis 
∆G°’   Gibbs free energy 
µ   specific growth rate 
µg   microgram 
µL   microliter 
µmax   maximal growth rate 
16S rRNA   16S ribosomal RNA 
AA   auxiliary activity  
alc   alcohol dehydrogenase  
ald   aldehyde dehydrogenase  
ANI   average nucleotide identity  
asd   aspartate dehydrogenase 
BLASTn  basic local alignment search tool- nucleotide  
BLASTp  basic local alignment search tool- protein  
BMS   Brahman Methanosphaera isolate  
bp   base pair 
BRN-RF10  Balch – 10% rumen fluid medium 
BRN-RF30  Balch – 30% rumen fluid medium 
BSA   bovine serum albumin 
CAZyme  carbohydrate-active enzymes 
CBM   carbohydrate-binding module  
cDNA   complementary DNA 
CE   Carbohydrate esterase 
CH3CH2OH  ethanol 
CH3CHO  acetaldehyde  
CH3CO2
-  
acetate  
CH3OH   methanol  
CH3-S-CoM   2-(methylthio)ethanesulfonic acid  
CH4   methane 
CKD   chronic kidney disease  
COG   clusters of orthologous groups 
CoM-S-S-CoB  coenzyme M-HTP heterodisulfide  
CSIRO  Commonwealth scientific and industrial research organisation 
DEW79  diabetic European women Methanosphaera population genome 79 
DGGE   denaturing gradient gel electrophoresis  
DSMZ 1093
T
  Methanobrevibacter ruminantium strain M1 
DSMZ 3091
T
  Methanosphaera stadtmanae  
DSMZ 861
T
  Methanobrevibacter smithii strain PS 
e
-
    electron  
EDGAR efficient database framework for comparative genome analyses using 
BLAST score ratios 
EDTA   ethylenediaminetetraacetic acid 
ehaRST  energy conserving hydrogenase 
ESRD   end stage renal disease  
fno   F420:NADP oxidoreductase 
frhADGB  F420-reducing hydrogenase complex 
GC   gas chromatograph 
GDH   glutamate dehydrogenase 
GH   glycoside hydrolase 
GS1   glutamine synthetase gene Type 1 
GS-GOGAT  glutamine synthetase-glutamate synthase pathway 
GT   glycosyltransferase  
H
+
    hydrogen proton 
H2   hydrogen  
H2O   water  
HdrABC   heterodisulfide reductase  
HS-CoB   coenzyme B 
HS-CoM   coenzyme M 
hyp   hypothetical protein  
IBD   inflammatory bowel disease 
IBS   irritable bowel syndrome  
IBS-C   irritable bowel syndrome- constipation  
IBS-D   irritable bowel syndrome- diarrhoea  
IBS-M   irritable bowel syndrome- both constipation and diarrhoea 
IFNα    interferon alpha 
IFNγ    interferon gamma 
IgG   immunoglobulin G 
IHT   interspecies hydrogen transfer 
IL-10   interleukin-10 
IL-12p70  interleukin-12 p70 
IL-17A  interleukin-17A 
IL-18   interleukin-18 
IL-1β   interleukin-1β 
IL-23    interleukin-23 
IL-33   interleukin-22 
IL-6   interleukin-6 
IL-8   interleukin-8 
JTT   Jones-Taylor-Thornton 
Kb   kilo bases 
KEGG   Kyoto Encyclopedia of Genes and Genomes 
KJ/mol  kilo joules per mole 
kPa   kilo pascal 
KS   substrate affinity  
LPS   lipopolysaccharide 
map   methionine aminopeptidase 
Mbb.   Methanobrevibacter  
Mbp   mega base pair 
MCP-1  monocyte chemoattractant protein-1 
mL   millilitre  
mM   millimolar  
Mms.   Methanomassiliicoccus  
moDCs  monocyte-derived dendritic cells 
mrtABG   methyl-coenzyme M reductase  
Msp.   Methanosphaera  
MtaABC   coenzyme M methyltransferase 
mtaB1   methanol-cobalamin methyltransferase 
MvhADG   non-F420-reducing hydrogenase 
NADPH  nicotinamide adenine dinucleotide phosphate-oxidase 
NAFLD   non-alcoholic fatty liver disease  
NCBI   national centre for biotechnology information 
NF-κB   nuclear factor- kappa beta 
nifH   nitrogenase reductase 
nm   nanometres 
OD600   optical density at 600nm 
omp   outer membrane protein 
PBMC   peripheral blood mononuclear cells 
PBS   phosphate-buffered saline 
PCR   polymerase chain reaction 
PL   polysaccharide lyase 
qPCR   quantitative polymerase chain reaction 
RAST   rapid annotation using subsystem technology 
RBB+C  repeated bead beating plus column  
rholeuAM130  Rhodes and leucine bovine Methanosphaera population genome 130 
rholeuAM270  Rhodes and leucine bovine Methanosphaera population genome 270 
rholeuAM6  Rhodes and leucine bovine Methanosphaera population genome 6 
rholeuAM74  Rhodes and leucine bovine Methanosphaera population genome 74 
RNA   ribonucleic acid 
rRNA   ribosomal ribonucleic acid 
S   concentration of the limiting substrate for growth 
SEM   standard error of mean 
SHI1033  ovine Methanosphaera population genome 1033 
SHI613  ovine Methanosphaera population genome 613 
SRA   sequence read archives 
Tg   trillion grams  
TMAO  trimethylamine-oxide 
TNF-α   tumour necrosis factor alpha 
UV   ultra violet  
vol   volume 
WGK6   Western Grey kangaroo isolate 6 
 
 1 
 
Chapter 1 Introduction and Literature Review 
1.1 Methanogenic archaea, their niche and biochemistry 
The world’s societies are being challenged to reduce their greenhouse gas emissions, in 
response to global concerns about our impacts on the environment and climate change. 
Methane is recognized to be a potent greenhouse gas, and much of it arises during anaerobic 
decomposition of organic matter by the microbial world. The processes governing 
methanogenesis reside within members of the Archaea and more specifically, the phylum 
Euryarchaeota. Five orders of methanogens have long been recognized: Methanopyrales, 
Methanococcales, and Methanobacteriales (class I); the Methanomicrobiales (class II) 
(Bapteste et al., 2005); and the Methanosarcinales (class III) (Anderson et al., 2009). 
However, this has since expanded to recognise Methanocellales (Sakai et al., 2008) as well as 
the recently proposed seventh order of methanogens Methanomassiliicoccales (Paul et al., 
2012, Oren and Garrity, 2013). The role methanogens play within microbial communities 
supports the recycling of complex organic materials through a 'three-step process’ of 
bioconversion (Fig. 1.1) in which methanogenesis is the final step (Liu and Whitman, 2008).  
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Figure 1.1. An extract from Liu and Whitman (2008) demonstrating the ‘three step process’ 
for the anaerobic breakdown of complex organic matter within a methanogenic microbial 
community.  
 
While the metabolic versatility of the members of each order of methanogens may differ, 
methanogenesis is only known to occur through three different processes: the carbon dioxide-
reduction, methyl-group reduction and acetic acid cleavage (acetoclastic) reactions (Fig. 1.2 
(Liu and Whitman, 2008, Thauer et al., 2008)). Not surprisingly then, methanogens are found 
in many environments, especially those where sulphate is limiting; including fresh water 
sediments and rice paddies, landfills, moist soil biomes, the human, animal and some insect 
gastrointestinal tracts and their waste streams (Edwards and McBride, 1975, Liu and 
Whitman, 2008, Evans et al., 2009). Although the presence and role of methanogenic archaea 
in gut environments has long been recognized, greater attention has been directed to studying 
methanogens from other environments. It is only in recent years that there has been a 
renewed interest in gut methanogens, driven in part by the desire to reduce livestock methane 
emissions, as well as the possibility that methanogens might influence human gut function 
and health.  
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Figure 1.2. The three different metabolic schemes for methanogenesis: hydrogenotrophic 
(carbon dioxide or formate reduction, red arrows); acetoclastic (green arrows); methyl group 
reduction (disproportionate reaction solid blue arrows or hydrogen-dependant reduction 
broken blue arrows). Modified from Professor Dr. Michael Rother, Dresden University of 
Technology and Welander and Metcalf (2005).  
 
1.2 Methane emissions, methanogenic archaea and the ruminant host 
Various studies have reported that the global annual methane production ranges from 500-
600 Tg (trillion grams); as much as 20% of this amount is currently attributed to ruminant 
livestock such as cattle, sheep, deer and goats (Lowe, 2006). The global demand for meat and 
milk is predicted to increase by 60% before 2050, in response to the world’s growing human 
population (2012). Australia in particular has been identified as one of the world’s largest 
producers of greenhouse gases on a per-capita basis (Garnaut, 2008) and methane emissions 
from ruminant livestock are now being targeted as a critical control point. There is an 
increased focus on the development of novel approaches and technologies to manage 
livestock methane emissions, so it seems logical that without a thorough characterisation of 
the gut methanogenic archaea responsible, it will be difficult to achieve success. Ruminants 
rely upon their microbial community to breakdown plant biomass in a manner that is 
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consistent with that illustrated in Figure 1 (13, 14). Upon ingestion of plant biomass by the 
host, it is initially broken down by hydrolytic enzymes, then fermented by a diverse 
community of prokaryote and eukaryote microbes (Bryant, 1979); subsequently synthesizing 
short chain fatty acids, hydrogen and carbon dioxide (Karasov and Carey, 2009). Within this 
community hydrogen accumulation can result in the inhibition of further metabolism of 
certain microorganisms (Hobson, 1988); so hydrogen utilising microbes are very important, 
as they allow the rest of the rumen microbial community to function most efficiently (Hobson 
and Stewart, 1997). Within the rumen, this niche is most often filled by methanogens; 
demonstrating this symbiotic relationship, of “interspecies hydrogen transfer” (IHT) as first 
described by Bryant and Wolin (1975). Since that time, much of the research has focused on 
confirming the class I methanogens, and especially the autotrophic Methanobrevibacter spp. 
are numerically most predominant (~6.0 x 10
8
 cells per gram of sample) (Janssen and Kirs, 
2008, Evans et al., 2009). These archaea are best known for their use of the hydrogenotrophic 
pathway for methanogenesis, which involves the use of either CO2 or formate as the principal 
C-sources for reduction with H2 gas and methane formation (Miller et al., 1982, Miller and 
Lin, 2002). Accordingly, Mbb. spp. have been the primary focus of cultural, biochemical and 
genomic methods of analysis (Samuel et al., 2007, Leahy et al., 2010) with either draft or 
closed genome sequences publically available for no less than 41 axenic isolates from both 
the rumen and human digestive tracts. Despite the current research interests seeking 
abatement of livestock methane emissions in total only seven types of rumen methanogens 
(Mbb. spp., Methanobacterium spp., Methanomicrobium sp., and Methanoculleus sp.) have 
been described in any detail (Attwood et al., 2011, Janssen and Kirs, 2008) and relatively 
little attention has been paid to the heterotrophic members of the community.  
 
In recent years, the application of “omics” approaches has provided new insights into the 
roles the archaea might play in rumen function. Poulsen et al. (2013) showed that the reduced 
methane emissions from dairy cows fed rapeseed oil could be attributed to a selective 
suppression of the “Methanomassiliicoccus”, with coincident decreases in transcripts 
encoding for methylotrophic methanogenesis from the rumen contents of these animals 
(Poulsen et al., 2013). New Zealand and US-DOE researchers have also studied the rumen 
microbiota of sheep stratified with respect to methane production, and demonstrated that the 
trait is heritable (Shi et al., 2014). Using a combination of metagenomic and 
metatranscriptomic methods they found no significant differences in total methanogen 
numbers between the “low” and “high” methane producers, although there were differences 
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in the relative abundances of the methylotrophic Methanosphaera spp. (increased in “low 
methane” sheep) and the hydrogenotrophic Mbb. gottschalkii clade (increased in “high 
methane” sheep). The metatranscriptomic data revealed that 7/10 genes coordinating the 
hydrogenotrophic pathway were significantly increased in high methane producing sheep. 
Additionally, New Zealand researchers have used metagenomics to build a comparative 
profile of methanogenic diversity across 252 sampled animals (eight cohorts of sheep and 
cows) from around New Zealand (Seedorf et al., 2015). While Mbb. and Mms. spp. dominate 
the communities of all the cohorts sampled, the less abundant Msp. spp. were also 
consistently identified within the sampled animals. Parallel studies in Europe with beef cattle 
produced similar findings with respect to higher numbers of Mbb. spp. in the “high” emitters, 
while changes in the bacterial population favouring the succinate-producers like 
Succinivibrionaceae were found in the “low” emitting animals. Furthermore, these variations 
in metagenomic data between the “high” and “low” emitters have been proposed as 
biomarkers for animal selection and breeding strategies that seek to reduce methane 
emissions and/or improve feed efficiency (Wallace et al., 2015). Indeed, it would seem that 
the alterations in methanogen profiles observed among animals stratified by their methane 
emissions involves genotype x environment interactions that affect rumen fermentation and 
gaseous hydrogen formation (Kittelmann et al., 2014). Collectively, these findings suggest 
that while the inhibition of select populations of methanogens can mitigate livestock methane 
emissions, it is also a heritable trait, suggesting host-mediated effects on the rumen 
microbiota. In that context, “high methane” emitting animals have been postulated to possess 
a longer retention of feed within the rumen as well as alterations in the bacterial 
“ruminotype” increasing the levels of ruminal hydrogen, with coordinate elevated expression 
of genes encoding the hydrogenotrophic pathway and greater methane yield (Janssen, 2010, 
Kittelmann et al., 2014) . It seems intuitive then to further suggest that the increased relative 
abundance of hydrogen-dependent methylotrophic methanogens in “low methane” animals 
relates to their capacity for growth when the bacterial ruminotype favours less hydrogen 
production during fermentation (Janssen and Kirs, 2008, Attwood et al., 2011). 
 
1.3 Australia’s macropodids as the “low” methane agricultural model 
Australia’s native herbivores macropodids (kangaroos and wallabies) are similar to ruminants 
in that they rely on a fore stomach colonized by microbes for the breakdown of plant 
material, and production of protein- and energy-yielding nutrients. Interestingly, two studies 
in the late 70’s suggested the scheme of anaerobic digestion in macropodids results in 
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relatively low methane emissions per unit of digestible energy intake compared to sheep 
(Engelhardt et al., 1978, Dellow et al., 1988). These earlier observations have recently been 
validated using a colony of kangaroos and wallabies from a zoo in Denmark (Madsen and 
Bertelsen, 2012). Macropodids have been shown to harbour methanogenic archaea in their 
foregut; with Evans et al. (2009) demonstrating the methanogen-specific 16S rRNA gene 
clone libraries produced from macropodids are taxonomically similar to those produced from 
numerous rumen and human microbiota, namely Mbb., Msp., and uncultured Mms. archaea. 
However, their qPCR analyses established that the abundance of methanogens were 
substantially less in macropodids (7.0 x 10
5
 to 3.9 x 10
6
 cells per gram of sample) than that of 
ruminant livestock (~9.8 x 10
8
 cells per gram of sample) (Evans et al., 2009). Additionally, 
the recent identification of both acetogenic bacteria (Ouwerkerk et al., 2009) and 
Succinivibrionaceae WG-1 (Pope et al., 2011) suggests these bacteria could act as hydrogen 
sinks and effectively compete with methanogens for hydrogen, in a manner similar to that 
observed with some species of termites, and ostriches (Breznak and Switzer, 1986, Fievez et 
al., 2001). So how and why do methanogenic archaea colonise and persist in the foregut of 
these animals? Have at least some of these methanogens evolved to survive by using H2-
independent pathways for methane production and growth? These questions can be addressed 
by isolating methanogens from native Australian herbivores, in addition to comparing them 
with strains from other gut environments.  
 
1.4 Interactions between methanogenic archaea and the human host 
The last decade has also seen the emergence of widespread public interest in the human 
“microbiome” and its effects on our health and well-being, driven in large part by the 
technological advances in DNA/RNA sequencing technologies and related computational 
tools for data analysis (Eckburg et al., 2005, Dridi et al., 2011). Recently, IHT driving 
methane formation has been proposed as a mechanism positively affecting calorie release in 
the large bowel, and a possible contributing factor to adiposity (Samuel et al., 2007, Mathur 
et al., 2013, Gaci et al., 2014). Certainly there is evidence to suggest that this is not true for 
all races, there is an increased incidence of breathe methane in African rural and urban black 
populations in comparison to European Americans (Nava et al., 2012). Supported by another 
study which sampled and compared Native and American Africans in comparison with 
Caucasian Americans, again demonstrating that there was a significantly higher parts per 
million reading of methane for Native Africans and an average BMI of 28 (O'Keefe et al., 
2007). Nottingham and Hungate (1968) first isolated methanogens from human faeces in the 
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late 1960’s and the links between methane, methanogens and human gut function have been 
reported since the early 1970’s (Haines et al., 1977, Bond et al., 1971). The early studies 
suggested familial-based environmental (rather than genetic) effects influenced prevalence, 
with about one-third of “healthy persons” found to be methane excretors. Subsequent studies 
have suggested a higher prevalence of methane excretors (and when measured, methanogen 
abundance in faeces) among persons suffering from organic gastrointestinal disorders, 
including colorectal cancer and diverticulosis (Conway de Macario and Macario, 2009). 
Irritable bowel syndrome (IBS) is categorised by episodes of diarrhoea (IBS-D), constipation 
(IBS-C), or both (IBS-M), and breath methane measurement of IBS patients has been 
reported to be greater in IBS-C and lower or not detectable in IBS-D patients (Chatterjee et 
al., 2007). It has been demonstrated in animal and human models that methane can influence 
the intestinal motor function, with an abundance of methane resulting in a slow intestinal 
transit time as a result of augmented small bowel contractile activity (Pimentel et al., 2006).  
 
Since the pioneering efforts from the early-1980s by Miller and Wolin, which include the 
isolation and characterization of Mbb. smithii and Msp. stadtmanae DSMZ 3091
T
 (Miller et 
al., 1982, Miller and Wolin, 1985), the cultured lineages of human methanogens and rRNA–
based microbiota studies have expanded their prevalence to other body sites (e.g. oral cavity 
and vagina) and the hydrogenotrophic methanogens were again linked with alterations in 
anaerobic schemes of metabolism associated with disturbances to tissue homeostasis and 
inflammation (see Chaudhary et al. (2015) for a recent review). In recent years, the analysis 
of human microbiota samples from subgingival, intestinal or vaginal mucosae has further 
expanded the diversity of methanogenic archaea to include a new species of Mbb. (Mbb. 
oralis), as well as two isolates of methylotrophic archaea (Candidatus 
‘Methanomethylophilus alvus’ and Mms. luminyensis) affiliated with the newly defined 
seventh order Mms. (Dridi et al., 2012, Borrel et al., 2012, Borrel et al., 2013, Borrel et al., 
2014), which also includes the often referenced “rumen cluster C” from livestock surveys 
(Janssen and Kirs, 2008). A combination of both culture-based and genomic studies have 
characterised the narrow substrate range used by members of this order (methanol and/or 
methylated amines) and found that members of this order appear to be more prevalent in 
mature age persons (Borrel et al., 2014, Vanderhaeghen et al., 2015, Gaci et al., 2014). In 
addition to pectins being a source of methanol, other food components such as choline, 
lecithin and L-carnitine can be transformed by bacterial fermentation into methylated amines. 
The capacity of these “new” methanogens to utilize such products takes on added 
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significance given the growing evidence that trimethylamine production by the gut 
microbiota, and its subsequent oxidation in the liver to an oxide (trimethylamine-oxide: 
TMAO), is a primary contributor to cardiovascular disease pathogenesis and uremic toxin 
load in chronic kidney disease (CKD) patients (Tang et al., 2014, Wang et al., 2011). In 
summation, the links between gut methanogens and a person’s health and well-being has 
principally focused on their syntrophic associations and physiological ecology. In other 
words, their relative abundance is predicated on the fermentative activities of the gut bacteria 
providing substrates in support of their growth, and/or alterations in gastrointestinal motility, 
influencing their relative abundance. In that context, Conway de Macario and Macario (2009) 
proposed that their role in pathogenesis is largely indirect, and a better understanding of the 
metabolic interactions involving the methanogenic archaea are relevant in combating many 
non-communicable diseases, from periodontitis to obesity. For instance, efforts are now 
underway that parallel those with livestock: to identify specific methanogen inhibitors as a 
treatment for GI disorders (e.g. Gottlieb et al. (2016); the use of statins to inhibit archaeal 
membrane synthesis), as well as suggestions that the methylamine-utilizing archaea might be 
used prophylactically and therapeutically as probiotics to mitigate TMAO production 
(Brugere et al., 2014, Morrison, 2013, Gaci et al., 2014). In these respects, there are many 
correlates to draw, and lessons to be learned, from the studies of methanogenic archaea in 
ruminant livestock and potential interventions in humans positively affecting health.  
 
In their review, Conway de Macario and Macario (2009) also raised the spectre that the 
methanogenic archaea might also possess a more direct role in pathogenesis, via their 
interaction with the immune system, and outlined the differentiation of Mbb. smithii strains 
into no less than 7 “immunotypes”. Similarly, Horz and Conrads (2011) described the 
findings by Yamabe et al. (2008) of humoral (IgG) responses to the oral methanogens present 
in periodontal lesions. More recently, Blais Lecours et al. (2011) reported that Msp. spp. are a 
predominant form of bioaerosols in animal houses, and using a mouse model showed that 
Msp. stadtmanae provokes a stronger immune response within the lung tissue (including 
stimulation of macrophage, lymphocyte, neutrophil, and eosinophil recruitment to lung 
tissue) than mice exposed to preparations of a Mbb. smithii strain. In a subsequent report by 
the same group Blais Lecours et al. (2014), the abundances of Mbb. and Msp. spp. present in 
stool samples were determined from healthy control subjects and patients suffering from 
IBD. While the “total methanogen” count was dramatically decreased in IBD patients, there 
was a measurable and significant increase in both the prevalence and abundance of Msp. spp. 
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observed. Such findings suggest that the production of short chain alcohols (often observed 
during “dysbiosis”) might promote the growth of Msp. spp. and an expansion of their niche. 
Importantly, these authors also reported that not only does Msp. stadtmanae DSMZ 3091
T
 
provoke a stronger inflammatory response from the peripheral immune system than Mbb. 
smithii, but the archaeon also elicits a strong IgG response in IBD patients, compared to the 
humoral response found towards Mbb. smithii in either IBD patients or healthy control 
subjects. Further investigations by Bang et al. (2014) have also identified the expression of 
CD197 and CD86 cell-surface receptors by monocyte-derived dendritic cells (moDCs) after 
stimulation of cells with either Mbb. smithii DSMZ 861
T
 or Msp. stadtmanae DSMZ 3091
T
, 
providing further confirmation of earlier findings. 
 
1.5 Summary and research goals 
Despite the widespread recognition of the roles methanogenic archaea may play in gut 
environments, very little is known about their metabolic versatility, host adaptation, and 
immunogenic properties relevant to host health and nutrition. With the exception of some 
detailed examination of the physiological and genetic potential of the autotrophic Mbb. spp. 
(Leahy et al., 2010), much of the past efforts have been directed towards examining the 
ecological and taxonomic variations among these microbes in gut environments. To date, 
little is understood about the methylotrophic methanogens present in these environments (ie: 
Msp. spp.); I believe that these methylotrophic archaea may possess novel metabolic features 
associated with host adaptation. The fields of microbial genomics and metagenomics offer 
the potential to examine, and obtain a better understanding of the many microbes present in 
complex microbial communities, like those present in the bovine rumen, macropodid foregut 
and large bowel of humans.  
 
The overall goal for my PhD program was to gain a detailed understanding of heterotrophic 
methanogens, especially members of the genus Msp., by examining isolates recovered from 
the bovine, macropodid and human digestive tracts; and using biochemical, genomics, and 
cell biology approaches. While more specific aims of my project included: 
 
1. The isolation of ‘new’ heterotrophic methanogenic archaea from domesticated Australian 
livestock and native Australian herbivores, through a combination of culture dependant 
and independent approaches. 
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2. Develop a deeper understanding of the metabolic versatility of culture dependent isolates 
using biochemical and/or genetic strategies.  
  
3. Complete a comparative “pan-genome” analysis to identify core, shared and unique genes 
of macropodid, ruminant and human derived heterotrophic methanogenic archaea; in 
order to establish the links between genome variation and habitat adaptation/specificity. 
 
4. Investigate the variations in Mbb. and Msp. spp. populations in CKD clinical studies and 
perform an assessment of their immunomodulatory properties. 
 
This research should not only provide a stronger understanding of methanogen-host 
interactions, but should also aid in future research that seeks to find novel targets to 
manipulate these archaea in either agricultural or clinical scenarios. 
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Chapter 2 Differences down-under: alcohol-fuelled methanogenesis by 
archaea present in Australian macropodids 
2.1 Introduction  
Methane emissions from anthropogenic sources are viewed as a significant contributing 
factor to climate change and global warming and ruminant livestock populations are 
estimated to contribute between 13-19% of these emissions (IPCC, 2007, Leahy et al., 2010, 
Lowe, 2006, Johnson and Johnson, 1995, Lassey, 2007), which is a driving force behind 
global research efforts to productively alter livestock methane emissions. Recent studies have 
demonstrated that methane emissions by ruminant livestock is a heritable trait (Lassey et al., 
1997, Pinares-Patino et al., 2013, Pinares-Patiño et al., 2011b, Pinares-Patiño et al., 2011a) 
and that animals selected for a “low methane” phenotype do develop and sustain an altered 
rumen bacterial population (Shi et al., 2014). Interestingly, although the structure of the 
methanogenic community changes in these animals, metagenomic and other cultivation-
independent methods suggest the abundance of methanogens remains largely unchanged. 
Instead, there appears to be a reduction in the expression of genes that coordinate the 
hydrogenotrophic (autotrophic) pathway of methanogenesis in the “low emitters” suggesting 
that the archaeal populations need to adapt to changing environmental conditions via 
metabolic niche expansion. 
 
Kangaroos and wallabies are the most numerous members of the Macropodidae and produce 
substantially less methane per unit of digestible organic matter intake than ruminant livestock 
when fed the same diet (Engelhardt et al., 1978), and this difference was recently confirmed 
with captive zoo populations in Europe (Madsen and Bertelsen). Although both are foregut 
digesters the digestive anatomy and associated physiology of macropodids and ruminants is 
quite different (Hume, 1984), and as expected the microbial communities that have evolved 
to colonize and persist in these digestive chambers are also different. 
 
In that context, recent applications of metagenomic methods have revealed novel insights into 
the macropodid foregut microbiota that further explain their “low methane” emissions 
(Morrison, 2013). Evans et al. (2009) were the first to show that the macropodid foregut is 
colonized by methanogenic archaea, albeit at numbers substantially less than typically 
reported in ruminants (10
5
 to 10
6
 cells per gram of macropodid digesta as compared to 10
8
 to 
10
9
 cells per gram of ruminant digesta). Although the taxonomic assignments of the 
macropodid archaeal populations are largely similar to those from ruminant livestock 
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virtually nothing is known about their metabolic capabilities and adaptations to the different 
gut environments. Here, I show that a Msp. sp. isolated from the Western Grey kangaroo 
(Macropus fuliginosus) expands the metabolic versatility of this genus, to include the 
utilization of short-chain alcohols in the absence of hydrogen gas, to fuel carbon reduction 
and methanogenesis. 
 
2.2 Materials and Methods  
2.2.1 Animal sampling protocol and digesta preservation. 
The digesta samples used were collected from 17 Western Grey kangaroos (estimated to be 
between 1 month and 5 years of age, see section 6.1) during a culling exercise in 2008 by 
licensed hunters, as part of the state’s control procedures, on a CSIRO managed farm in 
Yallenbee (Western Australia). Digesta samples were collected from the anterior region of 
the sacciform forestomach, and representative contents were added directly to completely fill 
a 50 ml sterile Falcon tube and stored at -80 ºC. The remainder of the digesta sample was 
strained through muslin cloth, with ~2 ml of the strained liquid immediately mixed with 2 ml 
of an anaerobic, pre-sterilized solution of 30% (vol/vol) glycerol (see section 6.2). These 
samples were all stored at -80 
o
C and used for the subsequent PCR-DGGE and cultivation 
based studies. 
 
2.2.2 DNA extraction and PCR-DGGE analysis of Western grey 
kangaroo digesta samples. 
Samples of whole digesta (~0.5 g) were mixed with a disassociation buffer (see section 6.3, 
Whitehouse et al., 1994) to desorb the microbial cells adherent to plant particles, and the 
resulting liquid was used for total DNA extraction by the RBB+C method (see section 6.4, 
Yu and Morrison, 2004). The DNA was used as a template for nested PCR, with the initial 
PCR amplification performed using the Archaea-specific primers (see section 6.5 Table 6.1) 
86F/1340R (Wright and Pimm, 2003). The second, nested PCR was performed using 2 µl 
aliquots of the primary amplification mixture; combined with touchdown PCR amplification 
(Hwang et al., 2008) using primers 344F (Raskin et al., 1994) and 519R (Lane et al., 1985). 
The primer 344F was also contained a 38 nt G:C “clamp” (1999) for DGGE analyses (see 
section 6.6). Of the original 17 samples only 14 yielded PCR products which were subjected 
to DGGE using the Bio-Rad D-code System (Ouwerkerk et al., 2008) and the gel images 
were captured using a Typhoon scanner and Typhoon TRIO Variable Mode Imager (GE 
Healthcare Life Sciences, Parramatta, NSW, Australia).  
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2.2.3 Enrichment and isolation of Methanosphaera sp. WGK6 
The glycerol stock from two animals (#2 and #6) was selected for culture work, based on 
their distinctive PCR-DGGE patterns (see Results section 2.3.1). The isolation process was 
conducted over a period of two months, and was initiated by setting up enrichment cultures 
based on BRN-RF30 medium (see section 6.7, Joblin et al., 1990) with a mixture of hydrogen 
and carbon dioxide gases (80:20 vol/vol) added to the headspace within each tube to a final 
pressure of 150 kPa. In addition, a selection of these starter cultures were also supplied with 
methanol (1% vol/vol). Penicillin and streptomycin were added to final concentrations of 600 
µg/mL and 200 µg/mL, respectively (see section 6.8), and were incubated at 39
o
C. Samples 
were taken aseptically from the cultures every 2 or 3 days, to check for methane in headspace 
gases and the presence of autofluorescent cells, as biomarkers of methanogen enrichment. 
Positive cultures were then further treated with erythromycin (100 µg/mL final concentration) 
and serially diluted to extinction. The highest dilutions still exhibiting autofluorescent growth 
and methane production were then serially diluted and used to inoculate BRN-RF30 agar roll 
tubes for the generation of single colonies. Several colonies were picked using a sterile glass 
pipette and then transferred to fresh medium and incubated at 39
o
C. Following growth, each 
culture was confirmed to produce methane and to contain autofluorescent cells. Cell biomass 
from the candidate axenic cultures was harvested by centrifugation and DNA extracted using 
the RBB+C method (Yu and Morrison, 2004). The DNA samples were then used as 
templates for PCR amplifications with either Archaea- (86F/1340R) or Bacteria-specific 
(27F/1492R) primers (see section 6.5 Table 6.2) (Wright and Pimm, 2003) and the products 
were cleaned (see section 6.9) and sequenced using an Applied Biosystems 3130xl Genetic 
Analyser.  
 
2.2.4 Substrate utilization tests for strain WGK6 and 
Methanosphaera stadtmanae DSMZ 3091
T
 
A basal medium of BRN-RF10 “medium 1” (see section 6.10, Balch et al., 1979) was used 
for these studies, with the headspace purged with oxygen-free N2 gas to remove any carryover 
H2, and with the various substrates aseptically added to individual tubes. The individual and 
substrate combinations tested were: ethanol alone, ethanol and H2:CO2 (80:20 vol/vol), 
methanol alone, methanol and H2:CO2 (80:20 vol/vol), methanol and ethanol, 20 mM each of 
mono-, di- and trimethylamine, propanol alone, and H2:CO2 (80:20 vol/vol). In all cases, the 
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alcohols were added to give a final concentration of 1% (vol/vol), and when required the 
tubes were pressurized to 202 kPa with H2:CO2 (80%:20%). The two strains were also 
evaluated for growth and methane formation with acetate or formate as the principal carbon 
sources. Here, basal BRN-RF10 “medium 1” lacking these substrates was prepared and they 
were subsequently added as sterilized solutions post autoclaving to a final concentration of 20 
mM. For all these studies, culture tubes containing the different media were inoculated in 
triplicate with 0.1 mL aliquots of 6 day old cultures of either WGK6 or DSMZ 3091
T
, both of 
which possessed an optical density at 600 nm (OD600) ~1.0. Growth was monitored over time 
by measuring OD600 of all the cultures at fixed intervals over a 24 hour period (alternating 
between 9 and 15 hours apart) for 7 days. At the end of the incubation period a sample of the 
headspace gases were collected from all the cultures and subjected to GC analysis (Gagen et 
al., 2014).  
 
2.2.5 Comparative growth studies with Methanosphaera 
stadtmanae strain DSMZ 3091
T
 
The growth yields, substrate utilization and methane production profiles of WGK6 and 
DSMZ 3091
T
 were then examined in more detail using large scale batch fermentations. Here, 
the medium was prepared in custom made 1.2 L serum bottles with a H2-free headspace, as 
described above. The bottles were modified with a Balch tube fused to the wall of the bottle, 
so that the OD600 measurements could be made. Each bottle also contains a serum bottle 
closure to support aseptic sampling from the cultures. Each bottle was prepared to contain 
500 mL of BRN-RF10 medium and was inoculated with 2 day old diluted cultures of either 
WGK6 or DSMZ 3091
T
 to give a starting optical density at 600 nm (OD600) of ~0.02. The 
alcohols were added to these media to a final concentration of 1% (vol/vol), and when 
necessary, pressurized to 202 kPa with the H2:CO2 gas mix. The bottles were placed within a 
shaking incubator cabinet and agitated at 100 rpm for 6 days. Growth was monitored by 
OD600 measurements, taken at fixed intervals over each 24 hour period (5, 5, and 14 hours 
apart) using SPECTRAmax Plus 384 spectrophotometer. Samples (2 ml) were taken daily (at 
the time of the second OD600 measurement) from which cell biomass was harvested by 
centrifugation. Cell yields were calculated according to dry weight of cells per mol of 
methane measured at the peak of the exponential phase of growth (Miller and Wolin, 1985). 
The supernatants from these samples were stored at -80C prior to their analyses for 
methanol, ethanol and short chain fatty acids, using published GC procedures (Pontes et al., 
 15 
 
2009), with the exception that the column temperature gradient was altered slightly to 
improve peak separation. Samples of the headspace gases were also removed each day, and 
the hydrogen, CO2 and methane concentrations were also measured by GC analysis (Gagen et 
al., 2014). 
 
2.2.6 Taxonomic assignment of strain WGK6, genome 
sequencing and analysis 
WGK6 cells were harvested after 5 days growth and the DNA was extracted using the 
RBB+C method (Yu and Morrison, 2004). The DNA was then quantified using the Quant-iT 
dsDNA BR Assay Kit according to the manufacturer’s instructions (Invitrogen); and the 
integrity of the DNA was determined by agarose gels and electrophoresis. The gene encoding 
16S rRNA was amplified with primers 86F and 1340R using methods as described above. 
The individual sequence reads were trimmed and assembled using Vector NTI to produce a 
near complete 16S rRNA gene sequence and used for phylogenetic analysis using MEGA5 
(Tamura et al., 2011). The stability of the neighbour-joining tree was evaluated by 1000 
bootstrap replications and Kimura 2-parameter modelling (Kimura, 1980).  
 
Genomic DNA from strain WGK6 was subjected to shotgun sequencing at the Australian 
Centre of Ecogenomics (ACE) using a 454 Roche GS-FLX system with titanium chemistry. 
The sequence data was quality checked, filtered and then de novo assembled using the Velvet 
assembler (Zerbino and Birney, 2008). The WGK6 contigs were re-ordered using Mauve 
(Darling et al., 2010) and with the DSMZ 3091
T
 genome sequence as a reference. Mauve is a 
genome alignment algorithm that allows an anchored (and rapid) alignment of two or more 
genomes, but also supports the rearrangement of these alignment anchors to support the 
identification of any genome rearrangements. By doing so, it provides information relating to 
genome synteny, xenologous regions, and genome rearrangements as evolutionary marks. 
The Mauve-generated assembly was submitted to the xBASE annotation pipeline (Chaudhuri 
et al., 2008), and the resulting output files examined using the Artemis genome browser 
(Rutherford et al., 2000). The WGK6 draft genome was further examined using JGI IMG/ER 
see Appendix 6.11, Table 6.3(Markowitz et al., 2012) which facilitated more genes being 
assigned to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and orthologous 
groups (Kanehisa and Goto, 2000, Kanehisa et al., 2010, Kanehisa et al., 2006). The draft 
genome has been deposited at JGI IMG/ER under the accession 2595698213 and the whole 
genome shotgun project has also been deposited at DDBJ/EMBL/GenBank under the 
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accession JRWK00000000. The version described in this paper with regards to annotations 
and locus tags is JGI IMG/ER version 2595698213. 
 
2.2.7 RT-PCR analysis of WGK6 alcohol (walc) and aldehyde 
(wald) dehydrogenase gene expression 
Strain WGK6 was cultured for 48 hours (OD600 ~0.6) with BRN-RF30 medium supplemented 
with either methanol and hydrogen, or methanol and ethanol, as previously described. The 
cells were harvested by centrifugation and subjected to phenol:choloroform treatment and 
bead beating to lyse the cells, followed by RNA purification with the Qiagen RNeasy mini 
kit. Residual DNA was removed from the extracts with the Ambion Turbo DNase “rigorous” 
protocol. The quality of the RNA was determined using Agilent RNA 6000 Nano Kit and 
those samples with a RNA Integrity Number (RIN) >9 were reverse transcribed using 
Invitrogen Superscript III reverse transcriptase and random hexamers, according to 
manufacturer’s specifications. The cDNA was then used as a template for qPCR, with 
primers targeting either the candidate alcohol (walc) or aldehyde (wald) dehydrogenase 
genes, as well as the intergenic transcribed space (Table S1). The primers were all designed 
using the online software Primer3 (Rozen and Skaletsky, 2000), and were cross checked to 
ensure non-specific binding to other regions of the WGK6 genome by using NCBI BLAST 
and pDRAW32. The cDNA was also used with 16S rRNA gene-specific primers. All these 
reaction mixtures were treated with RNaseH at 37ºC for 20 minutes, and aliquots (1 µL) were 
added to 12.5 µL of power SYBR green PCR Master Mix (Applied Biosystems), 0.25 µL 
each of forward and reverse primer pair, and then made up to a final volume of 25 µL. The 
PCR conditions used were one hold at 50 °C for 2 minutes, and then one hold at 95 °C for 2 
minutes, followed by 40 cycles at 95 °C for 15 seconds, and a 60 °C elongation for 1 minute. 
The real-time PCR efficiency (E) was calculated for all three primer sets, by setting up qPCR 
reactions with varying amounts of cDNA added to the reaction mixtures (0.016, 0.08, 0.4 and 
2 ng, each done in triplicate). The E values were calculated as described by Rasmussen 
where E =(10(
[–1/slope]
)-1)*100 (Rasmussen, 2001), and for both dehydrogenase primer sets 
was 90%, and 102% for 16S rRNA gene. Then, the fold-change for each of the 
dehydrogenase gene transcripts was calculated using (Pfaffl, 2001): 
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Here, “target” refers to either the walc- or wald-derived transcript, and “reference” refers to 
the 16S rRNA-derived cDNA. “Control” and “treated” conditions were growth of strain 
WGK6 with methanol:H2 and methanol:ethanol, respectively. 
 
2.2.8 Taxonomic assignment of WGK6 alcohol and aldehyde 
dehydrogenase genes 
The phylogeny of protein coding sequences for WGK6 alcohol and aldehyde dehydrogenase 
genes was constructed with sequences recovered from the NCBI and JGI databases.  MEGA5 
(Tamura et al., 2011) was used to construct phylogeny for each dehydrogenase gene 
respectively, ClustalW (Thompson et al., 1994) aligned the sequences, the stability of the 
Poisson modelled (Rosset, 2007) neighbour-joining tree was evaluated by 1000 bootstrap 
replications.  
 
2.3 Results  
2.3.1 Analysis of foregut digesta samples and isolation of 
Methanosphaera sp. WGK6 
The PCR-DGGE analysis of the digesta samples showed there were two dominant profiles 
(Fig. 2.1) and based on these results, digesta samples from two animals (#2 and #6 in Fig. 
2.1) were selected for methanogen enrichment and isolation. The digesta sample from animal 
#2 produced cultures with only weak growth (OD600 < 0.2) and a small amount of methane 
could only be measured in headspace gases when H2 and CO2 were provided for growth and 
without antibiotic additions, so were not pursued further. However, the sample from animal 
#6 produced more actively growing cultures and more methane in headspace gases when H2 
and methanol were provided for growth; and autofluorescent cells were also present upon 
UV-transilluminated microscopy. Interestingly, the addition of erythromycin solubilised in 
ethanol appeared to further improve growth of the culture. Upon microscopic examination, 
the culture appeared to be comprised exclusively of coccoid-shaped cells forming clumps, 
which were autofluorescent during UV-transillumination (Fig. 2.2). Four single colonies were 
propagated in broth cultures and were confirmed to share the same morphology, 
autofluorescence, and growth characteristics. Furthermore, each of these four cultures 
produced amplicons with Archaea-domain specific primers, with no detectable amplicon 
produced with Bacteria-domain specific primers. The PCR amplicon produced with Archaeal 
primers was sequenced and found to be 100% identical to each other, and share 97% 
sequence identity with the 16S rRNA gene sequence of Msp. stadtmanae (DSMZ 3091
T
). At 
 18 
 
this stage the individual cultures were presumed to be axenic and siblings of each other, so 
only one of these cultures, hereafter referred to WGK6, was selected for further study. 
 
 
Figure 2.1. Nested PCR-DGGE analysis of the archaeal populations recovered from 
sacciform foregut digesta samples collected from 14 Western Grey kangaroos, as described in 
the Materials and Methods. Lane M contains 2.5 µg of 100bp ladder, and lane numbers 
represent individual animal samples. Two profiles appear to dominate the samples: 8/14 
animals possess amplicons marked A and/or B, and 5/14 animals possess amplicons marked 
C and/or D. Strain WGK6 was recovered from digesta sample 6, which possesses both 
amplicons A and B. 
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Figure 2.2. Photomicrographs of Msp. sp. WGK6 upon UV-transillumination (left), or 
following Gram staining (right). Both images were produced from WGK6 cultures following 
growth with BRN-RF30 medium containing methanol and erythromycin. 
 
Cell biomass was harvested from a WGK6 culture to provide template DNA for 16S rRNA 
gene-specific PCR analysis. The phylogenetic analysis of the WGK6 and gut methanogen 
sequences shows that it is assigned to a cluster containing DSMZ 3091
T
, with other 
sequences recovered from the rumen microbiomes of cattle in North America (Wright et al., 
2007) and China (Pei et al., 2009), as well as other macropodids (Evans et al., 2009) (Fig. 
2.3). Of these, DSMZ 3091
T 
and Msp. cuniculi (DSMZ 4103
T
, originally isolated from rabbit 
rectum) appear to be the only members of this cluster that are available as axenic cultures; 
and to my knowledge DSMZ 3091
T
 is the only one to have its genome sequenced and 
publically available.  
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Figure 2.3. Phylogenetic analysis of the 16S rRNA gene sequence for strain WGK6 shows it 
is most similar to the human gut isolate Msp. stadtmanae DSMZ 3091
T
 and both are clustered 
with other clone sequences representing uncultured methanogens derived from ruminant and 
macropodid sources. Only bootstrap values greater than 50% are shown and the scale bar 
represents 2% sequence divergence, with S. acidocaldaricus and P. fumarii used as the 
outgroups. 
 
2.3.2 Alcohol-fuelled methanogenesis by Methanosphaera sp. 
WGK6 
Msp. stadtmanae DSMZ 3091
T
 has been shown by a combination of culture based and 
genomic methods to be a hydrogen-dependent methylotroph restricted to using methanol and 
H2 (Miller and Wolin, 1985, Fricke et al., 2006, Miller and Wolin, 1983), and incapable of 
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autotrophic growth. Conversely, growth of the WGK6 enrichment culture appeared to be 
stimulated by the addition of ethanol (and/or erythromycin), suggesting the strain may 
possess a greater metabolic versatility compared to that of DSMZ 3091
T
. Substrate utilization 
tests confirmed that neither strain WGK6 nor DSMZ 3091
T
 was capable of growth when 
methylated amines, acetate, formate, ethanol, propanol, or CO2 were provided as carbon 
sources in the presence of hydrogen (data not shown). However, differences between the two 
strains were observed in terms of their ability to utilise combinations of methanol, ethanol 
and hydrogen to support growth (Fig. 2.4). As expected, both strain DSMZ 3091
T
 and WGK6 
grew well when provided with both methanol and H2. Furthermore, neither strain was capable 
of growth with ethanol alone, nor with ethanol and H2. However, growth of strain WGK6 
with the combination of short-chain alcohols occurred sooner than in cultures provided 
methanol:H2 and the headspace gas pressure was also higher (280 kPa c.f. 145 kPa at 120 
hours growth). As anticipated, strain DSMZ 3091
T
 was not capable of growth under these 
conditions. Based on these results, I hypothesized that strain WGK6 can use ethanol as a 
source of reducing power coupled to methanol reduction and methane formation. 
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Figure 2.4. Growth of Msp. sp. WGK6 and Msp. stadtmanae DSMZ 3091
T
 when provided 
with different combinations of methanol, ethanol and H2 added to BRN-RF10 basal medium, 
as described in the materials and methods. Note that measurable growth is only apparent for 
strain DSMZ 3091
T 
when provided with a combination of methanol and hydrogen, whereas 
growth of strain WGK6 can be supported by methanol and ethanol, as well as methanol and 
hydrogen. Individual values represent the mean (± SEM) produced from triplicate cultures.  
 
2.3.3 Alcohol-fuelled methanogenesis is coupled with ethanol 
utilization and acetate formation by Methanosphaera sp. WGK6 
Next, large-volume batch cultures of both WGK6 and DSMZ 3091
T
 provided with either 
methanol:H2 or methanol:ethanol were sampled longitudinally to determine substrate 
utilization, product (methane and acetate) formation, and growth kinetics, and the results of 
these experiments are illustrated in Fig. 2.5. Methanol utilization, methane formation and 
growth was observed for strain WGK6 under both conditions and the cell yields were 
estimated to be 2.4 and 4.0 g/mol methane produced with methanol:H2 and methanol:ethanol, 
respectively. Additionally, ethanol utilization by strain WGK6 (Fig. 2.5A) was coupled with 
the accumulation of acetate in these cultures only (Fig. 2.5C) suggesting strain WGK6 has the 
capacity to coordinate a two-stage oxidation of ethanol to provide the reducing power used 
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for methanol reduction and methanogenesis. As expected, methanol utilization, methane 
formation and growth of strain DSMZ 3091
T
 occurred only with methanol:H2 with a cell 
yield of 4.0 g/mol methane, which is virtually identical to the findings reported by Miller and 
Wolin (Miller and Wolin, 1985). Taken together, these results suggested that strain WGK6 
has an expanded metabolic versatility compared to strain DSMZ 3091
T
 via a capacity to 
catalyse ethanol oxidation via acetaldehyde to acetate. 
  
 24 
 
 
 
Figure 2.5. Longitudinal monitoring of the utilization of ethanol or H2 (A), and methanol (B), 
as well as the formation of acetate (C) and methane (D) in batch cultures of Msp. sp. WGK6 
and Msp. stadtmanae DSMZ 3091
T
 when provided with either methanol and hydrogen or 
methanol and ethanol. As expected methanol and hydrogen utilization, as well as methane 
formation, was observed for both WGK6 and DSMZ 3091
T
, when cultured using this 
substrate combination (▲ and ▼ for WGK6 and DSMZ 3091T, respectively). However, only 
strain WGK6 (●) and not DSMZ 3091T (■) demonstrated an ability to utilize both methanol 
and ethanol to support methane formation (and growth, as depicted in Fig. 2.3). Additionally, 
acetate accumulation over time was only evident when strain WGK6 was cultured with both 
methanol and ethanol, suggesting a two-step oxidation of ethanol can provide the reducing 
power required for methanol reduction and methanogenesis (and growth) in the absence of 
H2. With the exception of the results for ethanol measurements presented in Fig. 2.5A, the 
results represent the mean values obtained from duplicate experiments. 
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2.3.4 The WGK6 genome encodes dehydrogenase genes that are 
absent from the DSMZ 3091
T
 genome 
The WGK6 genome was assembled into 37 large contiguous sequences at 68x coverage, with 
its genome size estimated to be 1.732 Mbp. The WGK6 draft genome sequence was then 
further assessed for both genome completeness and contamination using CheckM v1.0.3, an 
automated method which examines a draft genome against a broad set of marker genes, 
specific to an inferred lineage within a reference genome tree (Parks et al., 2015). These 
analyses suggested the WGK6 draft genome sequence is 96.8% complete and has a 
contamination level of 0%. In comparison, CheckM analysis of the DSMZ 3091
T
 closed 
genome produced values of 97.6% completeness and 0% contamination. Additionally both 
genomes are calculated to possess G:C content of 28% and are also very similar in size, with 
the closed DSMZ 3091
T
 genome being 1.767 Mbp (Fricke et al., 2006). The basic annotation 
tables for both WGK6 and DSMZ 3091
T 
are provided in section 6.11 Table 6.3, and with the 
exception of the number of 16S rRNA genes found (1 copy in strain WGK6 c.f. 4 copies in 
DSMZ 3091
T
) the relative proportions of protein coding sequences with (and without) 
function predictions and/or KEGG pathway designations, are virtually identical. However the 
Mauve alignment of the two genomes, while showing there is extensive amount of synteny 
with only a few genome rearrangements between the WGK6 and DSMZ 3091
T
 genomes did 
reveal a region of genomic difference and found only in the WGK6 genome (Fig. 2.6). A 
closer examination of the annotation results for this region produced by JGI IMG/ER pipeline 
and KEGG-based pathway analysis showed this region to encode genes encoding putative 
alcohol (walc) and aldehyde (wald) dehydrogenases, and are positioned contiguously within 
this region. No orthologs of these genes could be identified anywhere else within the DSMZ 
3091
T
 genome. The walc and wald sequences were then used to query the NCBI non 
redundant BLAST databases, to find their closest matches with biochemically validated gene 
products. The closest for the walc gene product is with the NADPH-dependent butanol 
dehydrogenase from Clostridium saccharobutylicum (63% amino acid identity and 100% 
coverage, (Youngleson et al., 1989)); and the wald gene product best matches with an 
aldehyde dehydrogenase from Alcaligenes eutrophus (47% amino acid identity and 99% 
coverage, (Priefert and Steinbuchel, 1992)).  
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Figure 2.6. Alignment of the Msp. stadtmanae DSMZ 3091
T 
and Msp.sp. WGK6 genomes 
using the Mauve alignment software. In brief detail, the alignment algorithm facilitates the 
depiction of genome synteny (illustrated by the size and the colouring scheme used for the 
identified locally collinear blocks), regions of genome rearrangement (illustrated via the lines 
connecting locally collinear blocks between the two genome models) and any xenologous 
regions (illustrated by blank spaces). The region encoding the cotranscribed dehydrogenase 
genes in WGK6 is annotated by the red rectangle, and is notably different to the DSMZ 
3091
T 
genome in this region. 
 
Based on these comparative genome-wide analyses, I conclude that strain WGK6 is capable 
of utilizing ethanol as a source of reducing power because it possesses genes encoding for an 
alcohol and aldehyde dehydrogenase, whereas DSMZ 3091
T 
lacks both these genes and 
thereby is incapable of utilizing ethanol to support methanol reduction, methanogenesis and 
growth. 
 
2.3.5 The walc and wald genes are constitutively expressed and 
cotranscribed by Methanosphaera sp. WGK6.  
The expression of the walc and wald genes was assessed by qRT-PCR following growth of 
strain WGK6 with either methanol and hydrogen or methanol and ethanol, and the results are 
shown in Fig. 2.7. Both genes are expressed constitutively (Fig. 2.7A and B) and are also co-
transcribed under both growth conditions (Fig. 2.7C). The qPCR analyses showed there was a 
~2-fold increase in transcript abundance in response to growth with methanol and ethanol, 
when using cDNA produced from 16S rRNA as a reference. Based on these results, I 
conclude these genes can support ethanol oxidation and alcohol-fuelled methanogenesis by 
strain WGK6 and underpin its growth in the presence of both methanol and ethanol.  
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Figure 2.7. RT-PCR analysis of the walc and wald transcripts from Msp. sp. WGK6 during 
growth with either methanol and hydrogen, or methanol and ethanol, as described in the 
materials and methods. Both the walc transcript (panel A) and wald transcript (panel B) are 
detectable with both growth conditions. An amplicon was also produced using the walc-F and 
wald-R primers (panel C), suggesting the two genes are co-transcribed. In panels A-C, lane 
M shows a DNA standard ladder (sizes annotated), lanes 1 and 2 use cDNA produced from 
the RNA extracted from cultures provided with ethanol, or hydrogen, respectively; and lane 3 
shows the results of PCR only, using genomic DNA. In Panel D, lane M shows a DNA 
standard ladder, lanes 1 and 2 show PCR reactions using 16S rRNA gene specific primers 
and the two RNA samples, but with no prior RT step; and lane 3 shows the results with the 
same primers but using WGK6 genomic DNA as a template. 
 
2.3.6 Orthologs of the dehydrogenase genes from strain WGK6 
are also present in other members of the Methanobacteriales. 
I next chose to examine the phylogeny of the alcohol and aldehyde dehydrogenases from 
strain WGK6 using protein coding sequences recovered from the NCBI and JGI databases. In 
addition to a variety of bacterial sequences used to construct the trees, I also queried the draft 
genome sequences publically available for all Methanobrevibacter spp. (i.e. all 26 Mbb. 
smithii draft genomes, Mbb. ruminantium M1, Mbb. wolinii SH, Mbb. olleyae DSMZ 16632, 
 28 
 
Mbb. boviskoreani JH1, Mbb. millerae DSMZ 16643, Mbb. arboriphilus ANOR1, and Mbb 
sp. AbM4). First, none of the Mbb. smithii draft genomes were found to possess orthologues 
or partial hits to either dehydrogenase coding gene. Additionally, no aldehyde dehydrogenase 
gene has been identified from the Mbb. ruminantium M1 or Mbb. olleyae genomes, and there 
were no strong hits using the WGK6 gene as the query sequence. Although the M1 genome 
has been annotated to possess no less than 4 putative alcohol dehydrogenase genes (2010) 
none of these genes produce strong hits with the WGK6 aldehyde dehydrogenase gene. In 
that context, the phylogenetic tree constructed for the alcohol dehydrogenase genes (Fig. 2.8) 
clearly reveals a bifurcation of the alcohol dehydrogenases from these gut-derived 
methanogenic archaea: one branch represented by Mbb. ruminantium M1, and the second 
including Msp. WGK6 and the other Mbb. spp. Similarly, the phylogenetic tree of the 
aldehyde dehydrogenase gene retains this clustering of Mbb. spp. (Fig. 2.9). Furthermore, 
there appears to be a strong degree of gene synteny between Mbb. AbM4, Mbb. boviskoreani 
JH1 and Mbb. wolinii SH (Fig. 2.10), with the genes upstream of the dehydrogenases 
encoding for the coenzyme F420-reducing hydrogenase complex (frhADGB) and downstream 
genes encoding a putative transposase, F420:NADP oxidoreducatse, asparatate dehydrogenase 
(AbM4 and M. boviskoreani only) and a methionine aminopeptidase.  
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Figure 2.8. The phylogenetic tree constructed with the Jones-Taylor-Thornton (JTT) model, 
using BLASTp alignments of alcohol dehydrogenase genes sampled from NCBI non 
redundant BLAST databases. The scale bar represents 20% sequence divergence and the 
Saccharomyces cerevisiae ATCC 204508 alcohol dehydrogenase gene was used as the 
outgroup. Numbers represent the relative frequency of branch clustering based on 1000 
bootstrap runs, bootstrap values less than 50% are removed. Note that the WGK6 gene is 
closely grouped with similar genes recovered from the draft genomes of 4 different Mbb. spp. 
Notably the putative alcohol dehydrogenase genes from the Mbb. ruminantium M1 genome 
are only distantly related (only a single representative was chosen for display within the 
phylogenetic tree). 
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Figure 2.9. The phylogenetic tree constructed with Jones-Taylor-Thornton (JTT) model, 
using BLASTp alignments of aldehyde dehydrogenase genes sampled from NCBI non 
redundant BLAST databases. The scale bar represents 10% sequence divergence and the 
Saccharomyces cerevisiae ATCC 204508 aldehyde dehydrogenase gene was used as the 
outgroup. Numbers represent the relative frequency of branch clustering based on 1000 
bootstrap runs, bootstrap values less than 50% are removed. The WGK6 gene is again closely 
grouped with similar genes recovered from the draft genomes of 4 different Mbb. spp., but 
notably no putative aldehyde dehydrogenase gene(s) have been identified from the Mbb. 
ruminantium M1 genome. 
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Figure 2.10. Comparison of the genes flanking the alcohol (alc) and aldehyde (ald) 
dehydrogenase genes (red) in Msp. sp. WGK6, Mbb. sp. AbM4, Mbb. boviskoreani JH1, 
Mbb. wolinii SH, and Mbb. olleyae DSMZ 16632
T
 (A-E, respectively). A high degree of gene 
conservation is seen between strains AbM4, JH1, and SH, each possessing a coenzyme F420-
reducing hydrogenase complex upstream (frhADGB - purple); and a transposase (black), 
F420:NADP oxidoreductase (fno - orange), and methionine aminopeptidase (map - blue) 
located downstream; with strains AbM4 and JH1 also possessing an aspartate dehydrogenase 
(asd - brown). Mbb. olleyae DSMZ 16632
T
 is surrounded by hypothetical proteins (hyp - 
grey), however there is a transposase (black) downstream of the dehydrogenase genes, while 
strain WGK6 is flanked by an outer membrane protein (omp - green), hypothetical proteins 
(hyp - grey) and a putative histone (yellow). 
 
2.4 Discussion  
While Msp. spp. have long been recognized to colonize the gastrointestinal tracts of warm-
blooded animals, their metabolic niche has remained largely enigmatic, due in large part to 
the limited number of strains available for culture-based studies. Here, I demonstrate the 
ability of a new axenic isolate of Msp. spp. to use ethanol as a source of reducing power, and 
also show that biomass yield per mol methane produced is greater when ethanol rather than 
hydrogen is used as reductant. Furthermore, although previous studies have shown that 
ethanol can stimulate the growth of hydrogenotrophic methanogens such as Mbb. smithii 
(Samuel et al., 2007) and Mbb. ruminantium (Leahy et al., 2010), neither are capable of 
growth in the absence of hydrogen.  
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A proposed scheme involving a two-step oxidation of ethanol coupled with methanol 
reduction and methanogenesis by strain WGK6 is illustrated in Fig. 2.11. 
Thermodynamically, the 4 protons and electrons released by the oxidation of ethanol to 
acetate via acetaldehyde could support the reduction of two mols of methanol, compared to 
one mol when only hydrogen is present. The calculated free energy available (values and 
equation shown in section 6.12 Table 6.4) is more favourable with ethanol, calculated to be -
199.93 kJ/mol (equation i) compared to methanol and hydrogen at -121.16 kJ/mol (equation 
ii). Additionally, it is possible that the acetate produced from ethanol oxidation can also 
provide a source of cell carbon, not available via hydrogen-dependent reduction of methanol.  
 
i. 2CH3OH + CH3CH2OH  2CH4 + H2O + CH3COO
-
 (∆Gº’ = -199.93 kJ/mol) 
ii. CH3OH + H2  CH4 + H2O (∆Gº’ = -121.16 kJ/mol) 
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Figure 2.11. A model for methanol reduction via hydrogen (blue box) or ethanol (red box) 
present in Msp. sp. WGK6, based on the results of the genomic and culture-based results 
presented in this study. The reduction of methanol is initiated by coenzyme M 
methyltransferase (MtaABC) and coenzyme M (HS-CoM) which produces 2-
(methylthio)ethanesulfonic acid (CH3-S-CoM). Methyl-coenzyme M reductase (MrtABG) 
reduces the product CH3-S-CoM with coenzyme B (HS-CoB) to methane and coenzyme M-
HTP heterodisulfide (CoM-S-S-CoB). Heterodisulfide reductase (HdrABC) then acts on 
CoM-S-S-CoB using 2e
-
 and 2H
+
 to reduce the disulfide bond thus regenerating HS-CoM and 
HS-CoB. The necessary electrons and hydrogen protons are generated by non-F420-reducing 
hydrogenase (MvhADG) from hydrogen. Alternatively, Msp. sp. WGK6 can use a two-step 
oxidation process with ethanol, performed by the cotranscribed alcohol and aldehyde 
dehydrogenases, which would result in the provision of 4 protons and electrons used to 
reduce 2 methanol groups to methane and with acetate as an end product. 
 
The demonstration of an alcohol- rather than hydrogen-fuelled methanogenesis pathway 
suggests Msp. spp. have adapted in order survive in environments with small amounts of free 
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hydrogen gas, and provides an explanation for their persistence in presumptive “low 
hydrogen” and/or “low methane” environments. For instance, the nutritional ecology of the 
macropodids would favour the formation of methanol during pectin hydrolysis, as well as a 
microbiota capable of the production of some short chain alcohols during fermentation 
(Hume, 1984, Smith, 2009, Kempton et al., 1976). So even though the relative numbers of 
methanogenic archaea in these animals are much smaller than found in ruminant livestock, 
and it has been demonstrated that reductive homoacetogens are effective hydrogen 
scavengers in the macropodid foregut (Godwin et al., 2014, Gagen et al., 2010) my findings 
do provide a basis for the persistence of methanogenic archaea in these communities, via 
alcohol-fuelled methanogenesis.  
 
In ruminant livestock, a combination of metagenomic and metatranscriptomic methods have 
now showed that total methanogen numbers are similar between the “low” and “high” 
methane producing sheep, but there are differences in the relative abundances of the 
methylotrophic Msp. spp. (increased in “low methane” sheep) and the hydrogenotrophic Mbb. 
gottschalkii clade (increased in “high methane” sheep) (Shi et al., 2014). The abundance of 
transcripts encoding most functions coordinating the hydrogenotrophic pathway was also 
significantly increased in high methane producing sheep. The “high methane” emitting 
animals have been postulated to possess a longer retention of feed within the rumen as well as 
alterations in the bacterial “ruminotype” increasing the levels of ruminal hydrogen, with 
coordinate elevated expression of genes encoding the hydrogenotrophic pathway and greater 
methane yield (Janssen, 2010, Kittelmann et al., 2014) . So it seems intuitive then to further 
suggest that the increased relative abundance of methylotrophic methanogens like Msp. spp. 
in “low methane” animals may relate to their capacity for alcohol-fuelled methanogenesis 
when the bacterial ruminotype favours less hydrogen production during fermentation 
(Janssen and Kirs, 2008, Attwood et al., 2011).  
 
It is also notable that recent studies of the human large bowel microbiota in patients suffering 
from non-alcoholic fatty liver disease (NAFLD) and more severe conditions suggest that the 
microbiota is not only dysbiotic, but fermentation schemes favouring ethanol formation are 
more active (Zhu et al., 2013). Coincidentally, other studies have remarked that there is also a 
shift from hydrogenotrophic to methylotrophic methanogens under such conditions, as well 
as in patients suffering from IBD (Blais Lecours et al., 2014). 
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In conclusion, the presence of these dehydrogenase genes in multiple members of the 
Methanobacteriales suggests that the metabolic versatility of these gut-derived methanogens 
is broader than what has long been accepted, and that alcohol-fuelled methanogenesis may be 
an important evolutionary adaptation to persist in the gut environment.  
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2.5 Published journal article detailing work carried out in Chapter 2 
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Chapter 3 Culture- and metagenomics-based expansion of the genus Msp. 
reveals their evolutionary depth and metabolic versatility 
3.1 Introduction  
Methanogenic archaea colonise a variety of environments including the animal and human 
gastrointestinal tract (Brusa et al., 1993, Evans et al., 2009, Mao et al., 2011) and those 
present in ruminant livestock are widely perceived to contribute as much as 20% of the 
annual global anthropogenic greenhouse gas emissions (IPCC, 2007, Lowe, 2006, Johnson 
and Johnson, 1995, Lassey, 2007). Methanogenic archaea typically possess a restricted 
capacity in terms of the carbon sources and reducing power supporting energy transduction 
and growth (Liu and Whitman, 2008). The methanogenic archaea resident in the 
gastrointestinal tracts of warm-blooded animals have long been recognized for their key role 
in coordinating interspecies hydrogen transfer, promoting more efficient growth of 
heterotrophic, fermentative bacteria (Bryant and Wolin, 1975). Generally, the principal 
members of the gut methanogenic communities are Mbb., Msp. and Mms. spp. (Luo et al., 
2013, Poulsen et al., 2013, Eckburg et al., 2005). Mbb. spp. are often the numerically 
predominant members of these taxocenes, and favour hydrogen-dependent reduction of 
carbon dioxide and/or formate for methanogenesis and growth. There are currently no less 
than 41 axenic isolates of Mbb. spp. described, and for which either draft or complete genome 
sequences are publically available. In contrast, there are much fewer axenic isolates of Msp. 
and Mms. spp., and draft genomes are available for four hydrogen-dependent methylotrophic 
isolates of Mms. spp. from the rumen and human digestive tracts (Rea et al., 2007, Leahy et 
al., 2013, Leahy et al., 2010, Hansen et al., 2011, Dridi et al., 2012), and only one finished 
genome available for Msp. spp. (Msp. stadtmanae DSMZ 3091
T
, Miller and Wolin, 1985). 
Interestingly, Msp. spp. have recently been reported to be more abundant in “low methane” 
producing ruminants, as well as in human subjects suffering from IBD. Additionally, these 
patients (but not the healthy controls) were found to possess high titres for serum IgG 
reactive to Msp. stadtmanae DSMZ 3091
T
, and the archaeon was shown to be more 
immunogenic then Mbb. smithii in a murine model of respiratory disease, suggesting that 
Msp. may elicit proinflammatory effects in the gut (Blais Lecours et al., 2014, Blais Lecours 
et al., 2011).  
 
For these reasons, I contend the genus Msp. remains underexplored and poorly defined 
relative to their ubiquity and abundance in the gut of animals and humans, as well as their 
contributions to gut function, health and disease. In this chapter I describe the isolation and 
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genomic characteristics of Msp. sp. BMS from the bovine rumen, which is the first reported 
isolate of its type. I have also recovered seven Msp.-affiliated population genomes from 
human, ovine, and bovine metagenomic datasets, and I present the pan-genomic analysis of 
all these datasets. Collectively, these results show that the genus is comprised of two 
genomotypes, differentiated by their genome size, with the most recent evolutionary 
adaptations favouring a “smaller” genome (<2.0 Mbp).  
 
3.2 Materials and Methods  
3.2.1 Animal sampling, enrichment and isolation of 
Methanosphaera sp. BMS 
Rumen fluid was collected using previously described procedures (Chapter 2) from a 
fistulated Brahman steer grazing on native grass/legume forage at the Gatton campus of the 
University of Queensland’s School of Agriculture and Food Sciences approved by DEEDI 
(AEC Proposal Reference Number SA 2011/08/365). A subsample of the strained liquid 
(~2ml) was mixed with an equal volume of pre-reduced, anaerobic, and sterilized solution of 
30% (vol/vol) glycerol, then stored -80
o
C. 
 
Methanogen enrichment cultures were produced using BRN-RF30 medium (Joblin et al., 
1990) supplemented with either a combination of methanol and ethanol (each 1% vol/vol) or 
the same concentration of methanol, but with H2 gas added to a final pressure of 150 kPa. 
These media were inoculated with 0.2 mL of the glycerol stock and incubated at 39 
o
C for 36 
hours, when the cultures were subsampled and examined for headspace methane gas 
formation and autofluorescent cells (via UV transillumination of wet mounts). The 
methanol:H2 enrichments produced a culture that was positive for both criteria, and it was 
used to inoculate BRN-RF30 medium supplemented with methanol:H2, and 50 µg/mL 
penicillin. The second-round enrichment culture was again examined after 36 hours 
incubation for autofluorescent cells, and subcultured using the same medium, but with 100 
µg/mL penicillin added. This third-round enrichment culture was then serially diluted to 
extinction in BRN-RF30 medium containing methanol:H2 with 50 µg/mL tetracycline added. 
The greatest dilution still producing methane and autofluorescent cells was then used to 
inoculate BRN-RF30 agar roll tubes to isolate single colonies. Several colonies were picked 
using a sterile glass pipettes and then aseptically transferred to fresh medium, and incubated 
at 39 
o
C. At this point, the resulting culture was confirmed by microscopy to be comprised of 
two cell types, and 16S rRNA clone library sequencing confirmed the presence of both Msp. 
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(fluorescent) and Mms. (non-fluorescent) affiliated species. The co-culture was again serially 
diluted to extinction, this time with 100 µg/mL novobiocin added, and the outgrowth of the 
greatest dilution producing autofluorescent cocci and methane in headspace gases was used to 
inoculate agar roll tubes. Only one axenic colony pick for Msp. sp. was achieved (hereafter 
referred to as strain BMS), others had a bacterial contaminant when checked and for the sake 
of time they were not further purified. As described in Chapter 2 of this thesis the BMS 
culture was presumed to be axenic and used for further study after microscopic examination 
(the culture appeared to be comprised exclusively of autofluorescent coccoid-shaped cells 
forming clumps) and no detectable amplicon was produced with Bacteria-domain specific 
primers. The PCR amplicon produced with Archaeal primers was sequenced and found to 
share 96% sequence identity with the 16S rRNA gene sequence of Msp. stadtmanae DSMZ 
3091
T
. 
 
3.2.2 Methanosphaera sp. BMS substrate utilization and growth 
kinetics 
The substrate utilization profiles of Msp. strains BMS, as well as Msp. sp. WGK6 and Msp. 
stadtmanae DSMZ 3091
T
 were determined as previously described in detail in Chapter 2 of 
the thesis. To determine the substrate affinities and maximal growth rates (Kovarova-Kovar 
and Egli, 1998) for Msp. stadtmanae DSMZ 3091
T
, WGK6 and BMS when provided either 
ethanol or H2 as a reductant when grown in medium BRN-RF30 (Joblin et al., 1990). The 
substrate affinities and maximal growth rates were calculated from triplicate cultures grown 
with varying concentrations (S) of ethanol (0, 3, 10, 30, 50 and 171 mM) or H2 (0, 1.3, 1.8, 
2.6, 3.5 and 4.6 mM). The optical densities of these treatments were monitored longitudinally 
as described above for substrate utilization profiles. The linear phase of these growth profiles 
over time was used to calculate the specific growth rate (μ) relative to the concentration of the 
limiting substrate for growth (S). These data were plotted as double-reciprocal plots, similar 
to the Lineweaver-Burke using the Michaelis-Menten nonlinear regression type function used 
for characterising enzymes (Lineweaver and Burk, 1934, Johnson and Goody, 2011), with 
this an estimation of substrate affinity (Ks) was determined by finding the substrate 
concentration needed to achieve a half-maximum of the maximal growth rate (μmax).   
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3.2.3 Methanosphaera sp. BMS genome sequencing and closure 
For high molecular weight genomic DNA isolation, cultures (40 mL) of BMS were harvested 
by centrifugation (17,000 x g) after 5 days growth, and the cell pellets were subject to 15 
freeze-thaw cycles, followed by a phenol:chloroform extraction and ethanol precipitation (see 
Appendix 6.13), with the resulting DNA resuspended in ultra-pure water. The DNA was 
quantified using the Quant-iT dsDNA BR Assay Kit according to the manufacturer’s 
instructions (Invitrogen) and its integrity was determined by agarose gel electrophoresis. 
Aliquots (20 µg) of BMS genomic DNA was then sheared by Hydroshear® Shearing Device 
(Pacific Biosciences, CA, USA) to produce fragments ~20 Kb in length, which were then 
used for library construction and SMRT-cell sequencing with the PacBio RS2 “continuous 
long read” platform and the SMRT portal assembly (Pacific Biosciences). The genome 
assembly was performed using HGAP2 and a seed cut-off length of 10 Kb. The quality of the 
genome assemblies for all three strains was assessed using CheckM, which examines lineage-
specific marker genes in order to estimate genome completeness and contamination (Parks et 
al., 2015). In addition, the quality of the BMS genome assembly was assessed using the 
software program Contiguity used for contig adjacency graph construction and visualisation 
(Sullivan et al., 2015). Finally, specific primers were designed (see Appendix 6.5, Table 6.2) 
to sequence “walk” across the determined ends of the single BMS contig and sequenced 
using an Applied Biosystems 3130xl Genetic Analyser as described in Chapter 2 of this 
thesis. The closed BMS genome was further examined using JGI IMG/ER (Markowitz et al., 
2012) which annotates and assigns genes to Clusters of Orthologous Groups (COG) and 
KEGG pathways (Kanehisa and Goto, 2000, Kanehisa et al., 2010, Kanehisa et al., 2006). 
The genome has been deposited at JGI IMG/ER under the accession 2626541600, and 
DDBJ/EMBL/GenBank whole genome submission portal under the accession CP014213. 
 
3.2.4 Nucleotide pattern analysis and Mauve alignment of 
Methanosphaera genomes  
The genome “barcodes” for each Msp. sp. isolate was generated using barcodeByMers 
(https://github.com/minillinim/mikezbioscripts) to determine the tetramer frequency for 
window sizes of 2 Kb and the resulting heat map was generated in RStudio 
(www.rstudio.com) using the package ggplot2 (http://ggplot2.org/). Mauve (Darling et al., 
2010) was used to examine genome synteny and with Msp. stadtmanae DSMZ 3091
T
 as the 
reference genome, as described in Chapter 2.  
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3.2.5 Comparative analyses of Methanosphaera spp. genomes 
The GenBank annotations and COG gene profiles, mobilome, as well as the fused protein 
coding genes of each genome were obtained via JGI IMG/ER. The three genomes were also 
uploaded to the software platform EDGAR (Blom et al., 2009) to determine the core, shared 
and accessory genome for the isolate genomes, which were visualised using a Venn diagram. 
The atlas of fused protein coding genes and the mobilome were constructed using Gview 
(https://server.gview.ca/) by providing Genbank and fasta files of the genes of interest for 
each respective genome, recovered using BLASTn.  
 
3.2.6 Retrieval of Methanosphaera population genomes using 
MetaBAT 
The NCBI Sequence Read Archives (SRA) was queried with the 16S rRNA from Msp. 
stadtmanae DSMZ 3091
T
 to identify datasets most likely to contain sequences associated 
with Msp. spp. (see Appendix 6.14, Table 6.5). Metagenomic datasets identified as 
possessing Msp. spp. associated sequences included; 10 stool samples from the Karlsson et al. 
(2013) study of elderly European women with glucose control profiles considered either 
normal, impaired, or diabetic; Shi et al. (2014) analysis of ovines bred for “low” (n=4) or 
“high” (n=4) methane production; and an unpublished CSIRO study of rumen fluid 
collections of 10 Brahman steers consuming improved Rhodes grass pasture (Chloris 
gayana) +/- supplementation with Leucaena (Leucaena leucocephala), sequence data 
(Illumina HiSeq 2000; Macrogen Inc., Korea) provided by Chris McSweeney (unpublished 
work part of project 01200.035/B.CCH.6510). Datasets were quality checked with 
Trimmomatic v0.32 (Bolger et al., 2014) to remove adapters and trim low-quality bases, and 
bbmerge v34.49 (http://sourceforge.net/projects/bbmap/) was used to merge overlapping 
pairs. The quality checked paired-end and merged reads were assembled using CLC 
Genomics Workbench 8 (http://www.clcbio.com). MetaBAT v0.25.4 (Kang et al., 2014) was 
used to recover population genomes independently from the two metagenomic studies. An 
estimate of population genome completeness and contamination was performed with CheckM 
v1.0.3 (Parks et al., 2015). Annotations for the population genomes were generated through 
the Rapid Annotation using Subsystems Technology (RAST) server (Aziz et al., 2008). 
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3.2.7 Whole genome phylogeny 
Whole genome phylogeny was obtained using GTDBLite 
(https://github.com/Ecogenomics/GTDBLite), built from the concatenation of 122 universal 
marker genes identified by PhyloSift (Darling et al., 2014). Tree inference was performed 
with FastTree v2.1.7 (Price et al., 2010) and included all genomes in IMG v4.510 (Markowitz 
et al., 2012). The resulting tree was imaged using ARB (Ludwig et al., 2004). In addition the 
whole genome phylogeny was re-examined once the core genome (307 genes) was identified 
aligned and concatenated using the software platform EDGAR (Blom et al., 2009). The 
extrapolated genome size is also listed beside each genome, which was calculated based on 
draft genome size and CheckM completeness scoring (Parks et al., 2015). Both phylogenetic 
tress are identical and show a clear separation of smaller genomes (< 2.0 Mbp) which appear 
to be descendants of larger (> 2.1Mbp) ruminant genomes. However, only the tree resulting 
from GTDBLite is presented here. 
 
3.2.8 Comparative analysis of select functional gene sets across 
all Methanosphaera spp. isolate and population genomes 
The phylogeny of protein coding sequences for methyl-coenzyme M reductase component 
A2 (mrtA) and energy conserving hydrogenase (ehaRST) were constructed with sequences 
recovered from the EDGAR core genome assignment. MEGA6 (Tamura et al., 2011) was 
used to construct phylogeny for each dehydrogenase gene respectively, ClustalW (Thompson 
et al., 1994) was used to align the sequences, and the stability of the Jones-Taylor-Thornton 
modelled neighbour-joining tree was evaluated by 1000 bootstrap replications. EDGAR was 
also used to recover the gene alignment view for ehaRST. The DataBase for automated 
Carbohydrate-active enzyme Annotation (dbCAN;  Yin et al., 2012) was used to provide 
automated and comprehensive CAZyme annotation for each of the Msp. genomes, and genes 
encoding for enzymes of ammonium assimilation were also identified from the pan-genome 
collection produced using EDGAR. 
 
3.2.9 Average nucleotide identity (ANI) matrix and pan/core 
development plot 
The Genbank files prepared from RAST annotation system (Aziz et al., 2008) were provided 
to the software framework EDGAR for genomic comparative analysis including average 
nucleotide identity (ANI) matrix generation (Blom et al., 2009). The core-genome for the 10 
Msp. genomes were examined for their average nucleotide identity, which was calculated 
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from blast hit results between the orthologous genes of the core genome. The resulting ANI 
values are presented as a matrix based on phylogeny with ANI values higher than 95% 
considered to be the same species (Konstantinidis et al., 2006) and values from 62-100% 
belong to the same genus (Kim et al., 2014). To determine the development plots for the 
pan/core genome, the perl script PGap (Zhao et al., 2012) was used on the Bio-Linux 
Platform v.8.0.5 (http://environmentalomics.org/bio-linux-software-list/). The three files 
required by this script for each genome included: annotation file (.ptt), nucleotide sequences 
(.ffn) and protein sequences (.faa). The PGap analysis pipeline provided gene clusters 
assigned to either the core or pan-genome and was visualised using the software package 
PanGP (Zhao et al., 2014). 
 
3.3 Results 
3.3.1 Methanosphaera sp. BMS is a hydrogen-dependent 
methylotroph 
Methanogenesis and growth of BMS was not supported by methylated amines, acetate, 
formate, propanol or a mixture of H2:CO2; nor could strain BMS use ethanol as an alternative 
to hydrogen to support methanogenesis. Based on these results I conclude that strain BMS is 
a hydrogen-dependent methylotroph (Fig. 3.1), similar to that shown for Msp. stadtmanae 
DSMZ 3091
T 
rather than for strain WGK6, as presented in Chapter 2.  
 
 
Figure 3.1. Photomicrographs of Msp. sp. BMS upon UV-transillumination (left), or 
following Gram staining (right). Both images were produced from BMS cultures following 
growth with BRN-RF30 medium containing methanol and hydrogen. 
 
The growth of strains Msp. stadtmanae DSMZ 3091
T
, BMS and WGK6 with different 
amounts of hydrogen is shown in Fig. 3.2. Interestingly, and unlike the growth of the other 
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two strains (Fig. 3.2A and B) the growth rate of Msp. sp. WGK6 was found to slow with 
greater amounts of hydrogen added (Fig. 3.2C) and was slower than the growth rates 
observed for this strains when provided different amounts of ethanol as a reductant (Fig. 
3.2D). Based on these results the KS values calculated for hydrogen (0.09 mM) show that 
WGK6 has the strongest affinity, in contrast to DSMZ 3091
T
 (0.11 mM) and BMS (1.58 
mM), which of all three Msp. spp. examined has the weakest affinity for hydrogen. The 
affinity for ethanol by WGK6 (8.46 mM) however, is the weaker of the two reducing 
substrates examined. 
 
 
Figure 3.2. Longitudinal monitoring of the growth of Msp. stadtmanae DSMZ 3091
T
 (A), 
strain BMS (B) and strain WGK6 when provided with either methanol:hydrogen (C) or 
methanol:ethanol (D). The coloured lines and symbols denote different concentrations of 
either H2 (0 ●, 1.3 ■, 1.8 ▲, 2.6 ▼, 3.5 ♦ and 4.6 ○ mM) or in the instance of panel D, 
ethanol (0 ●, 3 ■, 10 ▲, 30 ▼, 50 ♦ and 171 ○ mM). The growth of the individual cultures is 
plotted until the time point at which maximal OD600 was measured. Individual values 
represent the mean (± SEM) produced from triplicate cultures. 
 
 
A) 
C) 
B) 
 
D) 
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3.3.2 The Methanosphaera sp. BMS genome is larger than the 
DSMZ 3091
T
 and WGK6 genomes 
The PacBio RS2 sequencing of the Msp. sp. BMS genome produced a draft genome 
comprised of 24,202 reads with an average reference coverage of 59.62, a mean length of 
8,411 nucleotides, and mean read score of 0.85 (N50 of 13,284 nt). The HGAP2 assembly 
resulted in a single contiguous sequence where the terminal ends overlapped each other 
suggesting a closed genome was produced, this was confirmed by Contiguity (Sullivan et al., 
2015) and sequenced amplicons from specific primers designed to target the overlap region 
validated the genome closure. The BMS genome was confirmed to be comprised of a single 
chromosome that is ~2.90 Mbp in size. The metrics for the BMS genome and the other two 
strains are shown in Table 3.1. In summary, the BMS genome (2.9 Mbp) is substantially 
larger than that of the human and kangaroo isolates of ~1.7 Mbp; and the G+C content is 
higher at 33%, compared to 28% for both strains DSMZ 3091
T 
and WGK6. The differences 
in relative proportions of the genome content from DSMZ 3091T and WGK6 that are readily 
connected with KEGG and COG pathways are slightly greater then stain BMS. Whereas 
strain BMS possesses a substantially larger proportion of its genome predicted to encode 
surface associated and/or exported proteins The CheckM analyses showed that the 
contamination level was estimated to be only 1.6% for BMS, and 0% for both DSMZ 3091
T
 
and WGK6, suggesting that the BMS genome is not a chimeric assembly and is genuinely 
larger.  
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Table 3.1. General genome features for Msp. isolate genomes DSMZ 3091
T
, WGK6 and BMS recovered using the JGI IMG/ER annotation 
engine. Both the number of genes and the proportion of the genome dedicated to these different categories are shown. Note the differences in 
relative proportions of the genome content from DSMZ 3091
T
 and WGK6 that are readily connected with KEGG and COG pathways, whereas 
strain BMS possesses a substantially larger proportion of its genome predicted to encode surface associated and/or exported proteins. 
  DSMZ 3091
T
 WGK6 BMS 
DNA, total number of bases 1767403 100.00% 1729155 100.00% 2868093 100.00% 
DNA coding number of bases 1508136 85.33% 1475054 85.30% 2374599 82.79% 
 DNA G+C number of bases 488399 27.63% 478894 27.70% 944504 32.93% 
Protein coding genes 1536 96.48% 1592 96.90% 2204 97.61% 
 rRNA genes 12 0.75% 6 0.37% 7 0.31% 
               5S rRNA 4 0.25% 2 0.12% 3 0.13% 
               16S rRNA 4 0.25% 1 0.06% 2 0.09% 
               23S rRNA 4 0.25% 3 0.18% 2 0.09% 
tRNA genes 42 2.64% 43 2.62% 40 1.77% 
Protein coding genes with function prediction 1004 63.07% 1197 72.85% 1500 66.43% 
Protein coding genes connected to KEGG pathways 572 35.93% 564 34.33% 603 26.71% 
Protein coding genes connected to KEGG Orthology (KO) 913 57.35% 912 55.51% 1002 44.38% 
Protein coding genes connected to MetaCyc pathways 472 29.65% 471 28.67% 508 22.50% 
Protein coding genes with COGs 1062 66.71% 1067 64.94% 1282 56.78% 
                with KOGs 333 20.92% 345 21.00% 377 16.70% 
                with Pfam 1228 77.14% 1256 76.45% 1590 70.42% 
                with TIGRfam 556 34.92% 554 33.72% 627 27.77% 
                with InterPro 1271 79.84% 807 49.12% 1020 45.17% 
Protein coding genes with enzymes 520 32.66% 520 31.65% 560 24.80% 
Protein coding genes connected to Transporter Classification 106 6.66% 109 6.63% 133 5.89% 
Protein coding genes containing signal peptides 39 2.45% 39 2.37% 133 5.89% 
Protein coding genes coding transmembrane proteins 216 13.57% 329 20.02% 531 23.52% 
Genes in Biosynthetic Clusters 39 2.45% 17 1.03% 143 6.33% 
Fused protein coding genes 92 5.78% 34 2.07% 86 3.81% 
47 
 
3.3.3 Genome “barcode” validates fidelity of Methanosphaera sp. 
BMS assembly 
I next produced a Mauve alignment between the three sequenced genomes as I described in 
Chapter 2, and which is illustrated in Fig. 3.3. The results show that there is a large amount of 
synteny among the three genomes, with the “additional” content present in the BMS genome 
assembly present in large blocks, concentrated to one end of the assembly, and with only a 
limited amount of collinear blocks interspersed throughout this region.     
 
 
Figure 3.3. The degree of genome synteny evident between the Msp. stadtmanae DSMZ 
3091
T
, WGK6 and BMS genomes using Mauve, as described in Chapter 2. The xenologous 
regions present in the BMS genome are not ubiquitous, as illustrated by the large high degree 
of synteny between all three genomes. 
 
To further establish whether the additional genome content may represent contaminating 
and/or chimeric assembly of DNA molecules, I used BarcodeByMers analysis to investigate 
the tetramer nucleotide frequency distributions across the three genomes. The results of these 
analyses are shown in Fig. 3.4 and illustrate that the profiles are all highly similar. Last, I 
selected regions based on the Mauve alignment “unique” to the BMS genome and used 
BLASTn to query the NCBI databases. I found no significant matches to large blocks of other 
bacterial or archaeal genomes, which would be expected if the assembly of the BMS genome 
was comprised of multiple genomes. Taken together, these results suggest that: i) the BMS 
genome is not a chimeric assembly and originates from an axenic culture and; ii) the extra 
genome content is not the result of recent gene transfer events.  
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Figure 3.4. The tetramer nucleotide frequency distributions (“barcode”) patterns produced by 
using the BarcodeByMers program with default settings, from the genomes of Msp. isolates 
BMS, DSMZ 3091
T
 and WGK6. Each column represents a specific tetramer nucleotide 
sequence, and each row represents windows of 2000 bp, with the occurrence frequency 
shown by the intensity scale (right). There appears to be no substantial variations in 
barcoding patterns across the three genomes, further supporting that neither a chimeric 
assembly, nor substantial amounts level of lateral gene transfer, are responsible for the 
increased size of the BMS genome. 
 
3.3.4 Methanosphaera sp. BMS has a larger mobilome compared 
to other Methanosphaera isolates 
Annotations for BMS in comparison to DSMZ 3091
T
 and WGK6 identified up to 36% of the 
genes in the BMS are strain specific, shown in Fig. 3.5. These accessory genes appear to be 
predominately comprised of hypothetical proteins as well as a substantial number of mobile 
elements (mobilome), including transposases and retroelements (Table 3.2). As shown by 
Table 3.2, a large portion of these “unique” genes are absent from the COG database (976) 
this is significantly higher in comparison to unassigned genes observed for DSMZ 3091
T
 
BMS 
DSMZ 3091T 
WGK6 
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(525) and WGK6 (576). In addition to this, the BMS genome also contains a larger 
proportion of genes assigned as “hypothetical/unknown function”, while the remainder of the 
“unique” gene set consists of mediators to resistance to antibiotics/toxic compounds, amino 
acid transport and metabolism, replication, recombination and repair, transcription, and 
posttranscriptional modification (Table 3.2). Indeed, the number of transposases and 
retroelements is dramatically different between DSMZ 3091
T
 (1 transposase in total), WGK6 
(0 in total), and BMS (30 transposase and 4 RNA-directed DNA polymerases). The 
mobilome of BMS shows that the genes are ubiquitous, spread throughout the genome (Fig 
3.6). This expanded mobilome may at one point have been responsible for the expansion of 
the BMS genome and closer BLASTn analysis show that over half of these genes are closely 
related to Mbb. spp., with other matches to genes from Megasphaera (16%), 
Caldicellulosiruptor (7%), Bacillus, Methanobacterium and Fusobacterium (<5%).  
However, the additional 1 Mbp of genomic data does not appear to be a recent acquisition for 
BMS, as indicated by a stable genomic signature across the genome (Fig. 3.4). Based on 
these results, I therefore hypothesised that the larger, BMS genome, is representative of the 
ancestral lineage for Msp. spp. and the smaller genomes have evolved as a result of 
substantial gene loss, possibly upon colonisation of “new” gut environments (i.e. human and 
kangaroo). 
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Figure 3.5. Venn diagram depiction of the core, shared and unique genes present in Msp. 
genomes from strain WGK6 (A), BMS (B) and DSMZ 3091
T 
(C). The gene counts are based 
on reciprocal BLASTp analysis of the EDGAR-based predictions of protein-coding genes 
from each genome. The Msp. core genome consists of 1155 genes with a low count assigned 
as shared (59-94), while the bulk of the remaining genes are classed as unique. Nearly half of 
the strain BMS genome is considered to be “unique” (935) in comparison to the other Msp. 
isolates.  
  
254 
239 935 59 
89 94 
1155 
A) 
B) C) 
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Table 3.2. Comparison of the COG categories for Msp. isolates DSMZ 3091
T
, WGK6 and BMS annotated by JGI IMG/ER. Note that the two 
main differences (both in gene count and proportion) are the number of genes either lacking a COG assignment, or predicted to possess prophage 
or transposon-like functions from strain BMS. 
COG categories DSMZ 3091
T
 WGK6 BMS 
Not in COG 525 32.65% 576 35.06% 976 43.15% 
Translation, ribosomal structure and biogenesis 168 14.53% 173 15.26% 175 12.67% 
General function prediction only 110 9.52% 110 9.70% 147 10.64% 
Coenzyme transport and metabolism 115 9.95% 111 9.79% 121 8.76% 
Amino acid transport and metabolism 105 9.08% 96 8.47% 118 8.54% 
Energy production and conversion 100 8.65% 106 9.35% 106 7.68% 
Function unknown 83 7.18% 78 6.88% 105 7.60% 
Cell wall/membrane/envelope biogenesis 76 6.57% 69 6.08% 79 5.72% 
Replication, recombination and repair 55 4.76% 54 4.76% 72 5.21% 
Transcription 47 4.07% 48 4.23% 63 4.56% 
Inorganic ion transport and metabolism 53 4.58% 44 3.88% 59 4.27% 
Posttranslational modification, protein turnover, chaperones 44 3.81% 45 3.97% 58 4.20% 
Nucleotide transport and metabolism 53 4.58% 53 4.67% 51 3.69% 
Carbohydrate transport and metabolism 43 3.72% 41 3.62% 46 3.33% 
Lipid transport and metabolism 25 2.16% 29 2.56% 38 2.75% 
Mobilome: prophages, transposons 1 0.09% 0 0.00% 34 2.46% 
Defence mechanisms 24 2.08% 22 1.94% 26 1.88% 
Signal transduction mechanisms 15 1.30% 13 1.15% 23 1.67% 
Secondary metabolites biosynthesis, transport and catabolism 6 0.52% 8 0.71% 18 1.30% 
Intracellular trafficking, secretion, and vesicular transport 13 1.12% 14 1.23% 16 1.16% 
Chromatin structure and dynamics 8 0.69% 7 0.62% 12 0.87% 
Cell cycle control, cell division, chromosome partitioning 8 0.69% 8 0.71% 10 0.72% 
Cell motility 3 0.26% 3 0.26% 3 0.22% 
Extracellular structures 1 0.09% 2 0.18% 1 0.07% 
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Figure 3.6. Linear representations of the genomes of DSMZ 3091
T 
(A), WGK6 (B) and BMS (C) showing the location of their respective 
mobilome and fused protein coding genes; as identified by JGI IMG/ER and COG assignment and visualised using Gview, as described in the 
materials and methods. The genome of strain BMS possesses the greatest number of genes assigned to the mobilome (34) and second highest 
number of fused protein coding genes (86) which are ubiquitous throughout the genome. The genome of strain DSMZ 3091
T
 is predicted to 
contain only one gene encoding mobilome function, but the highest number of ubiquitous fused protein coding genes (92) of the three isolate 
genomes. Finally, WGK6 has no genes assigned to the mobilome and only 34 fused protein coding genes assigned to a 0.75 Mbp region of the 
genome (1.7 Mbp in total). 
C) 
B) 
A) 
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3.3.5 The Methanosphaera population genomes extracted from 
other metagenome sequence datasets are comprised of two 
“genomotypes”   
Seven additional Msp. spp. population genomes were recovered from two publically available 
metagenomic datasets and one unpublished CSIRO project, and the statistics for each 
population genome are presented in Table 3.3. I have estimated the size of the “complete” 
genomes by using CheckM’s completeness score and the size of each population genome,  
and based on these calculations I was successful in recovering another two “small” (<2.0 
Mbp) and five “large” (>2.1Mbp) genomes, further validating that the BMS genome is a true 
representation of Msp. affiliated archaea. 
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Table 3.3. Summary statistics of the Msp. isolate and MetaBAT-recovered population genomes, with respect to population genome size, 
CheckM completeness and contamination scores, and the predicted complete genome size, based on these metrics.  
Genome designation Source Location 
Population 
genome size (bp) 
GC 
(%) 
CheckM completeness 
(%) 
CheckM contamination 
(%) 
Predicted 
complete genome 
size (Mbp) 
DSMZ 3091
T
 Human US 1767403 28.0 99.0 0 
 
WGK6 
Western Grey 
kangaroo 
AUS 1729155 28.0 98.1 0 
 
BMS Bovine AUS 2868093 33.0 99.1 0.8 
 
DEW79 Human Europe 1594581 27.6 97.2 0.8 1.6 
SHI613 Ovine NZ 1859301 33.0 90.4 0 2.1 
SHI1033 Ovine NZ 1496386 29.9 74.3 0 2.0 
rholeuAM6 Bovine AUS 1935828 32.9 92.7 0 2.1 
rholeuAM74 Bovine AUS 2004016 35.5 75.9 0.8 2.6 
rholeuAM130 Bovine AUS 2057527 34.8 77.6 4.7 2.5 
rholeuAM270 Bovine AUS 1763900 35.5 61.8 0 2.9 
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3.3.6 All Methanosphaera isolate and population genomes possess 
a high degree of synteny 
The Mauve alignments of the small genomotypes showed there is high level of synteny 
between all these genomes, illustrated in Fig. 3.7. Additionally, the Mauve alignments of the 
large genomotypes revealed a high level of synteny and importantly, the population genomes 
provide confirmatory evidence of syntenic regions extending across the 1 Mbp “unique” 
region produced by the sequencing of the BMS genome (Fig. 3.8). Based on these findings, I 
hypothesised that Msp. phylogeny could be reconstructed from a pan-genome approach. To 
address this hypothesis, I first constructed a phylogenetic tree using 122 universal marker 
genes identified by PhyloSift.  Next the core genome was identified, and these genes were 
concatenated with EDGAR and also used to construct a phylogenetic tree. Both these 
analyses produced similar results, as shown in Fig. 3.9; which depicts a clear separation 
between species with a smaller genome (< 2.0 Mbp: DSMZ 3091
T
, WGK6, DEW79 and 
SHI1033) from those with genomes larger than 2.1 Mbp. It would also appear that the smaller 
genomes have evolved from ancestral strains with a larger genome through gene 
dispensation, supporting my hypothesis that the human and kangaroo strains evolved through 
a loss of genomic content as a result of host adaptation. 
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Figure 3.7. Mauve alignments of the “small” (< 2.0 Mbp) genomes Msp. stadtmanae DSMZ 3091T, DEW79, WGK6 and SHI1033. The extent 
of the synteny between all the genomes is striking, and especially so between the Msp. stadtmanae DSMZ 3091
T
 and DEW79 population 
genome, both representing isolates of human origin. 
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Figure 3.8. Mauve alignments of the “large” (> 2.1 Mbp) Msp. spp. population genomes (rholeuAM270, rholeuAM130, rholeuAM74, SHI613 
and rholeuAM6) against reference isolate genome BMS. The extent of gene synteny among all ruminant originating species is notable, save for 
rhoeuAM270 and rholeuAM74, which have noticeable xenologous regions at the end of their sequence lengths. 
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Figure 3.9. The whole genome phylogenetic tree of the isolate and population genomes 
recovered for Msp. spp. The tree was constructed by ARB from concatenation of 122 
universal marker genes and genomes available in IMG v4.510 and shows a clear separation 
of “smaller” genomes (< 2.0 Mbp) which appear to be descendants of “larger” (> 2.1 Mbp) 
ruminant genomes. 
 
Comparative analyses of the 3 isolate and 7 population genomes core housekeeping genes 
were examined through phylogenetic placement and are shown in Fig. 3.10 and 3.12. The 
core methanol-reducing methanogenesis gene methyl-coenzyme M reductase component A2 
(mrtA) recapitulates the finding of the whole genome phylogeny (Fig. 3.10). In addition to 
this the comparison of the energy conserving hydrogenase gene (ehaRST) demonstrates a 
high degree of synteny (Fig. 3.11) across all the Msp. spp. representatives validating the 
initial Mauve alignment of whole genomes (Fig. 3.7 and 3.8). Phylogenetic placement for 
each of the Eha genes reveals the same findings as those shown for mrtA gene (Fig. 3.12).  
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Figure 3.10. The phylogenetic tree constructed with Jones-Taylor-Thornton (JTT) model, 
using BLASTp alignments of methyl-coenzyme M reductase component A2 (mrtA) genes 
sampled from the core set of the 10 Msp. genomes. Recapitulating the findings from the 
whole genome phylogeny (Fig. 3.8) the mrtA phylogeny shows a clear separation of 
“smaller” genomes (< 2.0 Mbp) which appear to be descendants of “larger” (> 2.1 Mbp) 
ruminant genomes.  The scale bar represents 10% sequence divergence. Numbers represent 
the relative frequency of branch clustering based on 1000 bootstrap runs, bootstrap values 
less than 50% are removed, with Mbb. ruminantium DSMZ 1093
T
 used as the outgroup. 
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Figure 3.11. EDGAR software alignment of gene regions containing the energy conserving 
hydrogenase gene (ehaRST) for the 10 Msp. genomes. The extent of gene synteny and 
conservation supports the contention that all these genomes are representative of the Msp. 
genus; Mbb. ruminantium DSMZ 1093
T
 is used as the outgroup.  
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Figure 3.12. The phylogenetic tree constructed with Jones-Taylor-Thornton (JTT) model, 
using BLASTp alignments of energy conserving hydrogenase gene (ehaR) genes sampled 
from the core set of the 10 Msp. genomes. Recapitulating the findings from the whole 
genome and mrtA phylogeny (Fig. 3.8 and 3.9), the ehaR phylogeny shows a clear separation 
of “small” genomes (< 2.0 Mbp) which appear to be descendants of “large” genome (> 2.1 
Mbp) ruminant ancestors. The scale bar represents 10% sequence divergence. Numbers 
represent the relative frequency of branch clustering based on 1000 bootstrap runs, bootstrap 
values less than 50% are removed, with Mbb. ruminantium DSMZ 1093
T
 used as the 
outgroup. 
 
KEGG pathways for methane metabolism for each of the population genomes are partially 
assembled, but it is apparent that methanol and no other methylated derivatives (i.e. 
methylamines) are the used as substrates for methanogenesis with the presence of coenzyme 
M methyltransferase subunits A, subunit B and/or subunit C. While hydrogen-dependent 
reduction of methanol to methane may be a common feature throughout my collection of 
genomes I have also identified some substantive differences which may support my previous 
findings that at least some species of Msp. are not strictly hydrogen dependent methylotrophs. 
As shown in Chapter 2 of this thesis, culture-based studies of WGK6 revealed that this 
archaeon can use ethanol as a sole source of reducing power for methanol reduction and 
methanogenesis, via genes encoding for alcohol- and aldehyde- dehydrogenases. 
Interestingly, homologues of these genes are also present in the ovine-derived population 
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genome SHI1033 (both dehydrogenase genes having 88% identity and 94% coverage 
compared to WGK6 dehydrogenase genes, see Fig. 3.13) which originates from animals 
described as “low methane” producers. Homologues of these genes are absent from all the 
other population genomes, as well as the BMS and DSMZ 3091
T
 genomes, which is 
consistent with BMS and DSMZ 3091
T
 culture-based studies. Consistent with analysis of the 
whole genome phylogeny I have also confirmed that WGK6 and SHI1033 are closely related 
(Fig. 3.9). 
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A) 
 
B) 
 
Figure 3.13. The clustalW alignment for the aldehyde (A) and alcohol (B) dehydrogenase genes identified in both Msp. sp. SHI1033 and 
WGK6, which are 88% identical across 94% of the two genes. 
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The CAZyme annotations from dbCAN for each of the Msp. genomes are shown in Table 
3.4. There are six CAZyme families identified across the 10 Msp. genomes and the general 
profile appears to be evolutionarily conserved and maintained across all genomes. This serves 
to validate the veracity of the population genomes recovered, considering the level of 
completeness of the population genomes the assembly would appear to be accurate and 
precise. Taking a closer look at the CAZyme families the first is defined as auxiliary activity 
(AA) classified as 1,4-benzoquinone reductase (KEGG enzyme EC. 1.6.5.6) for the shunting 
of protons and electrons for the conversion of NADPH, H
+
 and p-benzoquinone to NADP
+ 
and hydroquinone, for types AA3 and AA6 the profile is the same across the genomes. In 
contrast the carbohydrate-binding module (CBM) is poorly represented across the Msp. 
genome representatives. Carbohydrate esterase (CE) family plays a role in the metabolism of 
methane as S-formylglutathione hydrolase (KEGG enzyme EC 3.1.2.12) converting S-
formylglutathione to formate and the profile is again conserved across all genomes. The 
glycoside hydrolases (GH) have scant representation across the genomes, save for GH109, an 
α-N-acetylgalactosaminidase which supports the cleavage of peptidoglycan in the cell wall 
formed from linear chains of two alternating amino sugars, namely N-acetylglucosamine and 
N-acetylmuramic acid (Ashida et al., 2000, Balch et al., 1979). Of these CAZyme families 
the most numerically abundant and conserved is glycosyltransferases (GT), namely GT2 and 
GT4, these genes are involved with glycosylation, attaching glycans to proteins most 
commonly found in cell surface proteins (Jarrell et al., 2010, Magidovich and Eichler, 2009). 
These conserved GT modification enzymes decorate the cell wall and may play a role in the 
variation of immunomodulation between methanogenic archaea. Finally, the CAZyme family 
polysaccharide lyase (PL) had a low gene count but was still represented by most genomes, in 
particular was PL9 a pectate lyase (KEGG enzyme EC 4.2.2.2).  
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Table 3.4. Gene counts for CAZyme families obtained from annotation of the 10 Msp. spp. genomes by dbCAN. Overall the profile of CAZyme 
families and total gene counts represented by each genome are virtually the same, suggesting that these functions have been conserved and 
maintained across both genomotypes. 
CAZyme Family DSMZ 3091
T
 WGK6 BMS DEW79 SHI613 SHI1033 rholeuAM6 rholoeuAM130 rholeuAM74 rholeuAM270 
Auxiliary Activity 
          
AA3 1 1 1 1 1 1 1 1 1 1 
AA6 7 10 14 7 13 13 10 10 8 7 
AA9 
  
2 
 
1 
  
1 
  
Carbohydrate-Binding Module 
          
CBM35 
    
1 
   
5 
 
CBM54 
    
1 
     
Carbohydrate Esterase 
          
CE1 3 3 3 3 2 3 3 2 1 3 
CE10 
  
3 
   
1 
 
3 1 
CE2 
       
1 
 
2 
CE3 
      
1 
   
Glycoside Hydrolase 
          
GH10 
  
1 
      
1 
GH109 1 1 2 1 1 1 2 1 1 
 
GH120 
      
1 1 1 
 
GH2 
        
1 
 
GH20 
        
1 
 
GH24 
     
1 
    
GH46 
      
1 
   
Glycosyltransferase 
          
GT2 31 28 26 29 17 25 27 18 11 12 
GT27 
 
4 1 1 2 1 1 3 1 1 
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GT28 5 2 2 5 2 2 3 2 
  
GT31 
       
1 
  
GT4 12 15 14 12 14 15 12 14 13 13 
GT44 
  
1 
       
GT45 
 
1 1 
 
2 
 
1 1 
  
GT5 
        
1 
 
GT66 3 3 2 3 3 2 2 1 3 3 
GT8 
        
1 
 
GT81 1 1 1 1 1 1 1 1 1 
 
GT83 3 2 3 3 2 3 2 2 2 2 
GT93 
     
1 
    
Polysaccharide Lyase 
          
PL14 
      
1 
   
PL6 
     
1 
    
PL9 3 
 
2 3 
  
2 1 1 1 
Total 70 71 79 69 63 70 72 61 56 47 
Total based on completeness 71 72 80 71 69 88 77 76 69 65 
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Gene counts for the ammonium assimilation pathway were recovered from the pan-genome 
annotation for all 10 Msp. spp. and are shown in Table 3.5. Ammonium assimilation and 
metabolism is important for its incorporation into cell material, this occurs mainly by the 
glutamate dehydrogenase (GDH) and/or glutamine synthetase-glutamate synthase pathway 
(GS-GOGAT; Cabello et al., 2004). The NADP-specific GDH gene is present as a single 
copy across all of the isolate genomes, with only missing from 3 of the draft population 
genomes. The GS-GOGAT pathway is represented by conserved glutamine synthetase gene 
Type 1 (GS1) profile across all of the genomes averaging a single gene count while there is 
some variation for glutamate synthase. This variation is most notable for WGK6 as the other 
isolate and population genomes have 2-4 copies of the gene (consisting of the mainly of the 3 
glutamate synthase subunits) WGK6 only possesses one copy (GS-GOGAT subunit 2).   
 
Table 3.5. Profile of genes assigned to encode for NADP-specific glutamate dehydrogenase 
(GDH) or the glutamine synthetase Type 1 (GS1)/glutamate synthase (GS-GOGAT) 
pathways of ammonia assimilation. 
  
Glutamate 
dehydrogenase (GDH) 
Glutamate synthase 
(GS-GOGAT) 
Glutamine 
synthetase (GS1) 
DSMZ 3091
T
 1 3 1 
WGK6 1 1 1 
BMS 1 3 2 
DEW79 1 3 1 
SHI1033 
 
4 2 
SHI613 1 
 
1 
rholeuAM6 1 3 1 
rholeuAM74 2 
 
1 
rholeuAM130 
 
2 1 
rholeuAM270 
 
3 1 
 
3.4 Discussion  
Collectively my results demonstrate an expansion of the genomic representation for Msp. 
spp., which revealed 2 separate genomotypes characteristically identified as either possessing 
a “large” (>2.1 Mbp) or “small” (<2.0 Mbp) genome with evidence to suggest that the 
“small” genomotype is a more recent evolutionary event (Fig. 3.9) occurring through the 
dispensation of genes (Fig. 3.4). While there have obviously been events to drive these 
species to adapt to their respective host environments the average nucleotide identity (ANI) 
of the core-genome recovered from complete and draft genome (Fig. 3.14) supports my 
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identification of 9 new Msp. representatives. Of the ten genomes DSMZ 3091
T
 and DEW79 
have an ANI value above the generally accepted threshold for species recognition (> 95%) 
(Konstantinidis et al., 2006) while the others ranged between 77-85%, values which are still 
considered to occur within a genus (typically 62-100%) (Kim et al., 2014). Collectively these 
values suggest that of all the genomes recovered during this study 8/10 are novel species to 
the genus Msp. The findings presented in this Chapter are not an exhaustive comparative 
analysis and only provide preliminary findings which focus on differences in genome size 
and validation of this observation, for the previously poorly represented Msp. spp.   
 
 
Figure 3.14. The average nucleotide identity (ANI) matrix of both Msp. isolate and 
population genomes, calculated from blast hit results between the orthologous genes of the 
core-genome using software platform EDGAR. ANI values higher than 95% are considered 
to be the same species and values from 62-100% belong to the same genus. All ANI values 
displayed in the matrix are greater than 77% but only two genomes exceed 95%, indicating 
that they are members of the same species (i.e. DSMZ 3091
T
 and DEW79).  
 
Development plots for the core and pan-genome of these Msp. spp. representative genomes 
are showed in Figure 3.15. The pan-genome consists of 5,321 genes and 305 are assigned to 
the core-genome, which essentially consists of genes supporting methanogenesis (hdr 
Heterodisulfide reductase, mtd F420-dependent methylenetetrahydromethanopterin 
dehydrogenase, mcrA methyl-coenzyme M reductase A2, NADPH-dependent F420 
reductase, formylmethanofuran--tetrahydromethanopterin formyltransferase, coenzyme F420 
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hydrogenase), ABC transporters, glycosyltransferases, transcription/translational initiation 
factors and hypothetical genes. Growth of the pan-genome continues to trend upwards 
suggesting that there is still room for the development of this collection (Fig. 3.15). However, 
the core-genome would appear to be covered upon the addition of the eighth genome, a 
representation which may be improved if complete genomes were used rather than draft 
population genomes, as I have shown with the Msp. isolate core genome (n= 1155; Fig. 3.4).  
In addition to this we can see from the dbCAN profile (Table 3.4) that there is a level of 
conservation of enzymes linked to cell wall biosynthesis across both the isolate and draft 
population genomes. These findings not only confirm the veracity of the genome recovery 
and phylogenetic relatedness among the isolate and population genomes, but also provide 
important information for rumen microbiologists who are interested in developing vaccines 
for methane abatement strategies, as well as human immunologists who are investigating the 
role of methanogenic archaea in the onset and/or progression of non-communicable diseases. 
As demonstrated by Blais Lecours et al. (2014) persons suffering IBD had an increased 
prevalence of Msp. sp. as well as a high specific IgG response. Additionally, the human 
isolate of Msp. stadtmanae DSMZ 3091
T
 can elicit a stronger inflammatory response than 
Mbb. smithii (Blais Lecours et al., 2011, Blais Lecours et al., 2014, Bang et al., 2014). 
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Figure 3.15. Development plots depicting the growth of the core (green, y = 2349.33e
-0.55x
 + 
45.92) and pan-genome (blue, y = 14255.55x
0.55
 + 42.25) for the Msp. isolate and population 
genomes clustered through Biolinux command line PGap, and plotted with software package 
PanGP. The total pan-genome consists of 5,321 genes, while the core-genome for all 10 Msp. 
representatives has a relatively small gene count (305) in comparison to the isolate genomes 
(Fig. 3.5) most likely due to the incomplete nature of the population genomes. 
 
In Chapter 2, I showed that the alcohol-fuelled methanogenesis pathway of strain WGK6 
involves tandemly located alcohol and aldehyde dehydrogenase genes. Investigation of the 
isolate and population genomes showed that these dehydrogenase gene orthologs were only 
present in the ovine-derived population genome SHI1033 (Fig. 3.13). The SHI1033 
dehydrogenase genes originate from an ovine phenotypically typed as a low methane 
producing animal. I believe this is an example of adaptation in response to a “low hydrogen” 
environment, a pressure which would force Msp. spp. to utilise an alternate source of 
reducing power in order to persist within the microbiome. These findings not only validate 
the findings of Chapter 2 but I feel they also provide new insights into the nutritional ecology 
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of gut methanogens, and in particular the ability of methanogenic archaea to adapt to change. 
The question still remains, to what extent are these metabolically versatile Msp. spp. present 
within a wider variety of gut environments? Are they in fact present in environments which 
encourage adaption to “low hydrogen” or increased availability of short chain alcohols? Such 
findings are not only relevant to efforts curbing livestock methane emissions, but also have 
potential implications in regards to our understanding and monitoring of gut dysbiosis in 
humans. It has been shown that fermentation schemes favouring ethanol formation are more 
active in non-alcoholic fatty liver disease where periods of gut “dysbiosis” results in a shift in 
the microbial community structure (Lau et al., 2015). In fact Msp. spp. are receiving more 
attention as their potential link to gut “dysbiosis” conditions such as IBD become more 
likely. For instance, a notable shift from the prevalence of hydrogenotrophic to 
methylotrophic methanogenic archaea such as Msp. spp. has been reported for IBD patients 
(Blais Lecours et al., 2014).  
 
In conclusion, the identification of larger Msp. genomes, which appear to be the ancestor of 
the model representative Msp. stadtmanae, and presence of dehydrogenase genes within 
another “low methane” environment further validate my previous findings that Msp. spp. 
have undergone some important evolutionary adaptions to persist within a variety of gut 
environments and are more diverse/metabolically versatile than previously thought. 
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Chapter 4  Variations in Methanobrevibacter and Methanosphaera spp. 
populations in clinical studies and assessment of their immunomodulatory 
properties 
4.1 Introduction 
As outlined in the preceding Chapters of my thesis, the methanogen communities of livestock 
and other herbivores are typically dominated by Mbb. spp., which is widely recognized to 
sustain syntrophic metabolism via hydrogen and carbon dioxide utilization for 
methanogenesis (e.g. Miller et al., 1982, Bryant and Wolin, 1975). The methylotrophic 
methanogenic archaea such as Mms. and Msp. spp. are also commonly encountered, usually 
at lower numbers, but sometimes, they are the predominant members of these archaeal 
communities (Seedorf et al., 2015, Dridi et al., 2011, St-Pierre and Wright, 2013). Recent 
studies suggest that the abundance of these methylotrophic archaea may be linked with total 
methane output. For instance, an increased abundance of Msp. spp. were observed in the 
“low” methane sheep by Shi et al. (2014), in contrast to the typical Mbb. spp. domination 
seen within “high” methane emitting sheep. Parallel studies in Europe with beef cattle 
produced similar findings with respect to higher numbers of Mbb. spp. in the “high” emitters 
(Wallace et al., 2015). Such findings suggest that gaseous hydrogen formation by the 
microbiota can affect both the ecology and quantity of methanogenic archaea (Kittelmann et 
al., 2014). 
 
As outlined in my literature review, much of our understanding about human gut 
methanogens and methanogenesis is based on studies conducted with subjects from first-
world countries. A higher prevalence of methane excretors (and when measured, methanogen 
abundance in faeces) is seen among persons suffering from gastrointestinal disorders, 
including IBS-C, colorectal cancer and diverticulosis (Chatterjee et al., 2007, Conway de 
Macario and Macario, 2009). In a recent case-controlled study of inflammatory bowel disease 
(IBD), Blais Lecours et al. (2014) found that healthy control subjects had a higher prevalence 
of Mbb. smithii and a paucity of Msp. stadtmanae. However, the IBD group not only had a 
much reduced total number of methanogens, but the community had changed to a greater 
prevalence of Msp. stadtmanae. Although none of these associations establish whether 
methanogens and/or methanogenesis are the cause or a consequence of these conditions, 
Conway de Macario and Macario (2009) did propose that the role for methanogenic archaea 
in gut disorders may be indirect: a reflection of the nutritional ecology and metabolic 
interactions that “shape” the gut microbiota during the periods of microbial “dysbiosis” seen 
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with many non-communicable diseases, from periodontitis to obesity. In that context, recent 
studies of the gut microbiota of patients with non-alcoholic fatty liver disease and more 
severe conditions (i.e. end-stage renal disease (ESRD)) suggest that the microbiota is not only 
“dysbiotic”, but fermentation schemes favouring short chain alcohol formation are more 
active (Lee et al., 2012, Zhu et al., 2013). 
 
The interaction between methanogens and the host immune system have been relatively 
underexplored although Conway de Macario and Macario (2009) hypothesised that it may 
occur and have relevance to health and well-being. Consistent with this Blais Lecours et al. 
(2011) reported that Msp. spp. are a principal component of bioaerosols in animal houses, and 
using a mouse model showed that Msp. stadtmanae provokes a stronger immune response 
within the lung tissue (including stimulation of macrophage, lymphocyte, neutrophil, and 
eosinophil recruitment to lung tissue) than mice exposed to preparations of the Mbb. smithii. 
Blais Lecours et al. (2014) also found that with the increased prevalence of Msp. stadtmanae 
in IBD patients as determined by qPCR methods targeting the mtaB1 gene, there was a 
measurable production of anti-Msp. stadtmanae IgG antibodies in their serum, which was not 
seen in healthy controls, or patients found to be Msp. stadtmanae “negative”. Additionally, 
Msp. stadtmanae cell preparations were found to produce a much stronger release of the 
proinflammatory cytokine TNF-α from the peripheral blood mononuclear cells (PBMC) of 
healthy control subjects than similar preparations of Mbb. smithii. A separate study confirmed 
that Msp. stadtmanae cells stimulate a greater release of the proinflammatory cytokines IL-1β 
and TNF-α than Mbb. smithii from moDCs. However, there appeared to be no differences in 
the response of a human intestinal epithelial cell line (Caco-2/BBe) to these methanogens 
(Bang et al., 2014).  
 
Collectively, these findings suggest that: i) not unlike what is seen in ruminants, a change in 
the bacterial fermentation and nutritional ecology of the gut, such as reduced hydrogen 
formation and/or formation of short chain alcohols, can result in changes in both methanogen 
abundance and profile; ii) that the human isolate of Msp. stadtmanae can elicit a stronger 
inflammatory response than Mbb. smithii, and; iii) Msp. stadtmanae is also capable of 
triggering an adaptive immune response (via IgG).  
 
In this Chapter, I report the results from a collection of studies that seek to address some of 
these aspects of gut methanogen-host interactions. First, I have investigated whether and how 
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the composition of the methanogenic archaea in patients with CKD is altered in response to 
synbiotic administration, as an intervention designed to restore a “healthy” gut microbiota 
and fermentation pattern. I have also assessed the immunogenic properties of the type strains 
of Mbb. smithii DSMZ 861
T
, Mbb. ruminantium DSMZ 1093
T
 and Msp. stadtmanae DSMZ 
3091
T
 as well as my newly isolated strains WGK6 and BMS using a combination of mouse 
macrophage and human PBMC. I have conducted these studies because the findings could 
have important consequences for the diagnosis and treatment of gut diseases and disorders in 
humans. Furthermore, furthering our knowledge of how gut methanogens interact with the 
host immune system might prove to be valuable for the development of effective anti-
methanogen vaccines for livestock methane abatement. 
 
4.2 Materials and Methods 
4.2.1 Samples from the SYNERGY study 
Faecal samples from the SYNERGY study (Rossi et al., 2014) were kindly provided by 
Megan Rossi and the SYNERGY team based at the Princess Alexandra Hospital and 
Translational Research Institute (Brisbane, Australia). In brief detail, the SYNERGY study 
aimed to assess the effectiveness of synbiotics (the co-administration of pre- and probiotics) 
to 37 patients with moderate to severe CKD as a treatment to reduce the serum concentrations 
of indoxyl sulphate, endotoxemia and trimethylamine-N-oxide (TMAO). The study was 
designed as a double-blind, placebo-controlled, randomised, cross-over trial, with a 2 week 
pre-treatment period, a synbiotic therapy or placebo arm for 6 weeks, than a 4 week washout 
period before cross-over to synbiotic therapy or placebo for 6 weeks. Of the 37 CKD patients, 
21 consented to faecal sample collection at entry (week 0) and at the end point of the first 
treatment period and washout, and then at the end of the study (end of second treatment) as 
described by (Rossi et al., 2014). The samples were stored at -80 C prior to DNA extraction. 
 
4.2.2 Clinical samples from healthy subjects 
Six “healthy” volunteers were recruited under an ethics application #2015000775 approved 
by the University of Queensland HREC. This group is comprised of 2 males and 4 females 
between the ages of 21 and 36 years described as “healthy” (exclusion criteria: any chronic 
illness; any acute illness in the preceding 2 months; antibiotic use within the last 2 months). 
Blood (30 ml) was collected by a qualified phlebotomist via venous puncture into vacuum 
pressurised tubes containing EDTA, and processed immediately for PBMC isolation. Of the 6 
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volunteers, 3 (HMI0004-6) also consented to provide a stool sample that was stored at -80 °C 
with 1 hour of collection (collected in Sarstedt Feaces tubes (55x44mm) from Brisbane, 
Australia donors in September 2015) , prior to DNA extraction and PCR-based tests for the 
presence of Msp. and Mbb. spp. 
 
4.2.3 PBMC isolation procedures 
The whole blood was diluted 1:1 with PBS-EDTA, and PBMC were isolated using Ficoll-
Paque PLUS (GE Healthcare Life Sciences, Parramatta, NSW, Australia) separation, 
according to manufacturer’s specifications. In brief, 35 mL of the diluted blood was carefully 
layered onto 15 mL of Ficoll-Paque PLUS contained within a 50 mL Falcon tube, using a 
sterile plastic pipette. The mixture was then centrifuged at 400 x g for 30 minutes without 
braking at ambient temperature. The PBMCs were sedimented at the interface between the 
serum and Ficoll-Paque layer (Appendix 6.15), and this fraction (~10 mL) was collected by 
sterile, disposable pipette, and transferred into a new 50 mL Falcon tube.  This fraction was 
then diluted to 50 mL with PBS-EDTA to wash the PBMCs, which was harvested by 
centrifugation at 400 x g for 5 minutes with brake. After the supernatant was removed, the 
PBMCs were resuspended in 20 mL PBS only, and an aliquot (0.01 ml) was taken for PBMC 
counting using a hemocytometer. At this point, the PBMCs were harvested again by 
centrifugation and diluted to a final concentration of 2.7 x 10
6
 cells/mL. Cells were diluted 
with RPMI medium supplemented with foetal bovine serum (heat-inactivated and filter 
sterilised, 10% vol/vol) and also with penicillin-streptomycin L-glutamine (stock consists of 
10,000 units/mL pen-strep and 29.2 mg/mL L-glutamine; 1% vol/vol).  
 
4.2.4 Faecal DNA extraction, PCR and qPCR methods 
For each respective stool sample from the SYNERGY study, as well as those from the 3 
healthy subjects above, 0.15 g was weighed out and total DNA extracted. The weighed out 
samples had 0.4 g of sterile zirconia beads added with 600 µL of RBB+C lysis buffer (Yu 
and Morrison, 2004) which were first homogenized for 3 minutes at 5000 x g using the 
Precellys 24 (Bertin Technologies, France). This was followed by a 15 minutes heating step 
at 70 °C. The samples were then centrifuged at 17,000 x g for 5 minutes, with the 
supernatants collected and treated with 30 µL of 20 mg/mL Proteinase K (Promega, Madison, 
WI, USA) at 56 °C for 20 mins. The lysates were then processed with the Maxwell® 16 
Research Instrument, and the LEV blood DNA extraction kit (Promega) according to the 
manufacturer’s instructions. All DNA extracts were stored at -30 °C until required.  
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The PCR primers and conditions used to quantify Mbb., Msp., and Methanomassiliicoccus 
spp. (Mms.) groups are listed in Appendix 6.5 Table 6.2.  The primers used to quantify Msp. 
and Mbb. are the same as those described by Blais Lecours et al. (2014) and Johnston et al. 
(2010) which target the mtaB1 gene and nifH gene, respectively. For Mms, primers specific 
for the mttB gene, as described by Poulsen et al. (2013) were used only for  PCR and the 
conditions used were one cycle of DNA denaturation at 95 °C for 3 min, followed by 40 
cycles of denaturation at 95 °C for 30 seconds and subsequent elongation at 60 °C for 30 sec, 
with positive control consisting of Mms. sp. BMP DNA (see thesis Chapter 3). For both PCR 
and qPCR reactions, 100 ng total microbial DNA was used as a template. For mtaB1 and nifH 
gene qPCRs, aliquots (1 µl of 100 ng stocks) were added to 12.5 µl of power SYBR green 
qPCR Master Mix (Applied Biosystems), 0.25 µl each of forward and reverse primer pair, 
and then made up to a final volume of 25 µl. The qPCR conditions used were one hold at 95 
°C for 3 min, followed by 40 cycles at 95 °C for 30 sec, and an elongation step for 30 
seconds at either 55.5 °C or 57 °C, for Msp., and Mbb., spp., respectively. Standard template 
for both the mtaB1 and nifH gene qPCR/PCR consisted of genomic DNA from Mbb. smithii 
and Msp. stadtmanae DSMZ 3091
T
. The efficiencies (E) of the qPCR reactions were 
calculated from standard curves generated for each template of the type strains, by preparing 
a ten-fold serial dilution of each template between a range of 10
2
 and 10
6
 copies (each done 
in triplicate; as outlined at http://www.thermoscientificbio.com/webtools/copynumber/). The 
E values were then calculated as described by Rasmussen (Rasmussen, 2001) where E =(10(
[–
1/slope]
)-1)*100, and primer set efficiencies were 73% and 96% for the mtaB1 gene and nifH 
gene, respectively. 
 
4.2.5 Methanogen culture and cell preparations 
Initially, Mbb. smithii DSMZ 861
T
, Mbb. ruminantium DSMZ 1093
T
 and Msp. stadtmanae 
DSMZ 3091
T
 and Msp. sp. WGK6 and BMS were all cultured using 100 ml RF30 and 
H2:CO2 (80:20 vol/vol) pressurized to 150 kPa; and all the Msp. spp. cultures were also 
supplemented with 1% methanol (vol/vol). Subsequently, the culture volumes were reduced 
to 10 ml. All the cultures were incubated at 39 °C in a shaking incubator cabinet (Multitron 
Pro, Infors HT, Switzerland) and agitated at 100 rpm until they reached an OD600 of ~1 .0 
(within 48 hours, as previously described). The cells were harvested by centrifugation at 
21,000 x g for 5 min. The pelleted cells were resuspended with 0.5 vol of a sterile solution of 
saline (0.85% wt/vol) prepared with milliQ water, and centrifuged as before. This washing 
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step was repeated twice more, with the cells finally resuspended in 0.5 vol of the same buffer, 
then frozen and lyophilized (VirTis Benchtop K Freeze Dryer). The resulting preparations 
were all stored dry at ambient temperature until used for ELISA and RAW 264.7 assays, 
described below.  
 
For the later studies conducted with RAW 264.7, and the PBMCs prepared from subjects 
HMI0004-6 assayed using the Biolegend LEGENDplex multi-analyte flow assay kit, only 
Mbb. smithii DSMZ 861
T
 and Msp. stadtmanae DSMZ 3091
T
 were cultured using BRN-
RF30 medium, as described previously.  Duplicate cultures were harvested during 
exponential phase (OD600 of ~0.5) and late exponential phase (OD600 of ~1), and the cell 
biomass was collected by centrifugation (21,000 x g 15 mins). The supernatants were 
removed and the cell pellets were washed twice with 0.85% (wt/vol) saline solution as 
described previously. The combined cell washes were also collected and the washed cells 
were finally resuspended in 1 mL of 0.85% saline solution. 
 
Blais Lecours et al. (2014) added 0.05 mg/mL of cell dry weight to their challenge assays, 
and this protocol was followed for the ELISA-based assays described below. For all other 
assays I also determined the concentration of cellular protein for each of my preparations, 
using the Quick Start
TM
 Bradford Protein Assay kit (Bio-Rad, Hercules, CA, USA) and with 
Bovine Serum Albumin (BSA) used as a standard, according to the manufacturer’s 
instructions. These assays were performed using an added amount of biomass based on their 
respective protein concentrations to give a final concentration of 0.05 mg protein/mL for each 
assay (rather than dry weight). 
 
4.2.6 ELISA-based assay of TNF-α release from PBMC following 
methanogen challenge 
Aliquots (180 µL) of the PBMC preparations (2.7 x 10
6
 cells/mL) from 3 subjects (i.e. 
HMI0001-3) were transferred to individual wells of a 96-well microtiter plate and incubated 
at 37 °C in a 5% CO2 atmosphere for 30 min. The PBMCs were then challenged with 0.1 vol 
of one of the different lyophilized methanogen cell preparations, which had been resuspended 
in sterile saline buffer to a final concentration of 0.05 mg/ml. As a positive control, aliquots 
of the PBMC preparation from each subject were challenged with 0.1 vol of 1 µg/mL 
solution of LPS (lyophilized lipopolysaccharide from E. coli O55:B5 which was resuspended 
with PCR grade water, Sigma-Aldrich) solution, and negative controls consisted of adding 
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0.1 vol sterile saline solution (each done in duplicate). Following incubation for either 4 or 12 
hours (at 37 °C and within a 5% CO2 atmosphere) the cell-free supernatants were harvested 
by low speed centrifugation (400 x g for 5 min) and stored at -80 °C until required. The 
quantity of TNF-α released into the supernatants was then determined using BioLegend’s 
Human TNF-α ELISA MAX Deluxe kit (Biolegend, San Diego, CA, USA) according to 
manufacturer’s specifications. To determine the optimal dilution for detection of TNF-α 
release, the supernatant samples from HMI0003 challenged with Msp. stadtmanae DSMZ 
3091
T
 cells were diluted with PBS to 1:10, 1:50, 1:100, 1:200, 1:300 and 1:400 of their 
original concentration prior to TNF-α measurement, and on the basis of these results, the 
remaining samples were diluted 1:10 before assay. 
 
4.2.7 PBMC cytokine release in response to Mbb. smithii DSMZ 
861
T
 and Msp. stadtmanae DSMZ 3091
T
 cell preparations using the 
Biolegend LEGENDplex bead array 
The Biolegend LEGENDplex multi-analyte flow assay kit (#740118) quantifies a panel of 
cytokines (IFN-α, IFN-γ, IL-10, IL-12p70, IL-17A, IL-18, IL-1β, IL-23, IL-33, IL-6, IL-8 
and TNF-α) through flow cytometry rather than ELISA. I chose to use this product because it 
is offered as a time efficient, high throughput and overall holistic approach to the 
quantification of a range of (customisable) cytokines. However, because this assay is new and 
still in development, I first needed to perform a pilot experiment to optimize the conditions of 
the assay for the accurate and precise detection of the cytokine response.  For this purpose I 
used Mbb. smithii DSMZ 861
T
 and Msp. stadtmanae DSMZ 3091
T
 challenged PBMCs. To 
perform the pilot study, aliquots (180 µL) of the PBMC preparations (2.7 x 10
6
 cells/mL) 
from 3 subjects (i.e. HMI0004-6) were transferred to individual wells of 3 separate 96-well 
microtiter plates and incubated at 37 °C in a 5% CO2 atmosphere for 30 min. The PBMCs 
were then challenged with 0.1 vol of one of Mbb. smithii DSMZ 861
T
 or Msp. stadtmanae 
DSMZ 3091
T
 mid-exponential phase cell preparations, which had been resuspended in sterile 
saline buffer to a final concentration of 0.05 mg protein/mL. As a positive control, aliquots of 
the PBMC preparation from each subject was challenged with 0.1 vol of 1 µg/mL LPS 
solution, and negative controls consisted of adding 0.1 vol sterile saline solution (each done 
in duplicate). The individual 96-well microtiter plates were then incubated for 6, 12 or 24 
hours, and the cell-free supernatants were harvested at each time point by low-speed 
centrifugation (400 x g for 5 min), and stored at -80 °C until required. The quantities of the 
cytokines released from the PBMC after each time period was then determined using the 
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LEGENDplex multi-analyte flow assay kit according to manufacturer’s specifications. To 
determine the optimal dilution for detection of all the cytokines released, the supernatant 
samples from HMI0004 challenged with Msp. stadtmanae DSMZ 3091
T
 cells were diluted 
with the LEGENDplex assay buffer to 1:2, 1:10, 1:50 and 1:100 of their original 
concentrations prior to cytokine measurement. On the basis of these results, the remaining 
samples were diluted 1:10 and 1:100 before assay. The cytokine-analyte responses were 
measured using a BD LSR II fluorescence-assisted cell sorter, and the data were analysed 
using the software package available from Vigenetech LEGENDplex v7.0 
(http://www.vigenetech.com/LEGENDplex7.htm). The standard curves for each of the 13 
cytokines (see appendix 6.14) revealed that IFN-γ, IL-12p70, IL-17A and IL-23 were too 
inconsistent for use and these cytokines have been excluded from further sections.  
 
4.2.8 RAW264.7 cell preparation and NF-κB ELAM luciferase 
assay 
RAW264.7 expressing the ELAM luciferase reporter gene for NF-κB activation (Hume et al., 
2001) were cultured in RPMI medium supplemented with foetal bovine serum (heat-
inactivated and filter sterilised, 10% vol/vol) and also with penicillin-streptomycin L-
glutamine (1% vol/vol). The cells were collected and transferred into a 50ml falcon tube, and 
then centrifuged at 400 x g for 5 minutes at ambient temperature. After the supernatant was 
removed, the RAW264.7 cells were resuspended with 10 ml of culture medium, and an 
aliquot (0.01 ml) was taken for cell counting using a hemocytometer. At this point, the 
RAW264.7 cells were harvested again by centrifugation and diluted to a final concentration 
of 4 x 10
5
 cells/mL.  
 
Aliquots (100 µL) of the RAW264.7 cell preparations were transferred to individual wells of 
a 96-well microtiter plate and incubated at 37 °C in a 5% CO2 atmosphere for 30 min, then 
challenged with 0.1 vol of one of the different lyophilized methanogen cell preparations, 
which had been resuspended in sterile saline buffer to a final concentration of 0.05 mg 
protein/mL. In parallel, a series of assays were also set up as described above, but with 0.1 
vol of a 20 µg/mL LPS stock preparation added 30 minutes  after adding the methanogen cell 
preparations, to test whether the pro-inflammatory response of RAW264.7 cells to LPS was 
affected by the five methanogen strains. As a positive control, aliquots of the RAW264.7 
preparations were challenged with 0.1 vol of 20 ng/mL LPS solution, and negative controls 
consisted of adding 0.1 vol sterile saline solution. All assays were performed in triplicate. 
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Following incubation for 4 hours, the amount of luciferase activity produced was measured 
after the RAW264.7 cells were lysed with 50 µL of 1.25x Passive lysis buffer (Promega). 
Aliquots (30 µL) of luciferin substrate (Steady-Glo Luciferase assay system; Promega) were 
added to each well, and the luciferase activity was quantified using a Fluostar Optima 
Luminometer reading each well for 1 seconds with an Emission filter Gain of 4095 (BMG 
Labtech, Mornington, VIC, Australia).  
 
To determine whether the stage of growth stage affects the level of NF-κB response, mid and 
late exponential phase Mbb. smithii DSMZ 861
T
 and Msp. stadtmanae DSMZ 3091
T
 cell 
suspensions (0.5 mg protein/mL), culture supernatants, and cell washes were also used to 
challenge RAW264.7, as described above. As a positive control, aliquots of the RAW264.7 
preparations were challenged with 0.1 vol of 20 µg/mL LPS stock preparation, and negative 
controls consisted of adding 0.1 vol filter sterilised; saline solution; methanol; saline solution 
with 0.01 vol methanol; blank BRN-RF30 methanogen medium; BRN-RF30 with added 0.01 
vol methanol (each done in technical triplicate). 
 
Finally, to examine the NF-κB response elicited by the different Mbb. and Msp. isolates, 
cultures of Mbb. smithii DSMZ 861
T
, Mbb. ruminantium DSMZ 1093
T
 and Msp. stadtmanae 
DSMZ 3091
T
 and Msp. sp. WGK6 and BMS were harvested at late exponential stage of 
growth and the cells resuspended to give a final concentration of 0.05 mg protein/mL, then 
used to challenge RAW264.7 cells, with positive and negative controls as described above, 
each done in biological and technical triplicate. A series of assays with 0.1 vol of 20 µg/mL 
LPS stock preparation was added 30 minutes after adding the methanogen cell preparations 
was done as described earlier.  
 
4.2.9 Statistical analyses 
Cytokine concentrations and NF-κB luminescence values were plotted, standard error of the 
mean (SEM) calculated and analysed for statistical significance determined using the 
software package GraphPad Prism version 5.00, for Windows (GraphPad Software, San 
Diego California USA, www.graphpad.com). Statistical significance of results were 
determined through one-way ANOVA analysis with Tukey’s post-test performed, 
significance was assigned to p < 0.05, with a 95% confidence interval. 
 
4.3 Results  
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4.3.1 Synbiotic treatment of CKD patients has no effect on 
abundance or composition of the methanogen community 
Only a small number of the stool samples from the CKD patients in the SYNERGY study 
were found to contain detectable levels of the methanogenic archaea, and Mbb. spp. were the 
predominant type (Table 4.2). The dataset is limited to 81/84 samples due to failure to collect 
stool samples from 3 patients (at the end of the washout period). In general terms, the 
amplicon libraries (Rossi et al., 2016) and my PCR-based assays showed that: i) most of the 
CKD patients were found to have no detectable archaeal population in their stool samples; ii) 
for those patients that do possess a detectable abundance of methanogenic archaea, the 
population is predominantly Mbb. spp. and; iii) no amplicons were produced using the Msp.-
specific primers from any of the stool samples; nor were there sequence reads assigned to the 
Msp. genus from the amplicon libraries. In a small number of instances (9/81 samples) the 
Arch-specific primers did produce an amplicon, but the Mbb. and Msp.-specific primers did 
not. These stool samples were then used in PCR reactions using the Mms.-specific primers 
and a detectable amplicon was produced for 5/9 of these samples (see Table 4.1).  
 
Additionally, those patients with a detectable population of methanogenic archaea in stool at 
baseline retained a measureable population of archaea throughout the trial period, which was 
predominantly comprised of Mbb.-spp. Although the normalised read counts suggest there 
was some fluctuation in the population size of the archaea for these patients across the study 
period, these changes could not be attributed to the interventions (placebo or synbiotic) used 
in the SYNERGY study. As such, it would appear that the synbiotic intervention has neither a 
positive or negative affect on either the population size or composition of the methanogenic 
archaea in stool samples from this cohort of CKD patients. 
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Table 4.1. The prevalence and composition of the methanogen populations present in stool samples collected from patients enrolled in the 
SYNERGY study (Rossi et al., 2016). The percentage of Illumina MiSeq reads assigned to the Methanobacteriales order are shown (norm-
MiSeq), but all reads were further classified to the Mbb. genus. Stool samples producing a detectable amplicon by PCR-based screening with 
either the methanogen-specific primers (Arch), as well as the genus-specific  Mbb. primers are marked (+). Values annotated in red, represent 
periods during which the patient was also treated with antibiotics. Notably, none of the stool samples produced an amplicon with the Msp.-
specific primers, and are therefore not annotated in the Table. 
Patient Baseline (week 0) Placebo (week 6) Wash-out (week 10) Synbiotic (week 16) 
  Norm-Miseq Arch Mbb. Norm-Miseq Arch Mbb. Norm-Miseq Arch Mbb. Norm-Miseq Arch Mbb. 
A   +   <0.10%   +   + +       
B                         
C       <0.10%                 
D 0.90% + + 3.20% + + <0.10%   +       
E 0.70%     4.10% +   4.00% +   1.00% + + 
F 4.60% + + 4.90% + + 3.50% +   2.30% + + 
G     +     + N/A N/A N/A     + 
H     +           +     + 
I             N/A N/A N/A <0.10% +   
J                         
K             <0.10%     <0.10%     
L               + +     + 
M             <0.10%           
N         +   <0.10% + + <0.10%     
O                   <0.10%     
P                         
Q     +       <0.10% +   <0.10%     
R <0.10%                       
S 3.30% + + 3.80% + + N/A N/A N/A 9.00% +   
T <0.10% + + 0.20% +   <0.10% + + 0.10% + + 
U <0.10%                       
 83 
 
4.3.2 The TNF-α release from PBMC varies in response to 
challenge with the different methanogens 
The TNF-α release from PBMC in response to their exposure to the five methanogen strains 
for either 4 or 12 hours are shown in Figs. 4.1 and 4.2, respectively. Relative to the negative 
controls, the release of TNF-α by PBMC was induced by all the methanogen strains except 
Msp. BMS. After 4 hours exposure, there was a significantly higher release of TNF-α by 
HMI0001 PBMC in response to Msp. stadtmanae DSMZ 3091
T
 cells (1495.6 ± 107.9) 
compared to Mbb. smithii DSMZ 861
T
 cells (1033.9 ± 33.6, p < 0.05, see Fig. 4.2). The 
PBMC from all 3 subjects exhibited an overall increase in the amount of TNF-α released after 
12 hours exposure to the 4 methanogens (Fig. 4.1), and again, the amount released from the 
PBMC of both HMI0001 and HMI0002 was significantly greater in response to Msp. 
stadtmanae DSMZ 3091
T
 (1991.1 ± 137.3 and 1190.7 ± 135.4, HMI0001 and HMI0002 
respectively; see Fig. 4.2) compared to Mbb. smithii DSMZ 861
T
 (710.4 ± 18.1 and 740.4 ± 
29.4, HMI0001 and HMI0002 respectively; see Fig. 4.2, p < 0.05). Interestingly, Mbb. 
ruminantium DSMZ 1093
T
 cells induced TNF-α release comparable to that of Msp. 
stadtmanae DSMZ 3091
T
 at both time points, while Msp. sp. WGK6 cells induced a response 
similar to that measured for Mbb. smithii DSMZ 861
T
 cells. Unfortunately, subjects 
HMI0001-0003 did not consent to stool sample collection, so I was unable to measure the 
presence and proportions of methanogen species present within these persons. Subsequently, 
the LEGENDplex PBMC challenge work was performed with three new subjects willing to 
provide both a blood and stool sample.  
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Figure 4.1. ELISA-based measurement of the concentrations of TNF-α released into culture 
fluids from PBMC (2.7 x 10
6
 cells/mL), in response to 4 hours challenge with either whole 
cell preparations of the five individual methanogen strains, or saline (negative control), as 
described in materials and methods. For PBMCs recovered from HMI0001 and HMI0003, the 
maximal response (5000 pg/mL) was observed for LPS (100 ng/mL, positive control), while 
HMI0002 had a minimal response (540 pg/mL) to the LPS challenge. In addition there was 
significant variation between each subject in terms of their response to the different 
methanogen preparations: a greater release of TNF-α was observed in response to the Msp. 
stadtmanae DSMZ 3091
T
 challenge, when compared to that of Mbb. smithii DSMZ 861
T
. Of 
the non-human isolates the greatest responses were observed for Mbb. ruminantium DSMZ 
1093
T
 and Msp. sp. WGK6, with only a minimal release measured in response to Msp. sp. 
BMS, and the negative control. 
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Figure 4.2. ELISA-based measurement of the concentrations of TNF-α released into culture 
fluids from PBMC (2.7 x 10
6
 cells/mL), in response to 12 hours challenge with either whole 
cell preparations of the five individual methanogen strains, or saline (negative control), as 
described in materials and methods. 
 
4.3.3 The cytokine profiles released from the PBMC of healthy 
subjects was similar, in response to Msp. stadtmanae DSMZ 3091
T
 
and Mbb. smithii DSMZ 861
T
 cells, and LPS 
The cytokine release from the PBMC prepared from HMI0004-0006 in response to their 
exposure to either LPS, saline, Mbb. smithii DSMZ 861
T
 or Msp. stadtmanae DSMZ 3091
T
 
cells for 6, 12 or 24 hours, and measured with the LEGENDplex multi-analyte flow assay, are 
shown in Figs. 4.3A-F. As expected, LPS resulted in a strong release of the pro-inflammatory 
cytokines IL-1β, TNF-α, IL-6, IL-8 and MCP-1 (Fig. 4.3A-E). Similar cytokine profiles were 
also observed for the PBMC challenged with Msp. stadtmanae DSMZ 3091
T
 or Mbb. smithii 
DSMZ 861
T
, but in these assays, the Mbb. smithii DSMZ 861
T
 cells appeared to induce a 
stronger release of pro-inflammatory cytokines compared to Msp. stadtmanae DSMZ 3091
T
. 
However, the statistical analyses suggested that only the differences of TNF-α release across 
all time points (Fig. 4.3B) were statistically significant. While the statistical analyses 
suggested that Mbb. smithii DSMZ 861
T
 had a significantly higher release of IL-1β (6 hours, 
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Fig. 4.3A) and TNF-α (all time points, Fig. 4.3B) compared to LPS. Finally, statistical 
analyses of PBMC challenge with LPS challenge suggested that only the differences of MCP-
1 release at 12 and 24 hours (Fig. 4.3E) are statistically significantly when compared to the 
second highest challenge, Mbb. smithii DSMZ 861
T
. In addition to the release of these pro-
inflammatory cytokines, release of the “anti-inflammatory” IL-10 cytokine was also 
measureable over the 24 hours incubation period, and not significantly different between 
PBMC challenged with either LPS or the two methanogen cell preparations (Fig. 4.3F).  
 
The PCR assays of DNA extracted from the stool samples of HMI0004-0006 showed that all 
3 subjects were PCR-positive for the Mbb.-spp. primers but not for Msp.-spp. primers. The 
Mbb.-spp. amplicon from HMI0004 stool DNA was larger than anticipated (~175 bp) and 
produced a different melt curve in qPCR assays compared to the Mbb. smithii DSMZ 861
T
 
DNA used as a standard (Fig. 4.4). The best match (<100% identity and <26% coverage) for 
the sequenced HMI0004 amplicon included various parasites (i.e. Toxocara canis and 
Schistosoma mattheei) and bacteria (i.e. Staphylococcus agnetis and Treponema putidum). 
Based on these results it was concluded that the amplicon produced from subject HMI0004 
stool DNA is unlikely to be derived from Mbb. spp. The qPCR analysis estimated that per 
gram of stool sample HMI0005 and HMI0006 possess 8.7 x 10
5
 and 3.3 x 10
5
 copies of the 
Mbb.-specific 16S rRNA gene, respectively.  
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Figure 4.3. Cytokines concentration profiles produced from the PBMC harvested from three 
donors (HMI004-006) as determined using the LEGENDplex assay, after 6 (●), 12 (■) and 24 
(▲) hours challenge with either saline (negative control), LPS (100 ng/mL, positive control), 
Msp. stadtmanae DSMZ 3091
T
 or Mbb. smithii DSMZ 861
T
. Each datum point represents the 
mean value for triplicate samples from each respective donor. In summation, the LPS, Msp. 
stadtmanae DSMZ 3091
T
 and Mbb. smithii DSMZ 861
T
 challenges resulted in the same 
cytokine profiles with respect to the release of IL-1β (A), TNF-α (B), IL-6 (C), IL-8 (D), 
MCP-1 (E) and IL-10 (F). The cytokine profile of saline challenged cells differed slightly 
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with only an induction of TNF-α, Il-6, IL-8 and MCP-1 observed. The data were analysed by 
one-way ANOVA and significant differences are denoted by * (Table 6.4).   
 
 
Figure 4.4. The qPCR Melt curve for positive control Mbb. smithii (white), HMI0004 (blue), 
HMI0005 (green) and HMI0006 (orange) using Mbb.-specific primers designed by Johnston 
et al. (2010). Subject HMI0004 produced a larger PCR product with these primers as well as 
a different melt curve compared to the other subjects and positive control Mbb. smithii 
DSMZ 861
T
 as a result it was concluded that the product for HMI0004 was not a Mbb. spp. 
 
4.3.4 The five methanogen cell preparations induce similar NF-
κB activated responses from RAW264.7 macrophage cells 
The variations in the immunomodulatory capacity of RAW264.7 macrophage cells in 
response to whole cell preparations from the five methanogen strains, in the presence or 
absence of LPS stimulation, are shown in Fig. 4.5A-B. For both types of assays, all of the 
methanogen strain challenges resulted in a significantly higher activation of NF-κB reporter 
activity compared to the positive control (LPS 10 ng, p < 0.05). None of the Mbb. or Msp. 
strains tested result in a suppression of NF-β activation when the macrophage cells were 
first challenged with LPS (Fig. 4.5A); nor did the methanogen cell preparations result in any 
additive effect of NF-κB activated reporter gene activity when co-cultured with LPS (Fig. 
4.5B).   
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Figure 4.5. The immunomodulatory response of RAW264.7 mouse macrophage cells in 
response to whole cell preparations of the 5 methanogen strains, normalised with respect to 
total cell protein added, and the response measured by NF-κB directed transcription of the 
luciferase reporter gene. The results obtained when the cells were also challenged with LPS 
(10 ng/ml), or not, are shown in panels A and B, respectively. The presence of LPS did not 
have an additive affect to that of any of the methanogen challenges. Individual values 
represent the mean (± SEM) produced from three technical triplicates. 
 
4.3.5 The NF-κB response of RAW264.7 cells to Msp. stadtmanae 
DSMZ 3091
T
 and Mbb. smithii DSMZ 861
T
 is limited to whole cell 
preparations 
The reporter gene responses to the spent culture fluids, cell wash fractions, and whole cells of 
Msp. stadtmanae DSMZ 3091
T
 or Mbb. smithii DSMZ 861
T
, and harvested at either mid- and 
late-exponential phase are shown in Fig 4.6. Both the mid- and late-exponential phase spent 
culture fluids produce a smaller NF-κB reporter gene response compared to sterile, un-
inoculated BRN-RF30 medium. When the sterile fluids from mid or late exponential growth 
phase cultures were compared, no significant differences were seen for Msp. stadtmanae 
DSMZ 3091
T
 or Mbb. smithii DSMZ 861
T
. For the cell wash collections there was no 
difference between mid- and late-phase NF-κB inductions for both methanogen strains. The 
most significant level NF-κB activation is that seen for mid- Msp. stadtmanae DSMZ 3091T 
whole cell harvest with approximately half the NF-κB observed for late- whole cell harvest, 
even though all whole cell stimulants were standardised based on the total protein 
A) B) 
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concentration (0.05 mg protein/mL). A similar profile is observed for Mbb. smithii
 
DSMZ 
861
T
 (Fig. 4.6B) whole cell harvest with the exception that the level of NF-κB activation was 
reduced across all components in comparison to Msp. stadtmanae DSMZ 3091
T
 (Fig. 4.6A). 
 
 
Figure 4.6. The immunomodulatory response of RAW264.7 mouse macrophage cells in 
response to either whole cells, cell washes, or the residual medium fluids from Msp. 
stadtmanae DSMZ 3091
T
 (panel A) or Mbb. smithii DSMZ 861
T
 cultures (panel B); as 
measured by NF-κB directed transcription of the luciferase reporter gene. Individual values 
represent the mean (± SEM) produced from technical triplicates. 
 
4.4 Discussion  
Based on our current knowledge of the pathways and substrates that are required for 
methanogen growth, it is plausible that changes in bacterial fermentation coincident with 
“dysbiosis” may result in alterations in the total and/or specific abundances of gut 
methanogens. In addition the growing evidence that gut methanogens can modulate an 
immune response suggests that instances of “dysbiosis” with gastrointestinal inflammation 
may be due to methanogenic archaea.  Persons suffering CKD experience intestinal 
inflammation, constipation, accumulation of nitrogenous waste products and most notably 
increased levels of TMAO and methanol (Kang, 1993, Murtagh et al., 2007, Lee et al., 2012, 
Tang et al., 2014, Nallu et al.). As described earlier in this chapter’s introduction elevated 
levels of breath methane have been correlated to the severity of constipation for individuals 
diagnosed with IBS, while prevalence of Msp. spp. is increased in IBD patients (Chatterjee et 
al., 2007, Blais Lecours et al., 2014). With all these factors considered it led me to 
hypothesise that the abundance and profile of the methanogenic community within CKD 
A) B) 
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patients could favour methylotrophic methanogens such as Msp. and Mms. spp., a theory 
which has not been investigated by previous CKD microbiota profiling studies.  
 
The primary outcome measures of the CKD SYNERGY study were serum para-cresyl sulfate 
(PCS) and indoxyl sulfate (IS) concentrations. Both these uremic toxins were reduced in 
CKD patients during the synbiotic administration period, and significantly so for PCS in all 
patients, and for IS in patients not receiving antibiotic treatment (Rossi et al. 2016). These 
changes were coincident with measureable, statistically significant changes in gut bacterial 
composition, specifically in terms of an increased relative abundance of Bifidobacterium and 
Faecalibacterium spp. However, it appears that neither the abundance nor profile of 
methanogenic archaea in the stool samples were affected over the course of the SYNERGY 
trial, with both the PCR assays and MiSeq 16S rRNA profiling data suggesting Mbb. spp. 
dominated when present (Table 4.2). There were 5/81 samples that did appear to be PCR 
positive when the Mms.-specific primers were used, and TMAO was measureable in the 
serum of these patients (Rossi et al., unpublished data). However, there were no significant 
changes in serum TMAO during the course of the study, which is consistent with my results 
identifying only a few amplicons for the methylamine utilising Mms. spp., suggesting a low 
abundance. Notably, none of the stool samples proved to be PCR positive for Msp. spp. 
suggesting the nutrient and/or environmental milieu in these CKD patients was not sufficient 
to support its growth.  
 
Up to 28% of the CKD patients recruited as part of the SYNERGY study were found to be 
PCR positive for Archaea, which increased to 38% based on the recovery of MiSeq reads 
assigned to the Domain Archaea. In comparison, Scanlan et al. (2008) reported the 
prevalence and diversity of methanogenic archaea from the stool samples of 207 individuals 
considered to be either healthy (HC), or assigned to one of five non-communicable 
gastrointestinal disease groups: colorectal cancer (CRC), polypectomised (PPx), IBS, 
ulcerative colitis (UC), or Crohn’s disease (CD) patients. The PCR positivity was 48% for 
HC, 45% for CRC, 50% for PPx, 48% for IBS, 24% for UC, and 30% for CD patients.  
Protein and amino acid fermentation is elevated in CKD patients and in addition to uremic 
toxins there is also a high ammonia concentration, which raises the pH levels above neutral 
(Carrero et al., 2013, Nallu et al., 2016). Such conditions along with my PCR assay results 
would indicate that even though methylated compounds are increased in CKD patients the 
shift in fermentation schemes and shift in pH may result in a hostile environment for methyl-
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group utilising methanogens such as Msp. and Mms. spp. The examination of methanogen 
diversity for CKD patients was limited as I only had access to stool samples and preferential 
colonization of the colonic mucosa by methylotrophic methanogens could be an alternative 
explanation for relative low detection of this archaeal group in stool. This is an area of 
investigation that has not been rigorously pursued but would be of interest, considering how 
my results and those of Blais Lecours et al. suggest a role for some archaea to interact with 
and stimulate the immune system. 
 
The remaining discussion will be broken into two parts; first I will discuss the 
immunomodulation of human derived methanogenic strains, and; second the comparison of 
TNF-α and NF-κB activation after challenge with each of the five methanogenic strains 
respectively. Both Blais Lecours et al. (2014) and Bang et al. (2014) reported that cell 
preparations of the human type strain Msp. stadtmanae DSMZ 3091
T
 elicited a stronger 
release of TNF-α from PBMC and dendritic cells than similar preparations of Mbb. smithii. 
My findings using the same archaea and PBMC preparations from 3 healthy subjects are 
consistent with these results, as shown in Figs 4.1 and 4.2.  
 
The amount of TNF-α release from PBMCs in my assays ranged between 0.08 ng to 2 ng, 
which is approximately 4-fold less than that reported by Blais Lecours et al. (2014). At least 
part of this difference could be attributed to the cryptic description of the methanogen cell 
preparation methods used by Blais Lecours et al. (2011) and Blais Lecours et al. (2014) 
which precluded my replication of their approach. First, the specific strain of Mbb. smithii 
used in their studies is not described and there is no mention at which stage of growth the 
methanogen cultures were harvested. These are details which are highly relevant as 
demonstrated by the Conway de Macario et al. (1985) study where variation in 
immunogenicity was identified between strains Mbb. smithii DSMZ 861
T
 and Mbb. smithii 
DSMZ 2375
T
. Blais Lecours et al. (2011) also mention a “sonication step” for 1 minute 
before their pulmonary challenge assay, although no mention of this is made in their 2014 
paper. A sonication step, described as being performed to break up cell clumps, is also highly 
likely to cause cell lysis, releasing cytoplasmic elements and breaking up cell components 
which may increase the rate of recognition by PBMC receptors. 
 
In subsequent experiments, I chose to use the LEGENDplex multi-analyte flow assay kit with 
the goal of making a more holistic assessment of cytokine release from the PBMC 
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preparations; initially in a pilot study with the Msp. stadtmanae DSMZ 3091
T
 and Mbb. 
smithii DSMZ 861
T
 cell preparations and subsequently with all 5 methanogens.  Using the 
LEGENDplex method, I compared the PBMC responses from a further 3 donors.  In contrast 
to the results of ELISA and the RAW264.7 cell reporter system, Mbb. smithii DSMZ 861
T
 
appeared to generate an increased response. This may highlight the variations in immune 
responses across genetically diverse humans. However, it is worth noting that while the initial 
3 PBMC donors were stimulated using methanogen preparations based on total cell mass, the 
later subjects were stimulated with preparations based on total protein (discussed in further 
details below). 
 
Unfortunately, my pilot studies using this relatively new kit were affected by technical issues, 
specifically in terms of producing the reliable and consistent readouts needed to produce the 
standard curves for quantifying IFN-γ, IL-12p70, IL-17A and IL-23 release. I worked closely 
with technical representatives of the kit’s manufacturer over a period of weeks to improve the 
precision and accuracy of their “Human Inflammation Panel Standard Cocktail”, including 
their provision of a new batch of the “standard cocktail” free of charge, because of the 
variations in readouts measured and the use of polypropylene plates, to try to minimise 
cytokine “sticking”. Despite these efforts, I was not able to improve the standard curve 
generation for the abovementioned cytokines (see Appendix 6.15), and given the pending 
deadlines associated with my thesis completion date, I repeated the studies with PBMCs 
prepared from subjects HMI0004-6, and excluded the readouts produced for these cytokines 
from my comparisons. Overall, the profiles of the remaining cytokines quantified by this kit 
indicate that both methanogen cell preparations induce a profile much the same as that 
following the LPS challenge, with measureable amounts of IL-1β, TNF-α, IL-6, IL-8, MCP-1 
and IL-10 observed. Based on these results, I conclude that there is potential for these 
methanogens to modulate a strong immune response and the induction of TNF-α and IL-6 
suggests that there is a potential link to IBD (Mudter and Neurath, 2007). It is unfortunate 
that the full cytokine LEGENDplex profile failed as IL-23 has been associated with IBD as 
well as IL-17A being associated with UC (Geremia and Jewell, 2012, Cătană et al., 2015). 
Also, IFN-γ and IL-17A are produced by T cells and measuring these would have allowed me 
to start to investigate adaptive immune responses to the methanogens (reviewed by Weyand 
et al., 2011). 
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Using the RAW264.7 cell assay, I demonstrated that the stage of growth affects the 
immunomodulatory capacity of the human originating methanogen cell preparations (Fig. 
4.6). Previous studies have demonstrated that there is a correlation between the stage of 
growth of methanogen cell and the composition of tetraether lipids and fatty acid methyl 
esters, which decreases during later stages of growth (Kramer and Sauer, 1991). It was 
hypothesised that the increased composition of tetraether lipids could provide a more rigid 
membrane for younger cells. In addition the ratio change of diether and tetraether lipids 
demonstrated that there is a decrease in the level of biosynthesis as the cell ages. Since this 
assay demonstrates that it is indeed whole methanogen cells which mediate the immune 
response it seems reasonable to conclude that “late” growth harvest cultures have a reduced 
capacity to express and synthesis the MAMPs on their cell surface which is responsible for 
activating an immune response. These are considerations not previously examined by other 
researchers and demonstrate how big the knowledge gap surrounding methanogen and human 
health interaction actually is.   
 
The final section of this discussion will address the five methanogen strains and their 
immunomodulatory variation. In the PBMC stimulation with lyophilized strain preparations 
(Fig. 4.1-2), using ELISA to assay TNF-a production, the methanogen isolates of animal 
origin produced contrasting results. Mbb. ruminantium DSMZ 1093
T 
induced the strongest 
release, while the preparations from Msp. sp. WGK6 (“small” genome) and BMS (“large” 
genome) appeared to produce the weakest release of TNF-α. When comparing the animal and 
human isolates for the Msp. spp. the human type-strain Msp. stadtmanae DSMZ 3091
T
 had 
the strongest TNF-α production, followed by WGK6 and then BMS. However, for Mbb. spp. 
the reverse was true with the ruminant representative Mbb. ruminantium DSMZ 1093
T
 
producing a stronger TNF-α signal compared to the human type strain Mbb. smithii DSMZ 
861
T
. The variation in TNF-α production may be a result of a variable element between each 
genus and/or specific host adaption. A vaccine trial conducted by Subharat et al. (2015) in 
cattle investigated the induction of the immune response to a methanogen protein, 
recombinant glycosyltransferase protein (GT2). They showed a strong antigen-specific IgG 
and moderate IgA response was possible from both serum, saliva and rumen samples of the 
vaccinated animals. All Msp. spp. genomes generated and described in Chapter 3 where 
processed using the automated carbohydrate-active enzyme annotation web resource dbCAN 
(Yin et al., 2012) to determine the number of GT2 genes (see Table 4.3). In comparison to 
Msp. stadtmanae DSMZ 3091
T
 both WGK6 and BMS have fewer GT2 genes, as do both 
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Mbb. spp. So while the GT2 protein may induce a strong antigen-specific response in a 
vaccine trial of livestock it may not be completely responsible for the production of TNF-α 
from healthy PBMC.  
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Table 4.2. Glycosyltransferase protein (GT2) gene counts for all Msp. and Mbb. strain 
challenges used in this Chapter. The GT2 counts were determined using the automated 
carbohydrate-active enzyme annotation web resource dbCAN. While Msp. spp. had a higher 
GT2 gene count in comparison to Mbb. spp. the similar NF-κB luminescence profile for Msp. 
and Mbb. strains whole cell challenge (Fig. 4.5B) would suggest that there is potentially a 
conserved gene between the Msp. and Mbb. strains. 
Strain GT2 
Msp. stadtmanae DSMZ 3091
T
 31 
Msp. sp. WGK6 28 
Msp. sp. BMS 26 
Mbb. ruminantium DSMZ 1093
T
 20 
Mbb. smithii DSMZ 861
T
 20 
 
In addition to variations in response to the different methanogens, I also observed a variation 
in the level of TNF-α release from donors HMI0001-3 in response to LPS.  This is similar to 
findings reported by Liebregts et al. (2007) where PBMC isolated from 36 healthy subjects 
were challenged with LPS for 24 hours and showed a variation in TNF-α release that ranged 
between 80 and 550 pg/mL. Such inter-individual variations have been attributed to the 
amount of Toll-like Receptor 4 (TLR4) expression (Jaekal et al., 2007). An alternative 
explanation for the variation in response to both TNF-α and methanogen preparations could 
be a reflection of the different PBMC cell populations among the human donors.  PBMC are 
not a homogenous cell population but are constituted by several immune cell types including, 
among others, T cells (~60 %), B cells (~15 %), natural killer (NK) cells (~15 %), and 
monocytes (~10%; Autissier et al., 2010). Future experiments should account for this and the 
cell populations of PBMC donations should first be quantified to endeavour to account for the 
variability observed in Figures 4.1, 4.2, and 4.3. Interestingly, while the PBMC prepared 
from HMI0003 showed a minimal response to all five methanogen strains, these PBMC 
produced the greatest response to LPS challenge, suggesting that triggering TNF-α release in 
response to the methanogen cell preparations is mediated via cell receptor(s) other than 
TLR4. Once such class of receptors are the nucleotide-binding oligomerization domain-like 
receptors (NOD-LRs), which can activate NF-κB and thus trigger TNF-α release (Inohara and 
Nunez, 2001, Franchi et al., 2009, Shakhov et al., 1990, Yao et al., 1997, Shames et al., 
1999). These NOD-LRs are intracellular sensors, which recognise microbe-associated 
 97 
 
molecular patterns (MAMPs) entering the cell via phagocytosis. Archaea are structurally very 
different to that of bacteria lacking peptidoglycan in their cell wall with some methanogens 
instead containing pseudopeptidoglycan (also known as pseudomurein) which would provide 
a different profile of MAMPs recognised by the immune system (Balch et al., 1979). There is 
currently no literature on the mechanism of interaction between TLRs or NOD-LR and 
methanogens highlighting how poorly explored this area is.  
 
I next decided to pursue the use of the RAW264.7 NF-κB ELAM reporter macrophage cell 
line to assess immunomodulatory variation between the five methanogen cell preparations 
(Fig. 4.5). Interestingly, and in contrast to the results using human PBMCs and specific 
measurement of TNF-α, the results with the RAW cells shows that all 5 methanogen cell 
preparations result in similar levels of NF-κB mediated ELAM activation, and more so than 
that induced by LPS alone (Fig. 4.5B). This highlights the ability of all strains to induce a 
response, as suggested by the results of HMI0004-6. A key difference between these 
experiments was the amount of methanogen cell biomass added to the respective assays. In 
these initial studies, I followed as closely as possible the methods outlined by Blais-Lecours 
et al. (2011, 2014) by adding equal amounts of total cell biomass. However, as shown in 
Table 4.4, the protein content of the five lyophilized methanogen cell preparations was quite 
variable and as such, a standard addition of biomass to those assays resulted in different 
amounts of total protein being added. By adding an amount of each methanogen cell 
preparation that was standardised with respect to the amount of protein added, the degree of 
NF-κB activated ELAM activity was similar in response to all five strains; which is also 
similar to the observations made by the quantitative cytokine profiling results for Msp. 
stadtmanae DSMZ 3091
T
 and Mbb. smithii DSMZ 861
T
 challenges. Thus, perhaps the 
previously reported results are confounded by the method of methanogen preparation and my 
results show the important influence that sample preparation has on determining the 
immunomodulatory capacity of methanogens. Finally, the use of the RAW264.7 reporter 
gene assay is a rapid and high throughput method which can be utilised to screen a variety of 
methanogen cell components to determine their immunomodulatory capacity, criteria which 
would be highly beneficial in the development of anti-methanogen vaccine development.  
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Table 4.3. Total protein concentrations for 0.5 mg/mL of dry weight Msp. and Mbb. spp. 
demonstrates that the dry weight method does not ensure a standardised amount of total 
cellular protein is achieved and this varies even between genus members. 
Strain Total protein concentration (mg protein/mL) 
Msp. stadtmanae 0.26 
Msp. sp. WGK6 1.07 
Msp. sp. BMS 0.15 
Mbb. smithii 0.096 
Mbb. ruminantium 0.41 
 
In conclusion, the consistent immune response to representative isolates of both Msp. and 
Mbb. spp. could be a result of a shared cell surface protein, which has important implications 
for the development of anti-methanogen vaccines for livestock methane abatement. My 
results have also demonstrated that the potential of methanogens to elicit an immune response 
within humans is similar to that of LPS. The future for gastrointestinal inflammatory disorder 
research should include the profiling and quantification of methanogens as it is apparent that 
these archaea are important in the area of human health and are commonly over-looked. 
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Chapter 5  General discussion  
Unlike their bacterial counterparts, the methanogenic archaea are comprised of a small 
number of taxa, with just 7 orders currently identified. The order Methanobacteriales are 
numerically the most predominant in the gut environments of warm blooded animals, and 
accordingly, are the most intensively studied. However and as outlined in my literature 
review, the advent of metagenomics techniques and the recent interest in both reducing 
livestock methane emissions, and the impacts of human gut microbiome on our health and 
well-being, have revealed that the methylotrophic archaea warrant greater attention. I believe 
the results presented in my thesis have substantially advanced our knowledge and 
understanding of this taxocene of methanogenic archaea, which can be summarised as 
follows: 
1. The results presented in Chapter 2 show that Msp. sp. WGK6 is metabolically more 
versatile than other cultured Msp. spp., and employs a novel pathway of alcohol-
fuelled methanogenesis that supports growth.  
2. Chapter 3 presents the first isolate of a novel lineage of Msp. sp. (BMS) which 
possesses a substantially larger genome compared to the other known Msp. isolates.  
3. The results in Chapter 3 used metagenomics datasets to recover additional Msp. spp. 
population genomes that not only validate the existence of the large genomotype, but 
show a monophyletic origin for the genus, and with gene loss driving the evolution of 
Msp. spp. smaller genomes. 
4. Chapter 4 shows the methanogen profiles in stool samples from chronic kidney 
disease patients are unremarkable in terms of their composition and prevalence, and 
synbiotic intervention had little or no impact on their abundance and/or profile.  
5. Chapter 4 also shows the immunomodulatory properties of whole cell preparations of 
my Msp. isolates, and the human Mbb. and Msp. type strains, were similar when 
tested using PBMCs from healthy human subjects and a murine macrophage cell line.  
 
The macropodids (kangaroos and wallabies) are reliant on the microbiota colonising their 
foregut for the breakdown and fermentation of plant biomass. The relatively small methane 
emissions from these animals was first proposed in the late 1970’s and was later reconfirmed 
by studies using a colony of kangaroos and wallabies from a Denmark zoo (Madsen and 
Bertelsen, 2012, Engelhardt et al., 1978). Macropodids have been shown to harbour 
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methanogenic archaea in their foregut that are taxonomically similar to those found in 
livestock and humans, albeit at densities considerably similar to those found in humans rather 
than livestock (Evans et al., 2009). Although prior research with Mbb. ruminantium strain M1 
has shown that ethanol can stimulate its growth, I believe my results presented in Chapter 2 
are the first demonstration of a gut methanogen that can exclusively employ an alcohol-
fuelled, hydrogen-independent, pathway for methanol reduction, methanogenesis and growth. 
As such, I believe that these enzymes support the adaptation of methanogenic archaea like 
WGK6 to survive and persist in environments where gaseous hydrogen levels are limited. 
Such conditions are known to occur in the macropodids (Kempton et al., 1976) but recent 
studies have also shown that ruminant livestock can also be stratified according to their 
hydrogen release (and methane emissions) predicted from their rumen bacterial profiles (e.g. 
Shi et al., 2014, Wallace et al., 2015). Interestingly, both these studies also remarked on an 
increase in the relative abundance of Msp. in animals classed as being “low methane 
emitters”. Therefore, the pathway I have discovered provides a plausible explanation as to 
how these changes might be supported, via a shift in the nutritional ecology afforded to those 
archaea, like strain WGK6, bearing this alternative pathway. In that context, my results in 
Chapter 2 also show that homologs of the dehydrogenases specific for alcohol-fuelled 
methanogenesis can be identified within the genomes of other members of the rumen 
Methanobacteriales, including a number of Mbb. spp. Taken together, I contend that this 
pathway of methanogenesis is not uncommon in ruminant livestock and not just a specific 
adaptation of WGK6 to the macropodid foregut. In the future, it would be interesting to first 
attempt to culture some of the rumen strains available that also possess these dehydrogenases 
in the presence of ethanol, to ascertain their abilities to produce methane and grow with 
ethanol as the sole reductant. These findings also raise new questions in terms of the 
metabolic versatility of methanogenic archaea and how effective strategies designed to 
specifically reduce hydrogen availability in the rumen environment might be, in terms of 
reducing methanogen numbers and methane output. If such strategies result in the formation 
of short chain alcohols, rather than hydrogen gas, I would anticipate the niche occupied by 
methanogenic archaea like WGK6 would be expanded and their numbers increased. Based on 
my results in Chapter 2, I would also expect the methane output to be reduced, because of the 
improved growth efficiency per mol of methane produced with ethanol rather than hydrogen. 
For these reasons, I think it would be possible and interesting to use PCR primers specific for 
these dehydrogenase genes as “biomarkers” for low methane emitting livestock. 
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While my results and findings presented in Chapter 2 provide new evidence for metabolic 
versatility of Methanosphaera and other rumen-derived methanogens having been enhanced 
by the acquisition of just several genes, my isolation of strain BMS also shows that the 
evolutionary depth of the Methanosphaera genus may be much deeper and richer than the 
previously considered. While my culture-based studies confirmed strain BMS is a hydrogen-
dependent methylotroph, incapable of methane formation and growth via the 
hydrogenotrophic or methylated amines dependent pathways; the genome content is almost 
50% larger than that reported for the human isolate of Msp. stadtmanae DSMZ 3091
T
 and 
WGK6. At this time, much of the additional genome content is not annotated to known 
functional COG categories, which does raise the possibility these “unknown” gene products 
support metabolic pathways other than methanogenesis; and that permit the growth and 
persistence of BMS-like strains within the rumen environment. However, and with only three 
isolate genomes to compare, any hypotheses or conclusions drawn are potentially fraught. For 
these reasons, I pursued the extraction of Msp.-affiliated population genomes from 
independently produced ruminant and one human metagenomic datasets. These efforts 
proved to be very useful and helpful, with the recovery of seven new population genomes, of 
which 5 are also predicted to be “large”. Importantly, all these population genomes were 
found to possess a large degree of synteny with the regions “unique” to strain BMS, as well 
as the smaller genomes of Msp. strains WGK6 and DSMZ 3091
T
. Such findings support the 
contention that the Methanosphaera genus may possess members that are indeed facultative 
methanogens: capable of growth either independent of methane production or that is 
augmented by metabolic and/or nutrient acquisition pathways in addition to methanogenesis. 
One effective way of examining these concepts would be to undertake RNA-seq analysis of 
the three Msp. isolates following growth with methanol and hydrogen. Such studies would be 
expected to reveal the extent to which the “unique” genes of strain BMS are (or are not) 
expressed under these conditions, providing new insights into their physiology, metabolic 
capacity, and versatility. It might also be possible then to select genes of interest from strain 
BMS, for example, those hypothesized to support/augment their metabolic capacity for using 
different substrates for methanogenesis and/or growth; and perform gene “knock-in” studies 
in other methanogens to alter their phenotype (Buan et al., 2011). 
 
While I was able to recover seven new Msp. affiliated population genomes there is one 
limitation encountered by the MetaBAT method with its inability to effectively assign a 16S 
rRNA to any of the population genomes. However, I was able to build a 16S rRNA 
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phylogenetic comparison of both isolate and clone sequences from NCBI deposits for Msp. 
spp. of a variety of host gut environments, illustrated in Fig. 5.1. On the basis of the 
phylogenetic placement of the isolate strains it is apparent that the larger genomotype strain 
BMS is distantly related and deep branching in comparison to the smaller genomes of DSMZ 
3091
T
 and WGK6. These results again clearly validate my findings of whole genome 
phylogeny presented in Chapter 3 and are supported by the widely accepted view that the 
most common form of evolutionary drift is non-adaptive adaption involving gene loss 
(Ochman and Moran, 2001). Although more research needs to done, I would propose that the 
“small” genomotype observed for DSMZ 3091T, WGK6, DEW79 and SHI1033 is a result of 
such events and that they are the most recent evolutionary descendants from the “large” 
genomotype, due to their dispensation of genes. The tetramer nucleotide frequency 
distributions (“genome barcode”) comparisons between Msp. isolates BMS, DSMZ 3091T 
and WGK6 further supports this theory. Although a significant portion of the genome has 
been lost by the smaller genomotype, there is evidence of gene conservation, supported by 
the CAZyme family profile, which exhibits a similar profile for auxiliary activity enzymes, 
carbohydrate esterase and glycosyltransferases. Of particular note the glycosyltransferases are 
numerically the most predominant conserved profile across all isolate and population genome 
sequences. I believe this highlights their importance to Msp. spp. and potentially provides an 
opportunity to locate a conserved member responsible for cell wall decoration which could be 
used as a universal vaccine target against Msp. spp. to curb methane emissions in livestock.  
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Figure 5.1. Phylogenetic analysis of Msp. spp. isolate and clone 16S rRNA gene sequence 
recovered from NCBI BLASTn when queried with DSMZ 3091
T
, WGK6 and BMS. WGK6 
shows it most similar to clone sequences representing uncultured gut methanogens from the 
monogastric host the Tammar wallaby (Macropus eugenii, TW), hoatzin bird (Opisthocomus 
hoazin, HZ) and Msp. stadtmanae DSMZ 3091
T
. In comparison BMS is placed at some 
distance from these two isolates amongst ruminant uncultured clone sequences. Bootstrap 
Ruminants 
Monogastric 
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values are shown and the scale bar represents 1% sequence divergence, with Mbb. 
ruminantium M1 used as the outgroup.  
 
The final research Chapter of my thesis shifted in emphasis from my previous Chapters since 
during the latter stages of my program my primary supervisor, Professor Mark Morrison, 
changed his position from CSIRO and relocated to UQ Diamantina Institute. I took this 
opportunity to redirect my RHD studies, expanding my interests and incorporating some 
research of human-derived methanogenic archaea and their associated impacts on health and 
disease. I found this to be an exciting opportunity because it allowed me to expand my 
knowledge from the animal microbiome to include human microbiology host interaction. 
Although my knowledge and experience in the field of immunology was limited I felt that the 
change of focus provided me with an advantage; firstly to my project, secondly by giving me 
additional learning opportunities and finally expanding on future career opportunities. Even 
though there was a time cost by making this commitment, I thought it would be worthwhile 
as recent literature suggested that the methanogen profile can i) respond to diet/nutritional 
ecology and; ii) appeared to have systemic effects via both arms of the immune system 
(Conway de Macario and Macario, 2009, Blais Lecours et al., 2014, Bang et al., 2014). The 
SYNERGY study gave me an opportunity to address the first point while my efforts to work 
with PBMC and macrophage murine RAW264.7 cell line addressed the second point. In 
addition the findings from Chapter 3 raised questions as to whether the metabolic versatility 
and evolutionary diversity of Msp. spp. had an effect on their ability to thrive in a human 
“dysbiotic” gut environment; as well as their capacity to stimulate both arms of the immune 
system in mammals. I hypothesised that the “dysbiotic” gut microbiota of persons suffering 
chronic kidney disease (CKD) would be an ideal environment for methylotrophic 
methanogenic archaea Msp. and Mms. spp. with particular clinical significance. Interestingly, 
findings for Mms. sp. as demonstrated by Poulsen et al. (2013), Dridi et al. (2012), and Borrel 
et al. (2012) show these archaea are capable of using methylated amines arising from 
phosphatidylcholine metabolism to support growth. In that context, establishment of the 
Mms. in the human large bowel might be of clinical relevance for persons known to possess 
relatively high levels of trimethylamine-oxide in blood as a result of non-communicable 
diseases (ie: CKD), because of its association with cardiovascular disease pathogenesis (Tang 
et al., 2014, Brugere et al., 2014). In contrast Msp. could be used as a diagnostic tool 
indicating shifts in fermentation which favour the production of short chain alcohols in 
diseases such as CKD and non-alcoholic fatty liver disease (Lee et al., 2012, Zhu et al., 
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2013). However, my results presented in Chapter 4 would suggest that the SYNERGY trail 
utilising synbiotic intervention for patients suffering CKD had no effect on the structure or 
abundance of the methanogenic archaeal community. In fact, my analysis of the MiSeq data 
produced from these same samples that was assigned to the Methanobacteriales order showed 
that all reads were classified to the Mbb. genus. The stool sample PCR-based screening 
confirmed that the predominant archaeon was Mbb. smithii, in addition to identifying an 
infrequent occurrence of Mms. spp., but there were no detectable populations of Msp. spp. 
from any of these samples. Perhaps the changes in protein and amino acid fermentation 
schemes resulting in an increased gastrointestinal pH observed for CKD patients (Carrero et 
al., 2013, Nallu et al., 2016) causes conditions too hostile for the methylotrophic 
methanogenic archaea to thrive. I believe that this is the first experiment of its kind to 
investigate a link between CKD and methylotrophic methanogenic archaea and while it is 
limited to one case study I feel the clinical significance that these methanogens could provide 
is not something to be overlooked when profiling “dysbiotic” gut microbial communities. 
 
Although I was not able to demonstrate a “dysbiotic” methylotrophic methanogenic 
community within CKD patients’, previous studies have shown that both Msp. stadtmanae 
DSMZ 3091
T
 and Mbb. smithii are capable of eliciting a strong immune response. I have 
demonstrated in Chapter 4 that the immunomodulatory properties of whole cell preparations 
of human, kangaroo and bovine Msp. and Mbb. representative isolates were similar, when 
whole cell preparations were used to challenge PBMCs prepared from healthy human 
subjects, and a murine macrophage cell line. The similar level of response was achieved 
when methanogen challenges were standardised based on their total cellular protein 
concentration suggests a common immunostimulatory element. As demonstrated in Chapter 3 
the glycosyltransferases CAZyme family profile (Table 3.4) is conserved across all Msp. spp. 
and this may explain why the challenge assays yielded similar levels of immune activation. 
Perhaps a conserved glycosyltransferase is responsible for a glycosylated cell surface protein 
causing similar immunomodulation profiles when the challenge is standardised relative to 
protein concentration. This theory could be tested through the use of previously validated 
methods involving cell fractionation and selectively recovering methanogenic surface-
exposed proteins through the use of affinity tagging (Francoleon et al., 2009, Rohlin et al., 
2012). Alternatively, the level of immune activation for individual conserved genes can be 
examined by utilising the sequenced Msp. genomes and expressing genes of interest in a 
model system which can then be screened for its immunomodulatory capability. In fact each 
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process could take advantage of the high-throughput analysis method used within Chapter 4 
to rapidly screen genes of interest using the macrophage murine RAW264.7 cell reporter 
system. While macrophages make up the phagocytic branch of the innate immune system 
they also play an important role in the activation of the adaptive immune response through 
the presentation of antigens to T-lymphocytes (Alberts et al., 2003). With the activation of T-
lymphocytes recruitment of the major histocompatibility complex (MHC) complex supports 
the production of a new population of T-lymphocytes that provides immune memory 
(adaptive immunity). As demonstrated by Blais Lecours et al. (2014) a strong Msp. species-
specific IgG (adaptive) immune response is produced in persons suffering IBD suggesting 
that a specific antigen is sampled by macrophage and presented to T-lymphocytes. I propose 
that activation/training of the host immune response to methanogens occurs though the 
sampling of the archaeal cell wall components through the lumen by dendritic and 
macrophage cells. Dendritic and macrophage cells are spread throughout the lamina propria, 
which forms the core of the mucosa underlying the surface epithelium of the gut (Maric et al., 
1996, Cruickshank et al., 2009, Mowat and Bain, 2011). These leucocytes have been proven 
to sample the microbiota through pores connecting the basement membrane of intestinal villi 
and through the tight junctions of the gut epithelium (Takahashi-Iwanaga et al., 1999, 
Rescigno et al., 2001, Farache et al., 2013). With all this taken into account it advocates the 
idea that knowledge of what this specific “antigen” is could provide a long-term protection 
against Msp. at least. Therefore, the RAW264.7 reporter system would benefit both human 
immunological studies of methanogen immune interaction and the development of anti-
methane vaccines for livestock. Additionally I have evaluated the cytokine profile of 
peripheral blood mononuclear cells (PBMC) collected from healthy subjects after challenge 
with whole cell preparations of either Msp. stadtmanae DSMZ 3091
T
 or Mbb. smithii DSMZ 
861
T
 over a 24 hour period I would also find it interesting to examine the response of subjects 
suffering gut “dysbiosis” such as IBD or IBS. Blais Lecours et al. (2014) being the first to 
demonstrate that persons suffering IBD have a higher prevalence of Msp. as well as higher 
titres of Msp.-specific IgG antibodies. To examine the variation in immune response to Msp. 
stadtmanae DSMZ 3091
T
 challenge between subjects defined as healthy or diseased as well 
as subjects with and without a Msp. population would be enlightening in terms of the 
differences in activation of the innate and adaptive immune response. This could be evaluated 
through the use of the cytokine profiling systems developed by LEGENDplex as well as 
Indirect ELISAs to measure Mbb.- and Msp.-specific antigen responses. Unfortunately due to 
time constraints I was unable to address these studies directly, in large part due to the 
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technical difficulties encountered while using the LEGENDplex system. As described in 
Chapter 4 there were difficulties in reproducing consistent and reliable standard curves for 
4/13 cytokines assayed using the LEGENDplex system and a large portion of my time was 
dedicated to correspondents with the manufacture to trial new standard cocktails, 
consumables and improved processing techniques all with little success. With more time I 
think the LEGENDplex system can be improved to allow the rapid screening of a wide 
selection of cytokines from a range of donors and challenge scenarios. 
 
In conclusion, despite the intensification of research into the gut methanogens over the last 
decade, much still needs to be learned. Perhaps the most salient findings of my studies have 
been the metabolic versatility of gut methanogens, and that the crosstalk between 
methanogenic archaea and the host are more diverse and intimate than what was once widely 
accepted. In this thesis, I have focused on methylotrophic methanogens, Msp. spp., from two 
perspectives: the discovery of their expanded range in metabolic/genomic versatility, and the 
emerging evidence of their direct role in provoking an inflammatory and humoral response. 
In that context, I contend that the fields of ruminant microbiology and human “microbiome” 
research have something to learn from each other. Those interested in modulating the human 
gut microbiota could benefit from the experiences of rumen microbiologists, who have 
evaluated a variety of dietary interventions over many years to productively manage methane 
emissions from livestock. In a complementary manner, rumen microbiologists and animal 
scientists may benefit greatly from the growing interest in the immunomodulatory properties 
of the human methanogenic archaea, in consideration of their attempts to improve the 
efficacy and use of vaccine-based approaches to control livestock methane emissions.  
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Chapter 6  Appendix 
6.1 Western Grey kangaroo digesta sample descriptions 
Table 6.1. Description of Western Grey kangaroos sampled during a culling exercise in 2008 
by licensed hunters, as part of the state’s control procedures, on a CSIRO managed farm in 
Yallenbee (Western Australia). 
Sample Age (years) Sex Site of sample collection 
1 1 Female Sacciform 
2 2-3 Female Caecum 
3 2-3 Female Intestine 
4 3-4 Male Sacciform 
5 1-2 Female Sacciform 
6 3-4 Female Sacciform 
7 1-2 Female Sacciform 
8 2-3 Female Caecum 
9 2-3 Female Sacciform 
10 4-5 Male Tubiform 
11 4-5 Male Sacciform 
12 2-3 Female Intestine 
13 2-3 Female Tubiform 
14 2-3 Female Sacciform 
15 2-3 Female Sacciform 
16 2-3 Female Tubiform 
17 3-4 Male Tubiform 
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6.2 Glycerol 30% stock solution 
Measure the liquids into a flask and microwave to bring to a boil. Transfer to a magnetic 
stirrer and allow the solution to cool while bubbling with N2. Add dry ingredients in order, 
which should have a resulting pH of ~6.5. Add the L-cysteine and transfer solution to an 
anaerobic hood for dispensing. Seal the serum bottles containing dispensed solution with a 
rubber stopper and crimp seal. Autoclave bottles at 121ºC for 20 minutes under 172 kPa 
pressure.  
 38 mL mineral 2 solution 
o K2HPO4 6g/L 
 38 mL mineral 3 solution 
o  K2HPO4 6g/L 
o (NH4)2SO4 6g/L 
o NaCl 12g/L 
o MgSO44.7H2O 2.5g/L 
o CaCl2.2H2O 1.6g/L 
 1 mL resazurin solution (0.1%) 
 300mL glycerol “AR” grade 
 Make up to 1 L  with dH2O 
 1 g L-cysteine HCl 
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6.3 Dissociation of cells from plant material 
1. Resuspend in 0.1 vol of dissociation buffer by vortexing for 30 sec. 
2. Spin at 100 g for 20 seconds and remove supernatant to a new tube  
3. Repeat dissociation buffer step two more times placing each supernatant in the same 
tube (or until supernatant becomes clearer- ~5-6 times). 
4. Spin the collected supernatant at 100 g for 20 seconds and remove supernatant to a 
new tube and spin at 12,000 g for 5 min. remove supernatant. 
5. Resuspend in 0.1 vol of cell wash buffer and d then spin 12,000g 5 minutes remove 
supernatant. 
6. Store pellet alone in -20ºC or perform direct DNA extraction protocol. 
 
Buffers used 
Dissociation buffer saline (pH 2) 
 0.1% tween 80 
 1% methanol 
 1% tertiary butanol  
 
Cell wash buffer (pH 8.0) 
 10 mM Tris-HC1  
 1 M NaCI 
 sterilized by autoclaving 
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6.4 RBB+C DNA extraction method 
7. Resuspend in 0.1 vol of dissociation buffer by vortexing for 30 seconds. 
8. Spin at 100 g for 20 seconds and remove supernatant to a new tube  
9. Repeat dissociation buffer step two more times placing each supernatant in the same 
tube (or until supernatant becomes clearer- ~5-6 times). 
10. Spin the collected supernatant at 100 g for 20 seconds and remove supernatant to a 
new tube and spin at 12,000 g for 5 min. remove supernatant. 
11. Resuspend in 0.1 vol of cell wash buffer and d then spin 12,000g 5 minutes to remove 
supernatant. 
12. Store pellet alone in -20ºC or perform direct DNA extraction protocol. 
 
Buffers used 
Dissociation buffer saline (pH 2) 
 0.1% tween 80 
 1% methanol 
 1% tertiary butanol  
 
Cell wash buffer (pH 8.0) 
 10 mM Tris-HC1  
 1 M NaCI 
 sterilized by autoclaving 
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6.5 Primers used for during thesis 
Table 6.2. Primers used during this thesis. 
Gene target Primer Nucleotide sequence (5’-3’) Amplicon 
(bp) 
Annealing 
temp. (°C) 
Reference 
16S rRNA gene archaea 
specific 
86-F GCTCAGTAACACGTGG 1254 60 (Wright and Pimm, 
2003) 1340-R CGGTGTGTGCAAGGAG 
16S rRNA gene bacteria 
specific 
27-F AGAGTTTGATCMTGGCTCAG 1465 60 (DeLong, 1992) 
1492-R TACGGYTACCTTGTTACGACTT 
DGGE designed primers 
(inc. GC-clamp) 
344-F  
38nt GC-clamp 
TCGCGCCTGCTGCICCCCGT 
213 60 (Raskin et al., 
1994) 
519R GWATTACCGCGGCKGCTG (Lane et al., 1985) 
Alcohol dehydrogenase 
(WGK6) 
WALC-F TTCCACAAACAATGCCAAAA 219 60 This study 
WALC-R ATGCCATTCCTGCTTCACAT This study 
Aldehyde dehydrogenase 
(WGK6) 
WALD-F TTGTAAATGGGACATGGCAA 197 60 This study 
WALD-R TGATTTGTGCACCCATTTGT This study 
BMS closing  BMS B2-R ACCGTTCTGATTGTAGCCTGGT 364 60 This study 
BMS E5-F GCATGGTGAACAATGTGGTGT This study 
Universal methanogen 
(Arch) 
mcrA-F TTCGGTGGATCDCARAGRGC 140 60 (Denman et al., 
2007) mcrA-R GBARGTCGWAWCCGTAGAATCC 
Msp. stadtmanae (mtaB) 122-F CTAACATCAAAGTAGCTCC 292 55.5 (Blais Lecours et 
al., 2014) 414-R TCCTCTAAGACCGTTT 
Mbb. smithii (nifH) 202-F GAAAGCGGAGGTCCTGAA 151 57 (Johnston et al., 
2010) 353-R ACTGAAAAACCTCCGCAAAC 
Mms. spp. (mttB) mttB-F GYRCTTCMACCACATCGACC 160 60 (Poulsen et al., 
2013) mttB-R CRGCCATBGCCATGGACAG 
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6.6 DGGE denaturing solutions 
DGGE was completed using the Bio-Rad D-code System, as described by (Ouwerkerk et al., 
2008). The electrophoresis was performed within a buffer of 1x TAE for 12 hours at 75 volts 
and a constant temperature of 60
o
C. After electrophoresis the gel was stained for 20 minutes 
with SYBR safe (Invitrogen) according to the manufacturer’s instructions, and the gel images 
were captured using a Typhoon scanner and Typhoon TRIO Variable Mode Imager (GE 
Healthcare Life Sciences).  
 30% denaturing solution 
o 20 mL acrylamide/bis 
o 2 mL 50x TAE buffer 
o 12 mL formamide 
o 12.6 g urea 
o 20 mL 10% glycerol  
o Make up to 100 mL with dH2O 
o 60% denaturing solution 
 
 20mL acrylamide/bis 
o 2 mL 50x TAE buffer 
o 24 mL formamide 
o 25.2 g urea 
o 20 mL 10% glycerol 
o Make up to 100 mL with dH2O 
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6.7 BRN-RF30 media recipe  
This recipe makes 1 litre of BRN-RF30 (Joblin et al., 1990). Centrifuge the rumen fluid twice 
at 23,500 x g for 10 min. Transfer the supernatant to a heat proof 1L bottle and add the 
remaining ingredients, except for L-cysteine hydrochloride·H2O. The solution was 
microwaved for 3 minutes with a loose lid to remove oxygen. The solution was then placed 
onto a heated (75°C) magnetic stirrer, gassing with CO2 for 45 min; seal the bottle with foil 
during this step. After 45 minutes the bottle (while continuing CO2 gassing) was transferred 
to an ice bucket for 15 minutes to chill the solution to room temperature. After cooling add L-
cysteine, quickly remove the CO2 gas line and cap the bottle, mix well. Transfer solution to 
an anaerobic chamber, dispense 9 mL into Balch tubes and seal using butyl rubber stoppers. 
Remove sealed tubes from the anaerobic chamber and crimp seal with appropriate tin caps. 
Autoclave sealed tubes for 15 minutes at 121°C under 172 kPa pressure to serialise and allow 
cooling to room temperature. 
 300mL of rumen fluid 
 42.5mL mineral 2 solution 
o K2HPO4 6g/L 
 42.5mL mineral 3 solution 
o  KH2PO4 6g/L 
o (NH4)2SO4 6g/L 
o NaCl 12g/L 
o MgSO44.7H2O 2.5g/L 
o CaCl2.2H2O 1.6g/L 
 2g yeast extract 
 5g NaHCO3 
 100µl resazurin 
 615mL distilled water 
 0.5g L-cysteine hydrochloride·H2O 
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6.8 Antibiotic stock solution benzyl penicillin and streptomycin sulfate 
Benzyl penicillin and streptomycin sulfate 0.1 L
-1
 stock solution (Jarvis et al., 2000) begins 
with the mixture of salts solution A and B, sodium hydrogen carbonate, resazurin and 
distilled water. This solution was boiled for 3 minutes in the microwave and then cooled on 
ice while bubbling with CO2 for 15 min. After cooling benzyl penicillin, streptomycin sulfate 
and L-cysteine hydrochloride·H2O were added to the solution and mixed on a magnetic 
stirrer. The solution was then transferred to an anaerobic chamber and aliquots of 10 mL were 
removed and dispensed into autoclaved sterilised capped anaerobic Hungate tubes. To each 
10 mL tube of solution 0.1 mL of previously sterilised sodium sulfide solution (reducing 
agent) was added anaerobically and aseptically. Excess tubes were stored frozen at -20 °C 
until required.  
 6 g benzyl penicillin 
 2 g streptomycin sulfate 
 17 mL salt solution A 
o  KH2PO4 3 g/L 
o (NH4)2SO4 3 g/L 
o NaCl 6 g/L 
o MgSO44.7H2O 1.25 g/L 
o CaCl2.2H2O 0.8 g/L 
 17 mL salt solution B 
o K2HPO4·3H2O 3 g/L 
 10µL resazurin (0.1% solution)  
 0.5 g sodium hydrogen carbonate 
 50 mg L-cysteine hydrochloride·H2O  
 66 mL dH2O 
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6.9 Sequence cleaning protocol 
Agencourt CleanSeq (www.beckmangenomics.com) 
1. Shake CleanSeq bottle (stored at 4ºC) to resuspend magnetic particles 
2. Add 7 µ to each sequence reaction. 
3. For 20 µl sequence reaction, add 62 µl of 85% ethanol. Either pipette mix 7 times or 
seal and vortex for 30 seconds. 
4. Place reaction plate onto magnetic plate for 10 minutes to separate beads from 
solution. 
5. While leaving reaction on plate aspirate supernatant and discard. Be careful not to 
disturb the beads. It is important to remove all the supernatant at this stage. 
6. Dispense 100 µl of 85% ethanol to each well and incubate at room temperature for at 
least 30 seconds. Aspirate out supernatant and discard. 
7. Let the reaction air-dry at room temperature for 10 minutes. 
8. Take samples off plate and add 40µl of distilled water to each reaction and incubate 
for 5 minutes at room temperature to elute DNA. 
9. Place back onto magnetic plate for 5 minutes to separate. 
10. Transfer 20 µl to a new ABI plate ready to load into sequencer.  
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6.10 BRN-RF10 medium recipe 
This recipe makes 1 L of modified BRN-RF10 media (Balch et al., 1979). Centrifuge rumen 
fluid twice at 23,500 x g for 10 minutes. Transfer supernatant in to a heat proof 1 L bottle. 
Add remaining ingredients, except for L-cysteine hydrochloride·H2O and trace vitamins. 
Microwave the solution for 3 minutes with a loose lid to remove oxygen. Place heated 
mixture onto a heated (75 °C) magnetic stirrer, gassing with CO2 for 45 min. Seal the bottle 
with foil during this step. After 45 minutes the bottle (while continuing CO2 gassing) was 
transferred to an ice bucket for 15 minutes to chill the solution to room temperature. After 
cooling add L-cysteine, quickly remove the CO2 gas line and cap the bottle, mix well. 
Transfer solution to an anaerobic chamber, dispense 9 mL into Balch tubes and seal using 
butyl rubber stoppers. Remove sealed tubes from the anaerobic chamber and crimp seal with 
appropriate tin caps. Autoclave sealed tubes for 15 minutes at 121°C under 172 kPa pressure 
to serialise and allow cooling to room temperature. Once cooled add ~0.1 mL of anaerobic 
trace vitamins solution to each anaerobic tube aseptically with sterile needle and syringe.  
 100 mL of rumen fluid 
 50 mL mineral 2 solution 
o K2HPO4 6 g/L 
 50 mL mineral 3 solution 
o  KH2PO4 6 g/L 
o (NH4)2SO4 6 g/L 
o NaCl 12 g/L 
o MgSO4.7H2O 2.5 g/L 
o CaCl2.2H2O 1.6 g/L 
 10 mL trace minerals 
o Nitrilotriacetic acid 1.5 g/L 
o MgSO4·7H2O 3 g/L 
o NaCl 1 g/L 
o MnS04· H2O 0.5 g/L 
o FeSO4·7H2O 0.1 g/L 
o CoCl2·6H2O 0.1 g/L 
o ZnSO4·7H2O 0.1 g/L 
o CuSO4·5H2O 10 mg/L 
o AlK(SO4)2·12H2O 10 mg/L 
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o H3BO3 10 mg/L 
o Na2MoO4·2H2O 10 mg/L 
o NiSO4·6H2O 30 mg/L 
o Na2SeO3 20 mg/L 
o Na2WO·2H2O 20 mg/L 
o Distilled H2O 1000 mL 
 10 mL trace vitamins 
o Pyridoxine HCl (Vitamin B6) 10 mg/L 
o L-ascorbic acid (Vitamin C) 5 mg/L 
o Calcium pantothenate (pantothenic acid) 5 mg/L 
o Choline chloride 5 mg/L 
o Lipoic acid (D,L-6,8-thictic acid) 5 mg/L 
o i-Inositol (myo-inositol) 5 mg/L 
o Nicotinamide 5 mg/L 
o Nicotinic acid 5 mg/L 
o p-Aminobenzoic acid 5 mg/L 
o Pyridoxal- HCl 5 mg/L 
o Riboflavin (Vitamin B2) 5 mg/L 
o Thiamine-HCl (Vitamin B1) 5 mg/L 
o D-biotin (Vitamin H) 2 mg/L 
o Folic acid 2 mg/L 
o Vitamin B12 (cyanocobolamin) 0.1 mg/L 
o Distilled H2O 100 mL 
 5 g NaHCO3 
 2.5 g sodium acetate 
 2.5 g sodium formate 
 2 g yeast extract 
 2 g trypticase 
 100 µl resazurin 
 0.5g L-cysteine hydrochloride·H2O 
 Distilled H2O 780 mL 
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6.11 The basic annotations for both WGK6 and DSMZ 3091T 
Table 6.3. Basic genome annotations of isolate Msp. strains WGK6 and DSMZ 3091
T
 according to JGI IMG/ER. In brief summary, with the 
exception of the number of 16S rRNA genes found (1 copy in strain WGK6 c.f. 4 copies in DSMZ 3091
T
) the relative proportions of protein 
coding sequences with (and without) function predictions and/or KEGG pathway designations, are virtually identical. 
  WGK6 DSMZ 3091
T
 
  Number % of Total Number % of Total 
DNA, total number of bases 1729155 100.00% 1767403 100.00% 
        DNA coding number of bases 1475054 85.30% 1512642 85.59% 
        DNA G+C number of bases 478894 27.70% 488399 27.63% 
DNA scaffolds 37 100.00% 1 100.00% 
        CRISPR Count 3 
 
3 
 
Genes total number 1643 100.00% 1608 100.00% 
        Protein coding genes 1592 96.90% 1552 96.52% 
        RNA genes 51 3.10% 56 3.48% 
                rRNA genes 6 0.37% 12 0.75% 
                        5S rRNA 2 0.12% 4 0.25% 
                        16S rRNA 1 0.06% 4 0.25% 
                        23S rRNA 3 0.18% 4 0.25% 
                tRNA genes 43 2.62% 42 2.61% 
                Other RNA genes 2 0.12% 2 0.12% 
Protein coding genes with function prediction 1197 72.85% 1167 72.57% 
       without function prediction 395 24.04% 385 23.94% 
Protein coding genes with enzymes 499 30.37% 508 31.59% 
        w/o enzymes but with candidate KO based enzymes 73 4.44% 20 1.24% 
Protein coding genes connected to Transporter Classification 109 6.63% 105 6.53% 
Protein coding genes connected to KEGG pathways 547 33.29% 563 35.01% 
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        not connected to KEGG pathways 1045 63.60% 989 61.50% 
Protein coding genes connected to KEGG Orthology (KO) 895 54.47% 902 56.09% 
not connected to KEGG Orthology (KO) 697 42.42% 650 40.42% 
Protein coding genes connected to MetaCyc pathways 451 27.45% 461 28.67% 
          not connected to MetaCyc pathways 1141 69.45% 1091 67.85% 
Protein coding genes with COGs 1067 64.94% 1083 67.35% 
                with KOGs 345 21.00% 332 20.65% 
                with Pfam 1256 76.45% 1234 76.74% 
                with TIGRfam 554 33.72% 556 34.58% 
                with InterPro 807 49.12% 796 49.50% 
                with IMG Terms 265 16.13% 452 28.11% 
                with IMG Pathways 106 6.45% 172 10.70% 
                with IMG Parts List 96 5.84% 154 9.58% 
                in internal clusters 147 8.95% 141 8.77% 
                in Chromosomal Cassette 1587 96.59% 1560 97.01% 
Chromosomal Cassettes 205 - 214 - 
Biosynthetic Clusters 2 - 4 - 
Genes in Biosynthetic Clusters 17 1.03% 62 3.86% 
Fused Protein coding genes 34 2.07% 41 2.55% 
Protein coding genes coding signal peptides 39 2.37% 38 2.36% 
Protein coding genes coding transmembrane proteins 329 20.02% 321 19.96% 
COG clusters 878 82.29% 885 81.72% 
KOG clusters 295 27.65% 284 26.22% 
Pfam clusters 1042 82.96% 1035 83.87% 
TIGRfam clusters 539 97.29% 548 98.56% 
Internal clusters 66 
 
62 
 
 121 
 
6.12 Values and equations used to calculate Gibbs free energy 
Table 6.4. Gibbs free energy (∆G°’) equation was calculated under standard culture 
conditions; all reactants and products are at an initial concentration of 1M, pressure of 1 
ATM and temperature of 25°C (298 Kelvin) and using standard enthalpy of formation (∆H°) 
and standard entropy of formation (∆S°) values (1978, 2003). ∆G°’ was calculated using the 
following equation: ∆G°’ = (ProductMolarity1 * (Product∆H°1 – (298K * Product∆S°1)/1000) 
+ ProductMolarity
2
 * (Product∆H°2 – (298K * Product∆S°2)/1000)) – (ReactantMolarity1 * 
(Reactant∆H°1 – (298K * Rreactant∆S°1)/1000) + ReactantMolarity2 * (Reactant∆H°2 – 
(298K * Reactant∆S°2)/1000). 
 Reactants Products 
 Methanol Ethanol Hydrogen Methane Water Acetate 
Standard Enthalpy of 
formation (∆Hf
ᵒ
 kJ/mol) -239.03 -276.98 0 -74.85 -285.83 -486 
Standard Entropy of 
formation (∆Sf
ᵒ
 J/(mol.K) 127.24 161.04 130.59 186.27 69.91 85.3 
Standard GIBS formation 
@25ᵒC (∆Gf
ᵒ
 kJ/mol) -166.82 -174.18 0 -50.75 -237.18 -369 
Stoichiometry Meoh:Etoh 2 1 
 
2 1 1 
Stoichiometry Meoh:H2 1 
 
1 1 1 
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6.13 High molecular weight DNA extraction for Msp. sp. BMS 
1. Cells were removed from the spent media by centrifugation at 17,000 x g for 4 mins. 
Repeated if necessary to increase cell pellet collection (~10 mL total 0.8 OD600) 
2. The cells were washed in 1ml of cell lysis buffer and centrifuged as previously 
described. 
3. The cell pellet was resuspended in 400 µL of RBB+C lysis buffer and incubated at 75 
°C for 10 mins to inactivate nucleases. 
4. The sample was subjected to 15 rounds of 4 mins freezing on dry ice and 2 mins 
thawing at 55 °C. The sample was then left subsequently placed at room temperature 
to cool. 
5. When cooled 10 µL of lysozyme (200 mg/mL stock), 1 µL of mutanolysin (20 U/µl) 
and 5 µL of achromopeptidase (200 U/µL) was added to the cell suspension and 
mixed gently. 
6. The sample was then incubated at 37 °C for 1 hour. 
7. Following incubation 20 µL of 10% sodium laurylsarcosine (SLS) and 5 µL of 
proteinase K (20 mg/mL) were added and the sample was incubated at 55 °C for 30 
mins. 
8. The sample was extracted by gentle inversion with 400 µL of phenol:chloroform and 
then centrifuged at 17,000 x g for 5 mins. 
9. The aqueous phase was carefully removed to a clean microfuge tube while taking care 
not to disturb the interface. 
10. The sample was then further extracted repeating steps 8-9. 
11. A 0.1 volume of 3M sodium acetate (pH 5.2) was added and mixed by gentle 
inversion. 
12. Then one volume of isopropanol was added, gently mixed and left to incubate on ice 
for 30 mins. The DNA is visible as a coiled thread in the solution at high 
concentrations of extracted DNA. 
13. The sample was centrifuged at 17,000 x g for 5 mins and the supernatant carefully 
removed. 
14. The DNA pellet was washed twice by the addition of 500 µL 70% ethanol followed 
by centrifugation at 17,000 x g for 5 mins. 
15. The DNA was then allowed to air dry and the sample was resuspended in [50-100 µL] 
of TE buffer. 
16. The sample was RNase treated with 5 µL (10 mg/mL) and incubated at 37 °C. 
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17. Check quality of extraction on a 0.7% agarose gel at 80 volts for 90 mins. 
 
 Cell lysis buffer: Sterilise solution by autoclaving. 
o 6mM Tris-HCl (pH 8.0) 
o 100mM EDTA 
o 1M NaCl 
 RBB+C buffer: Sterilise solution by autoclaving. 
o 500 mM NaCl 
o 50 mM Tris-HCl, pH 8.0 
o 50 mM EDTA 
o 4% sodium dodecyl sulfate (SDS) 
 TE buffer: Sterilise solution by autoclaving. 
o 10mM Tris-HCl, 1mM EDTA.  
 
Ethanol Precipitate of DNA for PacBio sequencing 
1. Measure the volume of the DNA sample.  
2. Add 0.1 volume of sodium acetate, pH 5.2, (final concentration of 0.3 M)  
 - These amounts assume that the DNA is in TE only; if DNA is in a  solution containing salt, 
adjust salt accordingly to achieve the correct final concentration.  
3. Mix well.  
4. Add 2 to 2.5 volumes of ice cold 100% ethanol (calculated after salt addition).  
5. Mix well.  
6. Place on ice or at -20 °C for >20 mins.  
7. Centrifuge at maximal speed for 10-15 min.  
8. Carefully decant supernatant.  
9. Add 1 mL 70% ethanol. Mix. Spin briefly. Carefully decant supernatant.  
10.  Air dry or briefly vacuum dry pellet.  
11. Resuspend pellet in the appropriate volume of water. 
 
 3 M sodium acetate pH 5.2: Sterilise solution by autoclaving. 
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6.14 NCBI SRA chosen for MetaBAT 
Table 6.5. The NCBI SRA projects identified as containing amplicons specific for Msp. 
stadtmanae DSMZ 3091
T
 16S rRNA and as a result were chosen for MetaBAT population 
genome binning. 
SRA dataset  Sample source Study 
ERR260147 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR260158 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR260183 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR260195 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR260200 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR260216 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR260228 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR260234 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR260236 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
ERR275251 
Gut metagenome in European women with 
normal, impaired and diabetic glucose 
control 
(Karlsson et al., 2013) 
SRR094926 Metagenome isolated from cow gut (Hess et al., 2011) 
SRR1206671 
NZ high methane producing ovine- time 
point 1 
(Shi et al., 2014) 
SRR873595 
NZ low methane producing ovine- time point 
1 
(Shi et al., 2014) 
SRR873596 
NZ low methane producing ovine- time point 
1 
(Shi et al., 2014) 
SRR873597 
NZ low methane producing ovine- time point 
1 
(Shi et al., 2014) 
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SRR873599 
NZ low methane producing ovine- time point 
1 
(Shi et al., 2014) 
SRR873604 
NZ high methane producing ovine- time 
point 1 
(Shi et al., 2014) 
SRR873606 
NZ high methane producing ovine- time 
point 1 
(Shi et al., 2014) 
SRR873608 
NZ high methane producing ovine- time 
point 1 
(Shi et al., 2014) 
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6.15 PBMC extraction from whole blood diagram 
1. Pipette 15mL Ficoll-Paque into a 50 mL falcon tube. 
2. Dilute blood sample 1:1 with PBS-EDTA (2mM). 
3. Gently layer 35 mL of diluted cell suspension over the Ficoll, being careful not to mix 
the two layers. 
4. Spin tubes at 400 x g at 21 ºC without brake (Ficoll can burst cells if slowed abruptly 
or shaken) for 30 minutes. 
5. Aspirate top ~15 mL of plasma from each tube. 
6. Collect interface containing PBMC using a 10 mL pipette into fresh tubes, be careful 
to avoid the Ficoll. 
7. Top up (to 50 mL) freshly isolated PBMCs with PBS-EDTA. 
8. Wash at 400 x g for 5 minutes (brake on). 
9. Discard supernatant and resuspend cells by gently tapping tube.  
10. Add 50mL PBS, and wash; 400 x g for 5 minutes (brake on). Discard supernatant. 
11. Gently resuspend cells in 20 mL PBS. 
12. Take a 10L aliquot out for cell counts using a hemocytometer. 
13. Centrifuge at 400 x g for 5 minutes (brake on). 
14. Resuspend in appropriate volume of media for culture. 
 
 Culture medium:  
o RPMI medium  
o foetal bovine serum (heat-inactivated and filter sterilised, 10% vol/vol) 
o  penicillin-streptomycin L-glutamine (1% vol/vol) 
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6.16 Standard curves for LEGENDplex cytokine 
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Figure 6.1. The standard curves for each of the 13 cytokines assayed with the LEGENDplex 
kit. Due to an technical error within the kit which was unable to be resolved during 
correspondents with the manufacturer 4/13 cytokines (IFN-γ, IL-12p70, IL-17A and IL-23) 
produced standard curves which were too inconsistent for use and as a result were excluded 
from results section of Chapter 4.  
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6.17 LEGENDplex statistics  
Table 6.6. Statistics for cytokines (IL-1β, TNF-α, IL-6, IL-8, MCP-1 and IL-10) produced from the PBMC harvested from three donors 
(HMI004-006) as determined using the LEGENDplex assay, after 6, 12 and 24 hours challenge with either saline (negative control), LPS (100 
ng/mL, positive control), Msp. stadtmanae DSMZ 3091
T
 or Mbb. smithii DSMZ 861
T
. The data were analysed by one-way ANOVA and degree 
of significant differences are denoted by *. 
IL-1β Saline 
6hrs 
LPS 
6 hrs 
Msp. 
stadtmanae 
6hrs 
Mbb. 
smithii 
6hrs 
Saline 
12hrs 
LPS 
12 
hrs 
Msp. 
stadtmanae 
12 hrs 
Mbb. 
smithii 
12 hrs 
Saline 
24 hrs 
LPS 
24 
hrs 
Msp. 
stadtmanae 
24 hrs 
Mbb. 
smithii 
24 hrs 
Saline 6hrs   ns ns *** ns ns ns ** ns ns ns * 
LPS 6 hrs ns   ns ** ns ns ns ns ns ns ns ns 
Msp. stadtmanae 6hrs ns ns   ns ns ns ns ns ns ns ns ns 
Mbb. smithii 6hrs *** ** ns   *** ns ns ns *** ns ns ns 
Saline 12hrs ns ns ns ***   ns ns ** ns ns ns * 
LPS 12 hrs ns ns ns ns ns   ns ns ns ns ns ns 
Msp. stadtmanae 12 hrs ns ns ns ns ns ns   ns ns ns ns ns 
Mbb. smithii 12 hrs ** ns ns ns ** ns ns   ** ns ns ns 
Saline 24 hrs ns ns ns *** ns ns ns **   ns ns * 
LPS 24 hrs ns ns ns ns ns ns ns ns ns   ns ns 
Msp. stadtmanae 24 hrs ns ns ns ns ns ns ns ns ns ns   ns 
Mbb. smithii 24 hrs * ns ns ns * ns ns ns * ns ns   
             
             TNF-α  Saline 
6hrs 
LPS 
6 hrs 
Msp. 
stadtmanae 
6hrs 
Mbb. 
smithii 
6hrs 
Saline 
12hrs 
LPS 
12 
hrs 
Msp. 
stadtmanae 
12 hrs 
Mbb. 
smithii 
12 hrs 
Saline 
24 hrs 
LPS 
24 
hrs 
Msp. 
stadtmanae 
24 hrs 
Mbb. 
smithii 
24 hrs 
Saline 6hrs   ns *** *** ns * *** *** ns ns *** *** 
LPS 6 hrs ns   ns *** ns ns ns *** ns ns ns *** 
Msp. stadtmanae 6hrs *** ns   *** *** ns ns *** *** ns ns ** 
Mbb. smithii 6hrs *** *** ***   *** *** *** ns *** *** *** ns 
Saline 12hrs ns ns *** ***   * *** *** ns ns *** *** 
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LPS 12 hrs * ns ns *** *   ns *** * ns ns *** 
Msp. stadtmanae 12 hrs *** ns ns *** *** ns   *** *** ns ns ** 
Mbb. smithii 12 hrs *** *** *** ns *** *** ***   *** *** *** ns 
Saline 24 hrs ns ns *** *** ns * *** ***   ns *** *** 
LPS 24 hrs ns ns ns *** ns ns ns *** ns   ns *** 
Msp. stadtmanae 24 hrs *** ns ns *** *** ns ns *** *** ns   ** 
Mbb. smithii 24 hrs *** *** ** ns *** *** ** ns *** *** **   
             
             IL-6 Saline 
6hrs 
LPS 
6 hrs 
Msp. 
stadtmanae 
6hrs 
Mbb. 
smithii 
6hrs 
Saline 
12hrs 
LPS 
12 
hrs 
Msp. 
stadtmanae 
12 hrs 
Mbb. 
smithii 
12 hrs 
Saline 
24 hrs 
LPS 
24 
hrs 
Msp. 
stadtmanae 
24 hrs 
Mbb. 
smithii 
24 hrs 
Saline 6hrs   ns ns ns ns ** ns ns ns *** ns ** 
LPS 6 hrs ns   ns ns ns ns ns ns ns ** ns ns 
Msp. stadtmanae 6hrs ns ns   ns ns ** ns ns ns *** ns ** 
Mbb. smithii 6hrs ns ns ns   ns ns ns ns ns *** ns ns 
Saline 12hrs ns ns ns ns   ** ns ns ns *** ns ** 
LPS 12 hrs ** ns ** ns **   ** ns ** ns * ns 
Msp. stadtmanae 12 hrs ns ns ns ns ns **   ns ns *** ns * 
Mbb. smithii 12 hrs ns ns ns ns ns ns ns   ns ** ns ns 
Saline 24 hrs ns ns ns ns ns ** ns ns   *** ns ** 
LPS 24 hrs *** ** *** *** *** ns *** ** ***   *** ns 
Msp. stadtmanae 24 hrs ns ns ns ns ns * ns ns ns ***   ns 
Mbb. smithii 24 hrs ** ns ** ns ** ns * ns ** ns ns   
             
             IL-8 Saline 
6hrs 
LPS 
6 hrs 
Msp. 
stadtmanae 
6hrs 
Mbb. 
smithii 
6hrs 
Saline 
12hrs 
LPS 
12 
hrs 
Msp. 
stadtmanae 
12 hrs 
Mbb. 
smithii 
12 hrs 
Saline 
24 hrs 
LPS 
24 
hrs 
Msp. 
stadtmanae 
24 hrs 
Mbb. 
smithii 
24 hrs 
Saline 6hrs   ns ns ns ns ns ns ns ns *** ** *** 
LPS 6 hrs ns   ns ns ns ns ns ns ns ** ns *** 
Msp. stadtmanae 6hrs ns ns   ns ns ns ns ns ns ** * *** 
Mbb. smithii 6hrs ns ns ns   ns ns ns ns ns * ns *** 
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Saline 12hrs ns ns ns ns   ns ns ns ns *** * *** 
LPS 12 hrs ns ns ns ns ns   ns ns ns ns ns ** 
Msp. stadtmanae 12 hrs ns ns ns ns ns ns   ns ns * ns *** 
Mbb. smithii 12 hrs ns ns ns ns ns ns ns   ns ns ns * 
Saline 24 hrs ns ns ns ns ns ns ns ns   ** * *** 
LPS 24 hrs *** ** ** * *** ns * ns **   ns ns 
Msp. stadtmanae 24 hrs ** ns * ns * ns ns ns * ns   ns 
Mbb. smithii 24 hrs *** *** *** *** *** ** *** * *** ns ns   
             
             MCP-1 Saline 
6hrs 
LPS 
6 hrs 
Msp. 
stadtmanae 
6hrs 
Mbb. 
smithii 
6hrs 
Saline 
12hrs 
LPS 
12 
hrs 
Msp. 
stadtmanae 
12 hrs 
Mbb. 
smithii 
12 hrs 
Saline 
24 hrs 
LPS 
24 
hrs 
Msp. 
stadtmanae 
24 hrs 
Mbb. 
smithii 
24 hrs 
Saline 6hrs   ns ns ns ns ** ns ns ns *** ns ns 
LPS 6 hrs ns   ns ns ns ns ns ns ns *** ns ns 
Msp. stadtmanae 6hrs ns ns   ns ns *** ns ns * *** ns * 
Mbb. smithii 6hrs ns ns ns   ns ** ns ns ns *** ns ns 
Saline 12hrs ns ns ns ns   ns ns ns ns *** ns ns 
LPS 12 hrs ** ns *** ** ns   *** ** ns ** *** ns 
Msp. stadtmanae 12 hrs ns ns ns ns ns ***   ns * *** ns * 
Mbb. smithii 12 hrs ns ns ns ns ns ** ns   ns *** ns ns 
Saline 24 hrs ns ns * ns ns ns * ns   *** ns ns 
LPS 24 hrs *** *** *** *** *** ** *** *** ***   *** *** 
Msp. stadtmanae 24 hrs ns ns ns ns ns *** ns ns ns ***   ns 
Mbb. smithii 24 hrs ns ns * ns ns ns * ns ns *** ns   
             
             IL-10 Saline 
6hrs 
LPS 
6 hrs 
Msp. 
stadtmanae 
6hrs 
Mbb. 
smithii 
6hrs 
Saline 
12hrs 
LPS 
12 
hrs 
Msp. 
stadtmanae 
12 hrs 
Mbb. 
smithii 
12 hrs 
Saline 
24 hrs 
LPS 
24 
hrs 
Msp. 
stadtmanae 
24 hrs 
Mbb. 
smithii 
24 hrs 
Saline 6hrs   ns ns ns ns * ns * ns *** ** ** 
LPS 6 hrs ns   ns ns ns ns ns ns ns *** * * 
Msp. stadtmanae 6hrs ns ns   ns ns ns ns ns ns *** * * 
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Mbb. smithii 6hrs ns ns ns   ns ns ns ns ns *** * * 
Saline 12hrs ns ns ns ns   * ns * ns *** ** ** 
LPS 12 hrs * ns ns ns *   ns ns * * ns ns 
Msp. stadtmanae 12 hrs ns ns ns ns ns ns   ns ns ** ns ns 
Mbb. smithii 12 hrs * ns ns ns * ns ns   * * ns ns 
Saline 24 hrs ns ns ns ns ns * ns *   *** ** ** 
LPS 24 hrs *** *** *** *** *** * ** * ***   ns ns 
Msp. stadtmanae 24 hrs ** * * * ** ns ns ns ** ns   ns 
Mbb. smithii 24 hrs ** * * * ** ns ns ns ** ns ns   
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